data_1rq6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1rq6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.6 t . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.763 0.316 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -64.37 -36.12 83.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.064 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.8 t -66.3 -36.59 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.435 0.636 . . . . 0.0 109.721 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -66.39 -33.94 76.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.529 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 11' ' ' ARG . 33.6 ttt180 -66.75 -41.61 87.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.412 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.62 -40.26 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.345 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -60.54 -47.03 87.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.391 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 27.0 mmmt -56.63 -50.01 73.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.157 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.31 -39.01 78.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.808 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.571 ' SD ' HG11 ' A' ' 35' ' ' VAL . 37.6 ttm -69.82 -45.64 67.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.442 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.603 HG23 HD21 ' A' ' 34' ' ' LEU . 63.8 mt -75.38 -49.75 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.908 0.385 . . . . 0.0 111.481 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 1.7 tp10 -65.61 -8.89 22.58 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -169.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.474 HG22 ' CD1' ' A' ' 38' ' ' PHE . 5.9 t -76.69 -17.32 59.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.273 0.559 . . . . 0.0 109.808 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 18.1 t-160 -142.51 109.08 5.67 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 20' ' ' HIS . 20.7 Cg_exo . . . . . 0 CA--C 1.536 0.622 0 C-N-CA 123.704 2.936 . . . . 0.0 114.161 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -131.62 144.34 50.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -67.42 -36.18 80.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.389 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.506 ' O ' ' HD3' ' A' ' 33' ' ' LYS . 17.0 t70 -65.69 -39.56 91.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.104 0.478 . . . . 0.0 110.173 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 m -61.22 -52.07 66.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.853 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.438 ' O ' HG21 ' A' ' 35' ' ' VAL . 78.3 m-20 -65.06 -32.39 74.09 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.734 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 64.0 tttm -58.93 -53.83 53.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.353 176.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HD3' ' O ' ' A' ' 29' ' ' ASP . 1.2 mptm? -66.48 -36.27 82.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.919 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.603 HD21 HG23 ' A' ' 17' ' ' ILE . 43.4 tp -57.82 -40.63 80.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.609 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.571 HG11 ' SD ' ' A' ' 16' ' ' MET . 76.9 t -69.75 -46.31 74.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.907 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 43.4 mt-10 -70.99 -25.3 62.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -171.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.52 -15.42 58.62 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.117 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.521 ' HD2' ' HG3' ' A' ' 16' ' ' MET . 65.5 t80 -113.83 -80.47 0.59 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.5 m 63.84 103.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.7 0.625 . . . . 0.0 112.143 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 121.951 0.882 . . . . 0.0 109.589 176.38 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -78.78 -12.34 60.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.96 0.41 . . . . 0.0 110.841 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.516 HD11 ' HD2' ' A' ' 49' ' ' LYS . 38.7 tp -74.31 -21.75 59.58 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HG3' HG13 ' A' ' 35' ' ' VAL . 73.7 ttp85 -59.92 -30.25 68.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.586 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.69 -44.23 97.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.369 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HD2' HD11 ' A' ' 46' ' ' LEU . 68.1 mttm -67.62 -34.26 76.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.331 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.526 ' O ' HG13 ' A' ' 54' ' ' ILE . 50.5 mm -65.35 -49.48 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.524 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.05 97.3 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.89 -33.97 81.12 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.771 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 11.5 t80 -63.23 -45.94 89.29 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.502 0.321 . . . . 0.0 110.54 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.544 HG12 HD11 ' A' ' 17' ' ' ILE . 36.2 mt -58.9 -56.64 15.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.169 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -49.69 -40.24 39.42 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.677 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.09 -48.05 75.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.993 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.2 mt -59.21 -43.4 89.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 110.623 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.59 -48.99 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.73 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 p -65.31 -31.22 72.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -84.95 -18.53 34.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.875 0.369 . . . . 0.0 111.408 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.37 -37.76 65.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.242 -177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 65.0 tttp . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.764 -177.716 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 m . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -63.68 -43.53 96.42 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 122.298 -0.251 . . . . 0.0 111.307 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.52 -48.49 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.261 0.553 . . . . 0.0 110.628 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -64.12 -30.78 71.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.633 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.705 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -63.2 -52.98 60.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.51 177.087 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 74.5 mt -57.59 -44.41 85.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.809 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.71 -49.16 71.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.169 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -65.2 -44.24 89.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -62.36 -39.03 91.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.906 0.384 . . . . 0.0 110.53 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.495 ' SD ' ' HB2' ' A' ' 38' ' ' PHE . 27.2 tpp -55.97 -47.81 76.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.438 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.514 HD13 HG21 ' A' ' 54' ' ' ILE . 56.1 mt -76.86 -51.92 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.706 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.86 -25.92 67.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -168.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 p -61.29 -22.94 65.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 111.109 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -143.67 90.14 7.16 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.57 0.7 . . . . 0.0 109.324 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 C--O 1.232 0.216 0 C-N-CA 122.975 2.45 . . . . 0.0 113.223 -172.443 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.83 0.824 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -137.12 157.29 47.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.47 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.72 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 94.2 m-85 -62.22 -28.54 69.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.474 -176.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.58 -45.21 94.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.632 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.5 m -65.94 -51.57 57.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.883 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.72 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.4 p-10 -65.35 -28.92 69.63 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.978 -177.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -60.79 -49.23 78.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 109.88 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -63.65 -34.85 78.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.992 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.477 HD12 HG12 ' A' ' 17' ' ' ILE . 97.4 mt -68.17 -44.4 76.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.235 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.525 HG11 ' HG3' ' A' ' 47' ' ' ARG . 56.3 t -77.12 -43.75 31.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.504 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.53 -22.15 61.24 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 111.833 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' A' ' 37' ' ' GLU . 3.1 tp10 -65.63 -39.88 91.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.673 -174.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.495 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 81.8 m-85 -124.79 -52.14 1.69 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.6 t -49.47 110.95 0.43 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.229 0.538 . . . . 0.0 111.716 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 121.646 0.736 . . . . 0.0 110.029 179.073 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -129.23 3.45 5.19 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.233 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -71.69 -42.46 67.4 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.624 0.726 . . . . 0.0 109.169 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.525 ' HG3' HG11 ' A' ' 35' ' ' VAL . 18.9 ttt-85 -66.62 -36.98 83.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.86 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.62 -39.99 90.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.618 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -62.18 -47.24 85.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.966 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.46 ' O ' HG12 ' A' ' 54' ' ' ILE . 69.4 mt -61.64 -41.67 91.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.547 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.17 77.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.315 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.07 93.11 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.887 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -68.55 -30.31 69.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.557 ' O ' HG13 ' A' ' 58' ' ' ILE . 40.8 mm -60.29 -50.31 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.892 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -33.02 71.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.882 0.372 . . . . 0.0 110.914 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 -64.46 -48.68 74.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.376 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 54' ' ' ILE . 14.3 tt -69.02 -26.85 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 110.784 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 54' ' ' ILE . 78.8 mt -65.12 -47.75 86.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 174.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.2 p -66.35 -16.49 64.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.828 0.347 . . . . 0.0 111.112 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -76.02 -33.92 59.67 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.909 0.385 . . . . 0.0 110.249 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -76.33 -45.53 31.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.944 0.402 . . . . 0.0 110.4 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 tptm . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.505 -177.697 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.478 ' O ' HG13 ' A' ' 12' ' ' ILE . 64.4 m-85 -61.97 -58.25 8.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.71 -37.22 79.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.25 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -61.85 -42.61 99.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.64 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 8.1 tmm_? -68.39 -40.74 81.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.463 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 8' ' ' PHE . 86.0 mt -58.78 -45.59 91.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.016 0.436 . . . . 0.0 110.132 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.528 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -62.84 -43.63 98.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.42 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.448 ' HZ1' ' CD ' ' A' ' 18' ' ' GLU . 13.7 tmtt? -56.97 -43.39 81.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.452 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 11' ' ' ARG . 49.0 mt-10 -61.33 -41.43 97.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.982 0.42 . . . . 0.0 110.706 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.531 ' SD ' ' HA ' ' A' ' 35' ' ' VAL . 31.8 ttp -70.26 -48.52 56.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.437 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 13' ' ' ALA . 74.6 mt -58.47 -44.82 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.126 0.489 . . . . 0.0 111.441 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.448 ' CD ' ' HZ1' ' A' ' 14' ' ' LYS . 24.8 tt0 -65.94 -4.18 6.54 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.154 -172.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -77.66 -20.77 53.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.044 0.449 . . . . 0.0 110.416 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -140.44 84.83 13.81 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.487 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.462 -0.332 0 C-N-CA 122.483 2.122 . . . . 0.0 112.136 177.666 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 122.276 1.036 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -133.79 168.29 19.0 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.729 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -77.93 -18.6 55.9 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.905 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.89 -38.27 88.3 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 167.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.627 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 6.4 m -60.72 -62.06 2.13 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.814 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.693 ' O ' HG22 ' A' ' 35' ' ' VAL . 23.1 p30 -65.17 -49.25 70.55 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -173.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -55.5 -46.17 77.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 111.183 -176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -71.37 -27.84 63.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.016 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 30' ' ' THR . 64.5 mt -76.66 -32.57 58.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.979 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 31' ' ' ASN . 32.8 t -66.38 -34.12 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.261 0.553 . . . . 0.0 110.177 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.56 -12.24 61.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.386 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.99 -61.33 2.02 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.606 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.489 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 0.3 OUTLIER -97.92 -157.79 0.62 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.876 -171.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.2 t -90.47 126.1 35.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -168.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.812 169.399 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -115.81 -16.04 11.23 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.432 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.98 -23.66 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 166.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.527 ' HG2' HG13 ' A' ' 35' ' ' VAL . 6.2 ttt180 -50.84 -38.93 51.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.175 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.86 -39.0 93.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.763 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.443 ' O ' ' HD1' ' A' ' 53' ' ' TYR . 58.5 mttp -67.18 -40.37 86.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.144 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 54' ' ' ILE . 65.7 mt -60.08 -40.89 84.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.371 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.05 -40.1 84.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.667 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.23 -46.68 93.81 Favored Glycine 0 C--O 1.239 0.458 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.952 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.443 ' HD1' ' O ' ' A' ' 49' ' ' LYS . 57.4 m-85 -55.54 -43.72 76.04 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 176.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.522 HD11 ' HE2' ' A' ' 16' ' ' MET . 52.9 mt -53.61 -55.32 13.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 O-C-N 123.432 0.457 . . . . 0.0 111.758 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -48.34 57.34 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 111.55 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -67.68 -42.32 82.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.377 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 53' ' ' TYR . 84.1 mt -61.04 -43.46 96.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.745 0.307 . . . . 0.0 110.391 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.6 mt -62.7 -42.04 94.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.323 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.4 p -65.18 -24.68 67.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.019 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -85.83 -28.25 24.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.029 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -84.73 -35.46 22.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.517 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.672 -178.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.535 0.373 0 CA-C-O 121.431 0.634 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.494 ' O ' HG13 ' A' ' 12' ' ' ILE . 52.8 t80 -57.54 -43.45 84.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.849 176.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.38 -28.66 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 121.055 0.455 . . . . 0.0 110.518 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -70.12 -37.93 75.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.592 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -64.82 -43.71 92.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.166 174.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 8' ' ' PHE . 74.2 mt -54.93 -48.53 74.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.285 176.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.98 91.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.098 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -65.58 -49.79 67.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.75 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.04 -20.23 63.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.023 0.44 . . . . 0.0 110.838 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.413 ' SD ' HG22 ' A' ' 35' ' ' VAL . 51.2 ttm -70.58 -48.44 55.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.552 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.5 mt -75.08 -27.66 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 0.0 110.303 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 73.84 -59.39 0.56 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.959 0.904 . . . . 0.0 111.954 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 14.0 t -142.16 -170.04 3.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -175.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -89.53 108.53 25.59 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 19' ' ' THR . 92.3 Cg_endo . . . . . 0 N--CA 1.457 -0.634 0 C-N-CA 122.695 2.263 . . . . 0.0 112.615 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.466 0.346 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 29' ' ' ASP . 12.4 t70 -75.66 136.35 40.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.448 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 70.4 m-85 -64.35 -21.76 66.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.413 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 2.1 t70 -64.29 -30.85 71.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.327 0.584 . . . . 0.0 110.368 175.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.3 m -65.14 -61.73 1.97 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.156 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.538 ' O ' HG21 ' A' ' 35' ' ' VAL . 2.6 p-10 -64.23 -28.52 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 -178.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.9 -42.79 98.71 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.61 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -73.18 -27.5 61.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.973 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.8 mt -68.12 -47.19 68.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.371 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 31' ' ' ASN . 89.2 t -55.3 -57.56 7.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -64.99 -28.12 69.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.755 -173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.46 -48.4 67.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.922 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -85.55 -73.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.107 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 t -140.19 108.7 5.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.252 -173.707 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.0 tptp . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.729 0.299 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -154.86 21.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.77 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.3 tp -65.77 -29.48 69.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -54.29 -34.11 60.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.072 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -66.4 -35.38 80.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.768 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -69.19 -41.3 77.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.182 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 54' ' ' ILE . 57.2 mt -63.41 -47.92 89.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.046 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.465 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . . . -60.53 -44.41 96.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.174 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -63.01 -34.21 89.34 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.075 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.497 ' O ' HG13 ' A' ' 57' ' ' ILE . 34.9 t80 -67.04 -37.78 84.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 50' ' ' ILE . 75.0 mt -56.85 -50.03 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.489 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -53.12 -43.23 66.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.978 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.546 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 96.9 mtt180 -64.0 -41.71 97.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.395 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 53' ' ' TYR . 79.9 mt -59.17 -40.8 81.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.706 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 54' ' ' ILE . 76.2 mt -57.36 -43.13 81.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.072 0.463 . . . . 0.0 110.548 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.7 t -65.8 -29.47 69.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.974 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 72.5 mt-30 -82.18 -30.7 30.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.992 0.425 . . . . 0.0 110.556 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -64.77 -62.33 1.64 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.464 -171.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.238 -177.896 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.888 0.375 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.459 ' O ' HG13 ' A' ' 12' ' ' ILE . 9.1 m-85 -64.24 -65.74 0.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.229 0.538 . . . . 0.0 110.736 -176.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.436 ' HA ' HD11 ' A' ' 12' ' ' ILE . 40.0 t -65.57 -32.25 57.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.586 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.58 -43.46 97.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.836 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -74.04 -26.39 60.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.663 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 8' ' ' PHE . 75.0 mt -60.44 -43.27 93.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.879 0.371 . . . . 0.0 110.211 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.44 84.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.373 176.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.483 ' C ' ' HD3' ' A' ' 14' ' ' LYS . 12.0 tmtt? -61.12 -41.95 97.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.349 176.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -70.35 -27.14 64.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.184 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.472 ' HE3' HG13 ' A' ' 35' ' ' VAL . 42.7 ttm -70.17 -52.23 25.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.105 0.479 . . . . 0.0 110.538 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 mt -77.38 -1.37 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.074 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.406 ' O ' ' HB ' ' A' ' 19' ' ' THR . 14.1 tp10 -58.8 126.46 27.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.861 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 18' ' ' GLU . 93.1 m 76.62 -54.5 0.58 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.525 173.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 82.6 t60 -138.73 103.02 7.66 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.191 -176.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 20' ' ' HIS . 45.9 Cg_endo . . . . . 0 N--CA 1.46 -0.484 0 C-N-CA 122.326 2.017 . . . . 0.0 110.77 170.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 122.062 0.934 . . . . 0.0 111.778 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.67 132.89 33.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.906 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.631 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 70.5 m-85 -61.5 -19.39 62.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -172.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 18.1 t0 -63.77 -45.45 89.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.084 0.469 . . . . 0.0 109.763 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.574 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 96.8 m -65.31 -56.25 13.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.844 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.679 HD21 ' HB1' ' A' ' 51' ' ' ALA . 2.9 p-10 -61.94 -41.93 98.53 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -70.52 -31.29 68.32 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.462 -179.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.462 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 33.5 ttmt -74.83 -28.19 60.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.612 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 30' ' ' THR . 84.2 mt -67.32 -49.54 63.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.119 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.508 ' HB ' ' HG3' ' A' ' 47' ' ' ARG . 14.9 t -63.07 -26.62 41.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.129 0.49 . . . . 0.0 110.447 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -64.11 -16.47 61.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.569 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -156.68 53.51 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.485 0.659 . . . . 0.0 111.11 -173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.491 ' HE2' HD22 ' A' ' 34' ' ' LEU . 12.8 m-85 -148.55 -89.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.342 172.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.0 m -87.4 58.2 4.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 0.0 110.087 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.449 -0.514 0 CA-C-O 121.362 0.601 . . . . 0.0 110.922 -176.358 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.3 mttt . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.802 0.334 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -84.45 -13.87 50.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.027 0.442 . . . . 0.0 110.053 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.93 -27.48 66.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.824 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HG3' ' HB ' ' A' ' 35' ' ' VAL . 42.1 ttp180 -56.62 -35.04 67.84 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.559 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -65.63 -45.62 82.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.257 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.34 -45.17 48.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.545 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 54' ' ' ILE . 76.1 mt -61.65 -41.25 89.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.799 0.333 . . . . 0.0 110.535 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.679 ' HB1' HD21 ' A' ' 31' ' ' ASN . . . -60.13 -41.5 92.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.239 176.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.49 -42.63 99.14 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.985 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.445 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.2 m-85 -58.32 -42.87 87.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.009 -0.096 . . . . 0.0 110.898 176.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 50' ' ' ILE . 62.5 mt -55.92 -53.53 37.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.112 0.257 . . . . 0.0 110.769 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -40.32 73.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.641 0.257 . . . . 0.0 111.531 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -65.91 -41.86 90.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.945 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 53' ' ' TYR . 76.1 mt -65.84 -45.54 91.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.727 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.518 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 86.5 mt -58.11 -49.89 80.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.569 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.9 t -65.19 -29.03 69.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.38 -29.32 65.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.048 0.451 . . . . 0.0 110.23 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.867 HE21 ' HA ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -83.95 -30.92 25.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.309 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 17.8 ptpt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.948 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 120.677 0.275 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -64.8 -38.6 91.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.141 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.74 -50.93 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.815 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -61.68 -42.29 98.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.095 0.474 . . . . 0.0 110.473 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -58.77 -55.12 39.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.493 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.08 -42.42 94.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.545 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -61.31 -42.52 98.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -59.14 -48.48 81.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.953 0.406 . . . . 0.0 110.701 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.69 -25.81 64.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.261 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.9 ttm -72.13 -40.42 68.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.798 0.332 . . . . 0.0 110.932 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 13' ' ' ALA . 50.5 mm -66.0 -46.99 86.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.09 161.92 20.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.953 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.5 m 72.53 -57.37 0.63 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.399 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -129.08 78.08 76.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.858 0.361 . . . . 0.0 110.929 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 N--CA 1.463 -0.315 0 C-N-CA 123.09 2.527 . . . . 0.0 112.887 -177.087 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 120.82 0.343 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -71.43 127.9 34.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.865 0.364 . . . . 0.0 111.228 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -62.78 -41.34 99.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.408 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.18 -38.17 89.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.123 0.487 . . . . 0.0 110.317 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 54.5 m -62.4 -45.88 91.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.91 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.558 ' O ' HG23 ' A' ' 35' ' ' VAL . 77.0 m-20 -65.02 -37.28 87.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.506 176.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -60.12 -39.5 86.48 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.07 0.462 . . . . 0.0 110.478 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' THR . 6.8 tmtm? -56.07 -43.04 77.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.171 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.0 mp -73.61 -31.74 63.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.571 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 31' ' ' ASN . 59.4 t -66.99 -32.23 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 109.975 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.5 -45.87 92.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.061 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -70.36 -52.18 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.304 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -110.99 -141.94 0.38 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.563 -172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t 71.4 174.02 0.3 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.308 0.643 . . . . 0.0 109.701 -172.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 m . . . . . 0 C--N 1.322 -0.623 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.024 -177.849 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.3 mttp . . . . . 0 CA--C 1.528 0.123 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -95.64 -21.99 17.86 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.721 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.9 tp -70.88 -27.57 63.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.86 0.362 . . . . 0.0 110.245 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 ttm-85 -55.14 -41.39 71.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.518 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.06 -40.0 95.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.666 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -64.55 -46.93 80.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.851 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.541 ' O ' HG13 ' A' ' 54' ' ' ILE . 64.4 mt -61.77 -43.07 96.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.438 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.28 94.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.764 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.49 -37.28 92.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.182 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -60.05 -46.6 89.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.71 0.29 . . . . 0.0 110.515 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 50' ' ' ILE . 34.7 mt -60.89 -50.74 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.425 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 m -47.18 -44.13 21.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.561 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.586 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 13.1 ttm180 -61.08 -45.82 93.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.966 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.2 mt -56.81 -41.02 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.433 . . . . 0.0 110.383 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.3 mt -59.58 -49.94 81.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.82 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.1 p -65.69 -16.63 63.94 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.82 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 84.3 mm-40 -85.11 -40.09 17.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.029 0.442 . . . . 0.0 110.522 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -81.75 -33.54 30.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.711 -176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.5 mptt . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.167 175.506 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.528 0.124 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -57.85 -39.99 79.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.082 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.06 -44.11 78.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.975 0.416 . . . . 0.0 110.662 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.14 -28.75 67.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.416 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 37.0 ttt180 -61.82 -52.87 62.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.523 175.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.432 HG21 ' HE3' ' A' ' 16' ' ' MET . 63.5 mt -58.05 -37.73 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 0.0 110.455 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.41 -46.75 88.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.256 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 15' ' ' GLU . 36.4 pttt -69.09 -33.87 74.21 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.72 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 35.1 mt-10 -70.25 -23.05 62.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.142 0.496 . . . . 0.0 110.476 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.952 ' HB3' ' HB3' ' A' ' 38' ' ' PHE . 67.5 mtt -70.78 -48.85 52.1 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 169.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 69.6 mt -65.47 -31.6 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.271 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 10.5 pt-20 -60.89 -15.71 33.79 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -175.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.4 p -74.33 -26.76 60.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.936 0.398 . . . . 0.0 111.053 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.602 ' HB3' ' HE1' ' A' ' 38' ' ' PHE . 17.7 t-160 -148.77 89.41 5.01 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.213 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 CA--C 1.53 0.287 0 C-N-CA 123.641 2.894 . . . . 0.0 112.39 -178.738 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 122.032 0.92 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.31 143.25 46.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.654 -173.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.671 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 73.4 m-85 -74.03 -33.7 63.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.76 -173.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.67 -36.23 83.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.422 0.629 . . . . 0.0 109.649 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.539 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 96.4 m -61.72 -58.98 5.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.269 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.671 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.5 p-10 -63.69 -28.68 70.07 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.753 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -56.68 -54.18 49.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.179 0.514 . . . . 0.0 110.142 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -70.66 -27.27 63.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.864 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 30' ' ' THR . 69.8 mt -64.97 -51.05 63.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.761 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 31' ' ' ASN . 66.6 t -60.54 -33.09 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 110.528 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -59.25 -37.95 78.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.418 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.29 -53.82 6.02 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.19 0.519 . . . . 0.0 110.793 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.952 ' HB3' ' HB3' ' A' ' 16' ' ' MET . 14.2 m-30 -67.13 106.0 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.118 -173.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 p -144.35 98.49 3.21 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.335 0.588 . . . . 0.0 111.571 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 51.9 m . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.403 173.003 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.2 tptt . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.926 0.393 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -101.55 -25.7 13.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -68.72 -14.58 63.11 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.356 177.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 47' ' ' ARG . 43.7 ttp180 -59.21 -34.41 72.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.442 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -63.75 -43.87 95.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.411 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HB2' HD12 ' A' ' 46' ' ' LEU . 62.1 mttp -66.4 -43.74 85.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.549 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.482 ' O ' HG13 ' A' ' 54' ' ' ILE . 42.6 mm -57.46 -46.39 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.375 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.454 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . . . -57.45 -47.5 81.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.866 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.46 -35.41 91.92 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.323 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.446 ' O ' HG13 ' A' ' 57' ' ' ILE . 7.8 m-85 -71.37 -33.16 69.29 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.743 -0.269 . . . . 0.0 111.384 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 50' ' ' ILE . 58.4 mt -60.21 -49.3 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.511 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.82 -32.07 70.31 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.558 0.218 . . . . 0.0 111.348 175.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -70.07 -39.56 75.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.615 0.245 . . . . 0.0 110.988 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 53' ' ' TYR . 82.3 mt -64.03 -45.46 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.17 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.05 -38.19 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.995 0.426 . . . . 0.0 110.149 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -65.33 -30.88 71.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.799 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -73.49 -34.35 65.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 110.173 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -81.22 -6.45 58.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.634 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.169 -176.423 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.917 0.865 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.486 ' HA ' ' HB3' ' A' ' 11' ' ' ARG . 80.3 m-85 -71.21 -11.78 61.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.314 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.909 HG11 HD13 ' A' ' 50' ' ' ILE . 93.4 t -69.05 -38.84 78.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 173.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -66.19 -39.06 89.42 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 17.5 tpt180 -56.19 -51.95 66.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.808 173.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 8' ' ' PHE . 45.5 mm -65.87 -44.66 92.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.268 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.35 98.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.739 0.305 . . . . 0.0 111.222 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -61.03 -51.08 70.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.06 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.17 -23.08 61.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.531 ' HG3' ' HB2' ' A' ' 38' ' ' PHE . 49.0 ttm -68.65 -52.44 31.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.317 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.469 HG12 HD21 ' A' ' 34' ' ' LEU . 57.2 mt -75.81 -25.2 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.864 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 61.94 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.256 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 m -153.04 11.96 0.48 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.341 0.591 . . . . 0.0 109.43 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -144.63 101.8 4.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.413 -172.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo . . . . . 0 N--CA 1.461 -0.432 0 C-N-CA 122.87 2.38 . . . . 0.0 112.487 -179.829 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.97 0.891 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.05 148.37 46.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.729 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -71.82 -28.95 63.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.78 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.2 -37.39 85.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.144 0.497 . . . . 0.0 109.779 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.6 m -59.1 -48.76 80.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.406 173.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.39 -53.68 50.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.278 174.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -49.86 -55.21 15.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.521 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 59.4 tttm -65.09 -39.58 93.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.329 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.469 HD21 HG12 ' A' ' 17' ' ' ILE . 9.2 mp -71.76 -44.64 63.72 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.273 -0.171 . . . . 0.0 111.395 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 39' ' ' SER . 84.6 t -60.94 -50.56 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.83 0.348 . . . . 0.0 110.475 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -73.97 -7.76 53.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.647 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.588 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 5.1 tp10 -80.53 -47.39 14.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.058 0.456 . . . . 0.0 110.059 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.531 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 83.0 m-85 -110.52 -90.22 0.48 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.676 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.589 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 21.4 t 57.16 -169.37 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.509 0.671 . . . . 0.0 112.012 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.247 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.4 mttt . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.74 0.305 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.473 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 16.0 t-160 -67.32 -25.92 66.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.814 -175.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 tt -77.25 -41.52 40.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -59.34 -39.46 83.25 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.459 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -58.09 -37.33 74.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.266 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 45' ' ' HIS . 28.1 mmmt -70.15 -49.69 48.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.909 HD13 HG11 ' A' ' 9' ' ' VAL . 41.9 mm -61.71 -53.49 47.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.174 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.43 77.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.178 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -59.14 -45.32 95.49 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.113 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.479 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.9 m-85 -71.68 -37.19 70.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 50' ' ' ILE . 64.3 mt -57.71 -55.9 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.316 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 m -50.67 -44.73 57.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.055 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 98.3 mtt180 -58.82 -51.69 68.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.02 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 53' ' ' TYR . 78.8 mt -57.05 -47.11 84.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.622 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.37 -34.32 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.993 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.0 m -64.59 -40.28 95.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.775 0.322 . . . . 0.0 110.754 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -77.45 -28.34 52.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.059 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -85.18 2.67 42.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 0.0 111.0 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 62' ' ' LYS . 13.2 tppt? . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.859 -0.591 . . . . 0.0 109.426 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.235 0.317 0 CA-C-O 121.28 0.562 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.406 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.5 m-85 -57.97 -37.2 73.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.519 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.1 t -64.39 -37.94 81.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.567 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -60.03 -46.78 88.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.6 ttm-85 -64.64 -41.84 95.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.385 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 8' ' ' PHE . 77.3 mt -63.36 -44.13 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.414 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.87 -44.06 90.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.944 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -58.63 -49.86 75.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.255 0.55 . . . . 0.0 110.696 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.2 -26.77 65.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.702 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.5 ' O ' HG23 ' A' ' 19' ' ' THR . 37.2 tpp -70.36 -39.71 74.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.633 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 13' ' ' ALA . 87.3 mt -74.88 -42.12 46.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.276 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.21 -10.08 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 16' ' ' MET . 15.0 t -80.14 -27.51 39.05 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.193 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -130.41 97.65 21.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 111.137 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 C-N-CA 123.262 2.641 . . . . 0.0 112.051 178.957 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.51 0.671 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.435 ' O ' ' HB ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -98.91 144.6 27.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.704 -176.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.493 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 81.4 m-85 -74.76 -24.86 58.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.126 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 25.5 t70 -66.0 -33.95 76.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 109.697 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.517 ' O ' HD11 ' A' ' 34' ' ' LEU . 99.6 m -54.59 -59.68 4.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.438 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 3.3 p-10 -65.13 -28.12 69.21 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.688 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.25 -43.05 96.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.856 0.36 . . . . 0.0 110.458 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 75.0 mmtt -65.25 -32.98 74.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.661 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.517 HD11 ' O ' ' A' ' 30' ' ' THR . 8.4 mp -72.02 -43.19 65.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.754 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.509 HG12 ' HD2' ' A' ' 47' ' ' ARG . 84.4 t -72.49 -18.86 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.289 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -55.09 -39.18 69.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.271 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -76.52 -34.81 58.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.411 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 54.5 p90 48.25 114.47 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.152 1.381 . . . . 0.0 113.71 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 t -71.35 -29.98 65.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.298 177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.3 t . . . . . 0 C--O 1.24 0.599 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.288 -178.093 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -120.77 16.61 11.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 0.0 111.74 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 50' ' ' ILE . 36.9 tp -90.88 -33.8 15.5 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.969 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.509 ' HD2' HG12 ' A' ' 35' ' ' VAL . 22.6 tpp180 -55.12 -46.89 75.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.472 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -69.44 -32.11 70.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 110.702 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.58 -44.65 70.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.431 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.449 ' O ' HG13 ' A' ' 54' ' ' ILE . 44.0 mm -60.22 -45.63 95.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.772 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.436 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . . . -58.12 -45.91 86.5 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.477 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.662 ' O ' ' HG2' ' A' ' 56' ' ' ARG . . . -62.55 -42.73 99.67 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.054 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.5 ' CE2' HD11 ' A' ' 57' ' ' ILE . 66.9 t80 -57.62 -40.31 78.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.14 0.176 . . . . 0.0 110.626 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 50' ' ' ILE . 78.7 mt -56.14 -54.3 29.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.672 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -61.89 -35.77 79.31 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 52.8 mmm-85 -62.52 -41.83 99.11 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.68 0.276 . . . . 0.0 110.416 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.536 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 78.0 mt -58.66 -46.05 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.411 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.7 mt -57.73 -49.13 81.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -65.79 -37.0 85.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.579 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -71.62 -25.47 62.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.395 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 49.4 mt-30 -72.33 -18.43 61.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.119 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 C--O 1.246 0.897 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.794 179.163 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.846 0.355 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.42 ' O ' HG13 ' A' ' 12' ' ' ILE . 94.5 t80 -59.69 -48.19 82.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.528 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.7 t -66.21 -40.59 87.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.168 0.509 . . . . 0.0 110.194 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -60.76 -32.59 71.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.72 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -69.63 -35.86 75.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.682 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 16' ' ' MET . 29.4 mt -61.63 -40.38 86.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.99 0.424 . . . . 0.0 109.931 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.37 -35.02 79.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.962 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -64.68 -56.49 13.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.73 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.528 ' HA ' ' HB3' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -68.48 -15.26 63.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.171 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.462 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 6.8 tpt -64.98 -53.67 42.54 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.13 -28.87 21.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.688 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.528 ' HB3' ' HA ' ' A' ' 15' ' ' GLU . 11.4 tp10 -60.15 153.85 20.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.423 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 18' ' ' GLU . 52.2 m 82.08 -47.72 0.2 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.517 0.727 . . . . 0.0 111.18 -176.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -147.64 96.17 4.16 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.597 0.237 . . . . 0.0 110.89 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo . . . . . 0 N--CA 1.463 -0.308 0 C-N-CA 122.778 2.319 . . . . 0.0 111.315 176.643 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.536 ' HA ' HG23 ' A' ' 55' ' ' THR . 8.0 p-10 . . . . . 0 N--CA 1.464 0.271 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -94.96 145.43 24.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -66.82 -27.47 67.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.73 0.3 . . . . 0.0 110.953 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.5 -37.95 88.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.521 0.677 . . . . 0.0 109.27 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.582 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 22.2 m -65.81 -56.27 12.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.202 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -61.54 -27.83 68.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 111.247 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.73 -49.22 69.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.24 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -77.29 -21.02 54.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.877 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 30' ' ' THR . 41.7 mt -66.3 -50.11 64.75 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.18 174.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -56.14 -43.43 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.039 0.447 . . . . 0.0 110.025 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -58.24 -42.21 85.84 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.297 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.01 -48.86 11.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' A' ' 34' ' ' LEU . 17.1 m-30 -56.88 -76.24 0.04 OUTLIER 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -131.77 133.54 44.86 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 t . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.729 -175.048 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -133.63 13.25 4.08 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.415 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.426 ' O ' HG13 ' A' ' 50' ' ' ILE . 58.6 tp -88.62 -28.37 20.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.361 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -66.67 -34.81 78.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.431 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.72 -39.69 85.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.755 175.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -73.66 -31.91 63.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.551 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.505 ' O ' HG13 ' A' ' 54' ' ' ILE . 80.4 mt -62.74 -40.17 87.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.195 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.43 96.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.042 0.449 . . . . 0.0 110.558 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.92 -32.23 83.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.734 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.492 ' O ' HG13 ' A' ' 57' ' ' ILE . 23.5 t80 -71.4 -30.82 66.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 50' ' ' ILE . 79.3 mt -59.4 -49.54 83.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.894 0.378 . . . . 0.0 110.193 175.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -62.35 -29.23 70.31 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.559 176.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.3 ttt85 -68.69 -41.59 78.95 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 110.687 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 53' ' ' TYR . 77.6 mt -59.99 -45.9 94.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.378 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.8 -50.7 79.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.247 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.0 p -66.4 -35.3 79.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.725 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -73.73 -35.99 65.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -72.81 -52.32 15.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.145 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.538 ' NZ ' ' HB3' ' A' ' 62' ' ' LYS . 1.3 ttpm? . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.4 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.564 ' O ' ' HG2' ' A' ' 11' ' ' ARG . 1.5 p . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 120.45 0.167 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.514 ' O ' HG13 ' A' ' 12' ' ' ILE . 79.3 t80 -56.27 -40.61 74.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.031 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.87 -34.6 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.254 0.55 . . . . 0.0 110.192 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -68.04 -31.45 71.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.335 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 7' ' ' SER . 22.5 mmt180 -75.34 -31.77 60.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.075 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 8' ' ' PHE . 82.1 mt -61.75 -55.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.01 -39.13 77.53 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.452 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 38.7 tptt -52.78 -56.21 17.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.066 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.92 -28.29 64.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.588 -176.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.473 ' SD ' ' HA ' ' A' ' 39' ' ' SER . 87.1 mtp -66.65 -43.42 84.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.599 0.238 . . . . 0.0 110.979 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.3 mt -77.59 -31.68 17.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.108 0.48 . . . . 0.0 110.995 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -62.15 113.73 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.966 -175.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.608 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 93.1 m 76.31 -39.49 0.36 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.802 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -91.11 98.3 1.62 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.394 . . . . 0.0 110.149 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 19' ' ' THR . 27.5 Cg_endo . . . . . 0 N--CA 1.446 -1.272 0 C-N-CA 123.269 2.646 . . . . 0.0 112.69 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 121.149 0.5 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.37 162.12 14.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.716 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.3 -30.44 68.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.687 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.99 -30.63 71.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.211 0.529 . . . . 0.0 110.316 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.5 m -64.94 -52.86 54.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.393 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.74 ' OD1' ' HB ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -61.34 -37.98 85.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.074 178.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -50.1 -49.27 52.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.573 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.68 -39.16 73.69 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.997 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.5 mp -58.77 -39.24 80.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.471 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.464 HG11 ' HG3' ' A' ' 47' ' ' ARG . 57.0 t -75.49 -37.11 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.267 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.14 -49.21 76.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.877 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -63.54 -65.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.067 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -101.6 -84.46 0.44 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.637 -168.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.473 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 90.3 p 51.33 -172.65 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.915 0.886 . . . . 0.0 112.308 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.9 m . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 173.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.6 tttt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.648 0.261 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -31.23 50.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 110.501 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 mp -73.18 -18.7 61.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.49 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HG3' HG11 ' A' ' 35' ' ' VAL . 41.5 ttp180 -57.43 -43.66 84.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.4 0.619 . . . . 0.0 110.205 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -72.71 -23.17 60.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.574 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -71.23 -46.44 61.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.969 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.0 mt -63.24 -33.15 59.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.928 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.58 84.3 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.915 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.85 -41.22 88.84 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.76 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.441 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.0 m-85 -62.03 -61.45 2.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.496 0.189 . . . . 0.0 111.483 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.74 ' HB ' ' OD1' ' A' ' 31' ' ' ASN . 62.8 mt -60.84 -44.82 98.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -172.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 p -54.26 -45.76 72.5 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.243 0.474 . . . . 0.0 111.473 176.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -60.0 -43.83 94.93 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.418 176.095 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 53' ' ' TYR . 78.1 mt -62.76 -38.63 82.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.081 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 54' ' ' ILE . 75.7 mt -59.7 -51.36 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.865 0.364 . . . . 0.0 110.855 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.2 p -65.24 -22.3 66.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.573 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -84.99 -52.09 6.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.726 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -71.54 -36.31 70.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.085 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm . . . . . 0 C--O 1.25 1.097 0 O-C-N 123.838 0.711 . . . . 0.0 109.688 -172.539 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.461 ' O ' HG13 ' A' ' 12' ' ' ILE . 25.3 m-85 -65.58 -60.55 2.81 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.834 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.87 -34.64 71.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.214 0.531 . . . . 0.0 110.479 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -66.29 -33.66 76.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.545 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -72.86 -35.76 67.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.687 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 8' ' ' PHE . 72.4 mt -57.14 -49.95 78.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.208 177.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.3 -39.58 94.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -64.84 -34.51 78.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.77 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -69.86 -35.51 74.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.665 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.559 ' HA ' ' HD2' ' A' ' 38' ' ' PHE . 48.8 ttm -70.4 -42.63 71.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.684 177.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.577 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 53.5 mt -75.55 -5.84 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.385 0.612 . . . . 0.0 110.982 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.516 ' HG3' ' HG1' ' A' ' 19' ' ' THR . 5.5 tp10 -65.38 134.65 53.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.53 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.516 ' HG1' ' HG3' ' A' ' 18' ' ' GLU . 53.0 m 76.19 -66.74 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 170.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.586 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . 1.2 t-160 -89.64 -57.01 0.27 Allowed Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 120.483 -0.487 . . . . 0.0 112.219 -168.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.941 ' HB3' HD21 ' A' ' 34' ' ' LEU . 43.1 Cg_exo . . . . . 0 C--N 1.352 0.739 0 C-N-CA 122.151 1.901 . . . . 0.0 112.631 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 C--O 1.234 0.247 0 CA-C-O 120.7 0.286 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -100.05 160.34 14.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -71.96 -24.21 61.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.681 0.277 . . . . 0.0 111.618 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.43 -29.17 69.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.338 0.59 . . . . 0.0 109.462 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.605 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 14.3 m -65.59 -52.18 54.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.424 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.454 ' O ' HG21 ' A' ' 35' ' ' VAL . 27.2 p30 -65.87 -28.34 68.89 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.755 -177.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -64.19 -44.02 93.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.949 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -65.2 -34.39 78.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.812 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.941 HD21 ' HB3' ' A' ' 21' ' ' PRO . 59.8 mt -70.6 -43.8 68.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.291 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.528 HG12 ' HG3' ' A' ' 47' ' ' ARG . 56.4 t -69.74 -30.81 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.378 0.609 . . . . 0.0 110.301 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.83 -23.29 60.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.327 0.584 . . . . 0.0 109.928 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -80.01 -55.66 4.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.164 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.559 ' HD2' ' HA ' ' A' ' 16' ' ' MET . 34.2 t80 -132.57 148.19 52.37 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.1 p -162.55 153.74 17.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.773 0.32 . . . . 0.0 110.848 -173.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.5 m . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.581 177.66 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.2 tptm . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -101.59 13.65 34.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.398 0.618 . . . . 0.0 109.953 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.8 tp -95.15 -27.78 15.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.762 173.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.528 ' HG3' HG12 ' A' ' 35' ' ' VAL . 51.2 ttp180 -67.09 -47.64 70.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.586 -174.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -61.64 -34.98 76.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.996 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 72.2 mmtt -65.57 -51.16 61.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.528 ' O ' HG13 ' A' ' 54' ' ' ILE . 66.3 mt -65.28 -51.34 66.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.8 -48.83 77.05 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.926 0.394 . . . . 0.0 111.144 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.92 -37.94 95.75 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.96 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 57' ' ' ILE . 2.0 t80 -69.95 -33.13 71.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 50' ' ' ILE . 80.9 mt -56.84 -55.58 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.863 0.363 . . . . 0.0 110.265 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.17 -32.31 73.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -62.05 -46.64 88.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.958 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 53' ' ' TYR . 84.1 mt -62.57 -39.01 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.671 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 54' ' ' ILE . 71.8 mt -58.25 -51.87 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.526 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.9 p -65.86 -18.9 65.66 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.785 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -84.89 -38.96 18.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 0.0 110.372 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -73.84 -38.37 64.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.32 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.471 -179.395 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.667 0.27 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.437 ' O ' HG13 ' A' ' 12' ' ' ILE . 75.6 t80 -65.62 -37.19 85.88 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.7 t -66.12 -37.29 79.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.672 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -64.93 -33.33 75.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.448 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -28.24 62.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 8' ' ' PHE . 72.9 mt -70.71 -39.23 75.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.265 0.555 . . . . 0.0 109.547 173.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.31 90.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.484 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -63.03 -42.92 99.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.071 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -55.55 -45.73 77.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.503 ' SD ' ' HB3' ' A' ' 34' ' ' LEU . 46.3 tpp -55.77 -52.44 63.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.222 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.32 -49.73 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.236 -173.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -66.09 -33.08 74.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.728 0.299 . . . . 0.0 111.792 -173.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 m -84.11 -16.87 42.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.246 0.546 . . . . 0.0 110.579 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . 47.2 t-80 -132.55 69.39 79.75 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.064 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 C--N 1.344 0.321 0 C-N-CA 123.12 2.547 . . . . 0.0 112.716 -174.904 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 121.616 0.722 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -103.9 139.93 38.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.712 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.643 ' HA ' ' ND2' ' A' ' 31' ' ' ASN . 99.5 m-85 -72.14 -40.27 68.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.777 -174.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.56 -38.35 90.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.245 0.545 . . . . 0.0 110.358 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.434 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 67.3 m -62.71 -55.03 30.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.564 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.643 ' ND2' ' HA ' ' A' ' 28' ' ' PHE . 20.9 p30 -60.87 -30.05 69.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.702 0.287 . . . . 0.0 110.997 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.567 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 14.3 tmtt? -66.93 -52.13 46.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.082 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 52.3 mtmt -67.4 -26.8 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.727 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.503 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 95.2 mt -69.33 -48.17 62.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.65 0.262 . . . . 0.0 110.713 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.563 HG13 ' HA ' ' A' ' 47' ' ' ARG . 17.8 t -68.15 -24.58 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.429 . . . . 0.0 110.11 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 7.3 mm-40 -57.42 -38.51 74.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.245 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -159.09 89.76 0.94 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 -174.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 20' ' ' HIS . 51.3 t80 -175.65 -78.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.266 171.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.6 m -104.07 51.04 0.78 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.454 0.645 . . . . 0.0 109.347 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.8 m . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.585 -176.247 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.4 tttt . . . . . 0 N--CA 1.447 -0.581 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -98.18 -19.62 17.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.14 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.6 tp -64.87 -14.19 58.75 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.13 0.491 . . . . 0.0 110.589 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.563 ' HA ' HG13 ' A' ' 35' ' ' VAL . 38.1 ttm180 -49.49 -57.73 6.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.801 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -69.6 -18.33 63.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.538 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -75.32 -54.04 7.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.034 0.445 . . . . 0.0 110.109 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.452 ' O ' HG13 ' A' ' 54' ' ' ILE . 62.2 mt -64.69 -41.76 93.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.048 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB1' ' OD1' ' A' ' 31' ' ' ASN . . . -59.31 -38.64 80.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.172 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.86 -44.24 97.27 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.718 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -60.88 -49.83 75.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.952 -0.124 . . . . 0.0 111.08 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 50' ' ' ILE . 78.0 mt -49.05 -57.81 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 O-C-N 123.527 0.517 . . . . 0.0 111.111 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -47.32 -58.27 4.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.222 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 75.2 mtt-85 -70.8 -33.06 70.33 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -172.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.0 mt -65.26 -40.37 88.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.974 0.416 . . . . 0.0 110.118 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.35 -32.29 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.229 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.1 m -65.52 -24.62 67.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 176.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 83.4 mm-40 -75.38 -54.01 7.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.308 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.49 -51.38 8.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.637 0.256 . . . . 0.0 111.663 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.3 tttt . . . . . 0 C--O 1.249 1.071 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.329 -174.211 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.65 -48.57 80.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.5 t -63.59 -44.8 98.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.772 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.15 -29.7 67.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.817 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 8.6 tpt180 -64.49 -42.32 95.92 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 176.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.5 mm -59.24 -43.1 89.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.254 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.33 97.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.284 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -58.49 -41.66 85.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.779 178.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 11' ' ' ARG . 76.2 mm-40 -56.67 -47.08 80.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.829 0.347 . . . . 0.0 110.493 178.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.458 ' CE ' ' HB3' ' A' ' 39' ' ' SER . 42.0 ttm -65.83 -50.29 65.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.739 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.72 -46.29 86.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.602 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.452 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 5.2 tp10 -66.22 -46.48 77.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 m -69.19 -41.62 76.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.236 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -121.44 92.91 48.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 110.952 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo . . . . . 0 N--CA 1.46 -0.475 0 C-N-CA 123.589 2.86 . . . . 0.0 112.334 -179.643 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.97 0.414 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.463 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 4.3 p30 -89.45 159.3 17.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 176.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.664 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 62.2 m-85 -71.36 -28.24 63.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.118 -176.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.97 -36.76 85.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.121 0.486 . . . . 0.0 110.305 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.463 ' HG1' ' CG ' ' A' ' 27' ' ' ASP . 53.1 m -61.1 -56.81 16.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.661 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.664 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.7 p-10 -65.65 -23.97 66.92 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.395 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 20.6 ttpp -62.12 -52.06 65.36 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -56.58 -38.59 72.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.274 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 38' ' ' PHE . 7.7 mp -60.15 -51.53 69.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.4 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.419 HG11 ' HB3' ' A' ' 51' ' ' ALA . 35.7 m -82.46 -9.2 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 122.047 -0.408 . . . . 0.0 111.011 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.606 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 2.8 tp10 -76.08 -2.61 31.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -158.5 -48.14 0.06 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.854 0.359 . . . . 0.0 111.374 -171.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.461 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 36.9 m-85 -84.66 -165.98 1.34 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.809 -174.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.458 ' HB3' ' CE ' ' A' ' 16' ' ' MET . 93.3 p 62.23 174.42 0.13 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.397 1.079 . . . . 0.0 112.29 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -178.517 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.4 pttm . . . . . 0 CA--C 1.529 0.139 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -78.71 -13.18 59.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.955 0.407 . . . . 0.0 110.64 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -77.04 -39.6 49.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.044 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -69.78 -10.16 57.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.854 0.359 . . . . 0.0 111.682 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -69.59 -41.96 75.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.402 0.62 . . . . 0.0 109.635 172.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -73.24 -38.89 65.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.69 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.555 ' O ' HG13 ' A' ' 54' ' ' ILE . 50.4 mm -57.16 -49.18 80.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.487 177.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.541 ' HB1' HD21 ' A' ' 31' ' ' ASN . . . -57.85 -50.94 71.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.414 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.62 -28.48 73.65 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.767 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.503 ' O ' HG13 ' A' ' 57' ' ' ILE . 22.7 t80 -73.93 -37.27 64.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 50' ' ' ILE . 84.6 mt -58.63 -47.64 88.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 110.124 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.76 -42.23 75.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.414 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -66.22 -44.47 83.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.032 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 53' ' ' TYR . 80.9 mt -57.53 -49.36 80.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.68 -49.95 81.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.095 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 p -65.82 -25.39 67.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.709 0.29 . . . . 0.0 111.535 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -70.27 -34.19 72.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.044 0.449 . . . . 0.0 110.327 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.729 HE21 ' HA ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -86.39 -33.02 20.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.754 177.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.5 tttm . . . . . 0 C--O 1.253 1.275 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.811 -176.036 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.525 ' O ' HG13 ' A' ' 12' ' ' ILE . 55.0 t80 -64.16 -35.84 82.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.4 -48.78 85.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.095 0.474 . . . . 0.0 110.7 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.78 -40.2 83.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.544 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -59.44 -46.31 89.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.439 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 8' ' ' PHE . 73.3 mt -57.17 -53.5 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.745 0.307 . . . . 0.0 111.094 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.482 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -63.82 -45.78 88.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.432 -177.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.2 -39.51 94.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.42 -176.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.883 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 31.0 mt-10 -71.06 -30.62 66.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.748 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.502 ' HE2' HG21 ' A' ' 12' ' ' ILE . 59.9 mtt -55.34 -42.45 73.84 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.515 HD12 HG21 ' A' ' 54' ' ' ILE . 57.8 mt -65.23 -54.18 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.25 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.883 ' HG2' ' HA ' ' A' ' 15' ' ' GLU . 8.8 pt-20 -67.0 -6.01 15.19 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.5 m -57.59 -43.08 84.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.147 0.498 . . . . 0.0 110.662 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -150.44 120.09 3.73 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.959 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 CA--C 1.515 -0.429 0 C-N-CA 122.648 2.232 . . . . 0.0 111.914 177.364 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.694 0.759 . . . . 0.0 112.786 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.543 ' O ' ' HB ' ' A' ' 30' ' ' THR . 7.9 t70 -139.79 147.91 41.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.222 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -77.9 -35.25 50.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 110.633 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 36.2 t70 -65.63 -29.7 70.31 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.543 ' HB ' ' O ' ' A' ' 27' ' ' ASP . 2.5 m -61.06 -50.54 72.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.679 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 18.5 p30 -64.46 -34.77 78.97 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 110.507 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -63.41 -48.89 75.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.517 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 25.9 ttmt -69.67 -13.3 62.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.566 -173.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 30' ' ' THR . 96.7 mt -81.92 -49.9 9.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.941 0.4 . . . . 0.0 110.425 173.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.51 HG13 ' HA ' ' A' ' 47' ' ' ARG . 43.4 t -74.98 -28.39 21.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.212 -176.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -76.08 7.03 4.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -175.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 33' ' ' LYS . 12.4 pt-20 -155.98 -43.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.646 -0.421 . . . . 0.0 112.105 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -84.68 -85.45 0.14 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.494 ' HA ' ' HE3' ' A' ' 16' ' ' MET . 11.9 t 54.65 -159.36 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.752 0.787 . . . . 0.0 112.094 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.2 m . . . . . 0 C--N 1.319 -0.752 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.703 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.892 0.377 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -107.35 -9.06 16.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -173.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.7 tp -64.09 -34.85 78.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.51 ' HA ' HG13 ' A' ' 35' ' ' VAL . 14.6 ttm105 -47.17 -52.45 15.61 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.808 0.693 . . . . 0.0 110.992 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -78.36 -30.38 47.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.664 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -74.1 -51.1 16.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.854 0.359 . . . . 0.0 110.209 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.566 ' O ' HG13 ' A' ' 54' ' ' ILE . 10.6 tt -66.37 -34.05 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.447 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 31' ' ' ASN . . . -65.26 -40.32 93.8 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.039 0.447 . . . . 0.0 110.641 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.39 -41.18 99.47 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.415 ' CE2' HD12 ' A' ' 57' ' ' ILE . 61.4 t80 -63.38 -44.28 95.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.607 -0.297 . . . . 0.0 110.631 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 50' ' ' ILE . 91.4 mt -54.62 -57.84 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.753 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -56.24 -40.7 74.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.132 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -59.1 -39.54 82.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.058 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.415 HD12 ' CE2' ' A' ' 53' ' ' TYR . 70.7 mt -68.11 -42.33 84.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 110.436 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.09 -45.74 93.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.868 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -58.72 -37.41 76.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.754 0.311 . . . . 0.0 110.688 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.99 -36.0 81.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.079 0.466 . . . . 0.0 110.777 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -24.79 57.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.527 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.929 -176.044 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptp . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 120.929 0.395 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -128.6 -150.78 7.3 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -85.73 151.28 23.97 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 58.6 mt -72.47 -66.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.171 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 58.43 88.61 0.06 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.477 0.656 . . . . 0.0 112.317 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.1 t -164.73 -26.09 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.645 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.6 t -60.87 -30.48 70.16 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.658 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -64.37 -36.12 83.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.064 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.8 t -66.3 -36.59 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.435 0.636 . . . . 0.0 109.721 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -66.39 -33.94 76.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.529 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 11' ' ' ARG . 33.6 ttt180 -66.75 -41.61 87.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.412 178.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.62 -40.26 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.345 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.43 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -60.54 -47.03 87.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.391 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 27.0 mmmt -56.63 -50.01 73.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.157 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.31 -39.01 78.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.808 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.571 ' SD ' HG11 ' A' ' 35' ' ' VAL . 37.6 ttm -69.82 -45.64 67.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.442 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.603 HG23 HD21 ' A' ' 34' ' ' LEU . 63.8 mt -75.38 -49.75 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.908 0.385 . . . . 0.0 111.481 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 1.7 tp10 -65.61 -8.89 22.58 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -169.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.474 HG22 ' CD1' ' A' ' 38' ' ' PHE . 5.9 t -76.69 -17.32 59.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.273 0.559 . . . . 0.0 109.808 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 18.1 t-160 -142.51 109.08 5.67 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 20' ' ' HIS . 20.7 Cg_exo -67.7 25.83 0.12 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.704 2.936 . . . . 0.0 114.161 -176.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 20' ' ' HIS . . . -84.19 60.06 4.88 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 174.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -107.88 158.43 17.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.707 -169.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CD1' HG22 ' A' ' 58' ' ' ILE . 54.9 t80 65.07 54.91 1.18 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.562 0.696 . . . . 0.0 111.455 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.489 ' HB ' HG21 ' A' ' 30' ' ' THR . 6.1 m -105.75 0.43 26.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.502 0.668 . . . . 0.0 109.27 172.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.94 35.59 1.17 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.211 -1.359 . . . . 0.0 113.709 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -131.62 144.34 50.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -67.42 -36.18 80.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.389 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.506 ' O ' ' HD3' ' A' ' 33' ' ' LYS . 17.0 t70 -65.69 -39.56 91.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.104 0.478 . . . . 0.0 110.173 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.489 HG21 ' HB ' ' A' ' 25' ' ' THR . 8.7 m -61.22 -52.07 66.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.853 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.438 ' O ' HG21 ' A' ' 35' ' ' VAL . 78.3 m-20 -65.06 -32.39 74.09 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.734 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 64.0 tttm -58.93 -53.83 53.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.353 176.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.506 ' HD3' ' O ' ' A' ' 29' ' ' ASP . 1.2 mptm? -66.48 -36.27 82.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.919 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.603 HD21 HG23 ' A' ' 17' ' ' ILE . 43.4 tp -57.82 -40.63 80.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.609 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.571 HG11 ' SD ' ' A' ' 16' ' ' MET . 76.9 t -69.75 -46.31 74.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.907 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 43.4 mt-10 -70.99 -25.3 62.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -171.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.52 -15.42 58.62 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.117 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.521 ' HD2' ' HG3' ' A' ' 16' ' ' MET . 65.5 t80 -113.83 -80.47 0.59 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.5 m 63.84 103.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.7 0.625 . . . . 0.0 112.143 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.9 t -132.16 17.16 4.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.951 0.882 . . . . 0.0 109.589 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.0 p -107.75 138.61 33.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.83 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.6 m -87.8 164.93 15.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.898 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.3 m 72.38 107.53 0.07 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.462 0.648 . . . . 0.0 110.054 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -66.09 -35.25 80.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.595 -169.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -78.78 -12.34 60.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.96 0.41 . . . . 0.0 110.841 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.516 HD11 ' HD2' ' A' ' 49' ' ' LYS . 38.7 tp -74.31 -21.75 59.58 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.456 ' HG3' HG13 ' A' ' 35' ' ' VAL . 73.7 ttp85 -59.92 -30.25 68.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.586 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.69 -44.23 97.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.369 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HD2' HD11 ' A' ' 46' ' ' LEU . 68.1 mttm -67.62 -34.26 76.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.331 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.526 ' O ' HG13 ' A' ' 54' ' ' ILE . 50.5 mm -65.35 -49.48 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.524 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.05 97.3 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.89 -33.97 81.12 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.771 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 11.5 t80 -63.23 -45.94 89.29 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.502 0.321 . . . . 0.0 110.54 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.544 HG12 HD11 ' A' ' 17' ' ' ILE . 36.2 mt -58.9 -56.64 15.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.169 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -49.69 -40.24 39.42 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.677 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.09 -48.05 75.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.993 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.2 mt -59.21 -43.4 89.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 110.623 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.486 HG22 ' CD1' ' A' ' 24' ' ' PHE . 68.2 mt -62.59 -48.99 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.73 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 p -65.31 -31.22 72.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -84.95 -18.53 34.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.875 0.369 . . . . 0.0 111.408 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.37 -37.76 65.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.242 -177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 65.0 tttp . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.764 -177.716 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.984 0.421 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.15 31.75 2.5 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.747 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -62.2 -27.76 69.2 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.476 0.31 . . . . 0.0 111.792 -176.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.8 tp -85.13 -21.64 7.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.294 0.569 . . . . 0.0 110.477 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.8 mtm-85 -93.77 96.05 9.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.405 0.621 . . . . 0.0 110.336 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -164.48 -19.3 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.135 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 m -76.16 6.09 5.89 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.415 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -63.68 -43.53 96.42 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 122.298 -0.251 . . . . 0.0 111.307 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.52 -48.49 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.261 0.553 . . . . 0.0 110.628 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -64.12 -30.78 71.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.633 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.705 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -63.2 -52.98 60.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.51 177.087 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 74.5 mt -57.59 -44.41 85.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.809 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.71 -49.16 71.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.169 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -65.2 -44.24 89.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -62.36 -39.03 91.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.906 0.384 . . . . 0.0 110.53 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.495 ' SD ' ' HB2' ' A' ' 38' ' ' PHE . 27.2 tpp -55.97 -47.81 76.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.438 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.631 HG23 ' HE3' ' A' ' 23' ' ' LYS . 56.1 mt -76.86 -51.92 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.706 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.86 -25.92 67.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -168.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 p -61.29 -22.94 65.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 111.109 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -143.67 90.14 7.16 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.57 0.7 . . . . 0.0 109.324 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.4 163.4 34.77 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.975 2.45 . . . . 0.0 113.223 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.69 -61.29 0.66 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.485 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.631 ' HE3' HG23 ' A' ' 17' ' ' ILE . 54.1 mttp 62.32 -158.39 0.33 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -174.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -158.76 -72.7 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.907 0.384 . . . . 0.0 110.386 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.6 m -154.02 160.77 42.16 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -77.92 71.57 4.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.83 0.824 . . . . 0.0 110.722 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -137.12 157.29 47.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.47 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.72 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 94.2 m-85 -62.22 -28.54 69.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.474 -176.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.58 -45.21 94.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.632 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.5 m -65.94 -51.57 57.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.883 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.72 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.4 p-10 -65.35 -28.92 69.63 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.978 -177.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -60.79 -49.23 78.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 109.88 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -63.65 -34.85 78.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.992 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.477 HD12 HG12 ' A' ' 17' ' ' ILE . 97.4 mt -68.17 -44.4 76.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.235 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.525 HG11 ' HG3' ' A' ' 47' ' ' ARG . 56.3 t -77.12 -43.75 31.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.504 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.53 -22.15 61.24 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 111.833 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.401 ' HA ' ' OE1' ' A' ' 37' ' ' GLU . 3.1 tp10 -65.63 -39.88 91.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.673 -174.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.495 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 81.8 m-85 -124.79 -52.14 1.69 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.6 t -49.47 110.95 0.43 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.229 0.538 . . . . 0.0 111.716 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 t -124.33 11.74 8.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.646 0.736 . . . . 0.0 110.029 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.872 HG22 ' H ' ' A' ' 42' ' ' SER . 8.9 p -83.95 -163.22 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.596 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.872 ' H ' HG22 ' A' ' 41' ' ' VAL . 14.0 m -47.65 108.25 0.15 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.407 0.622 . . . . 0.0 110.921 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.751 HG23 ' HD3' ' A' ' 47' ' ' ARG . 18.9 m -88.0 -40.42 13.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.084 -170.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -24.19 -83.14 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.616 1.198 . . . . 0.0 113.667 -167.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -129.23 3.45 5.19 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.233 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -71.69 -42.46 67.4 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.624 0.726 . . . . 0.0 109.169 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.751 ' HD3' HG23 ' A' ' 43' ' ' THR . 18.9 ttt-85 -66.62 -36.98 83.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.86 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.62 -39.99 90.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.618 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -62.18 -47.24 85.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.966 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.46 ' O ' HG12 ' A' ' 54' ' ' ILE . 69.4 mt -61.64 -41.67 91.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.547 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.17 77.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.315 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.07 93.11 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.887 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -68.55 -30.31 69.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.557 ' O ' HG13 ' A' ' 58' ' ' ILE . 40.8 mm -60.29 -50.31 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.892 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -33.02 71.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.882 0.372 . . . . 0.0 110.914 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 -64.46 -48.68 74.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.376 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 54' ' ' ILE . 14.3 tt -69.02 -26.85 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 110.784 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 54' ' ' ILE . 78.8 mt -65.12 -47.75 86.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 174.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.2 p -66.35 -16.49 64.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.828 0.347 . . . . 0.0 111.112 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -76.02 -33.92 59.67 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.909 0.385 . . . . 0.0 110.249 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -76.33 -45.53 31.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.944 0.402 . . . . 0.0 110.4 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 tptm . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.505 -177.697 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtm . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 120.651 0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.49 82.11 0.16 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.98 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.22 100.18 1.26 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.394 0.616 . . . . 0.0 110.7 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 tt -98.12 -62.06 2.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.509 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.2 ttp180 -87.41 65.15 8.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.322 0.582 . . . . 0.0 111.331 -171.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.9 t -170.18 -39.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.325 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.9 m -73.56 -4.62 35.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.978 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.478 ' O ' HG13 ' A' ' 12' ' ' ILE . 64.4 m-85 -61.97 -58.25 8.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.71 -37.22 79.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.25 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -61.85 -42.61 99.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.64 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 8.1 tmm_? -68.39 -40.74 81.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.463 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 8' ' ' PHE . 86.0 mt -58.78 -45.59 91.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.016 0.436 . . . . 0.0 110.132 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.528 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -62.84 -43.63 98.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.42 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.448 ' HZ1' ' CD ' ' A' ' 18' ' ' GLU . 13.7 tmtt? -56.97 -43.39 81.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.452 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 11' ' ' ARG . 49.0 mt-10 -61.33 -41.43 97.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.982 0.42 . . . . 0.0 110.706 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.531 ' SD ' ' HA ' ' A' ' 35' ' ' VAL . 31.8 ttp -70.26 -48.52 56.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.437 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 13' ' ' ALA . 74.6 mt -58.47 -44.82 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.126 0.489 . . . . 0.0 111.441 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.448 ' CD ' ' HZ1' ' A' ' 14' ' ' LYS . 24.8 tt0 -65.94 -4.18 6.54 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.154 -172.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -77.66 -20.77 53.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.044 0.449 . . . . 0.0 110.416 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -140.44 84.83 13.81 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.487 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.49 -16.13 21.75 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.483 2.122 . . . . 0.0 112.136 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -83.34 63.07 4.53 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.94 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.505 ' HB3' HG21 ' A' ' 30' ' ' THR . 30.2 mmmt -145.76 -71.42 0.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.436 ' HA ' ' CG2' ' A' ' 58' ' ' ILE . 42.3 p90 42.5 28.63 0.12 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 172.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.7 m -85.62 -21.86 28.25 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.13 -0.356 . . . . 0.0 111.196 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 61.12 59.59 1.97 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 122.276 1.036 . . . . 0.0 109.53 -173.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -133.79 168.29 19.0 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.729 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -77.93 -18.6 55.9 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.905 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.89 -38.27 88.3 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 167.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.627 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 6.4 m -60.72 -62.06 2.13 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.814 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.693 ' O ' HG22 ' A' ' 35' ' ' VAL . 23.1 p30 -65.17 -49.25 70.55 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -173.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -55.5 -46.17 77.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 111.183 -176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -71.37 -27.84 63.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.016 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 30' ' ' THR . 64.5 mt -76.66 -32.57 58.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.979 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 31' ' ' ASN . 32.8 t -66.38 -34.12 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.261 0.553 . . . . 0.0 110.177 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.56 -12.24 61.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.386 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.99 -61.33 2.02 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.606 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.489 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 0.3 OUTLIER -97.92 -157.79 0.62 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.876 -171.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.2 t -90.47 126.1 35.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -168.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.9 p -144.23 114.44 7.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.812 169.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.62 125.97 73.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.113 0.483 . . . . 0.0 112.125 -172.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.9 m 62.45 16.58 8.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.906 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 16.1 p -115.81 37.51 3.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.18 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.72 -34.93 60.47 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -169.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -115.81 -16.04 11.23 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.432 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.98 -23.66 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 166.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.527 ' HG2' HG13 ' A' ' 35' ' ' VAL . 6.2 ttt180 -50.84 -38.93 51.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.175 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.86 -39.0 93.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.763 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.443 ' O ' ' HD1' ' A' ' 53' ' ' TYR . 58.5 mttp -67.18 -40.37 86.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.144 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 54' ' ' ILE . 65.7 mt -60.08 -40.89 84.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.371 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.05 -40.1 84.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.667 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.23 -46.68 93.81 Favored Glycine 0 C--O 1.239 0.458 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.952 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.443 ' HD1' ' O ' ' A' ' 49' ' ' LYS . 57.4 m-85 -55.54 -43.72 76.04 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 176.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.522 HD11 ' HE2' ' A' ' 16' ' ' MET . 52.9 mt -53.61 -55.32 13.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 O-C-N 123.432 0.457 . . . . 0.0 111.758 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -48.34 57.34 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 111.55 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -67.68 -42.32 82.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.377 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 53' ' ' TYR . 84.1 mt -61.04 -43.46 96.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.745 0.307 . . . . 0.0 110.391 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.436 ' CG2' ' HA ' ' A' ' 24' ' ' PHE . 72.6 mt -62.7 -42.04 94.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.323 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.4 p -65.18 -24.68 67.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.019 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -85.83 -28.25 24.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.029 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -84.73 -35.46 22.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.517 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.672 -178.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.944 0.402 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 161.04 109.75 0.25 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -84.79 99.6 10.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.007 0.432 . . . . 0.0 112.035 -172.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.711 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -94.67 157.95 2.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.507 ' HD2' ' C ' ' A' ' 5' ' ' ARG . 2.3 tmm_? 68.19 112.78 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -169.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.595 ' O ' HG12 ' A' ' 9' ' ' VAL . 12.6 t -163.21 30.21 0.09 Allowed 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.624 -173.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t -65.21 -13.87 59.29 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.431 0.634 . . . . 0.0 109.728 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.494 ' O ' HG13 ' A' ' 12' ' ' ILE . 52.8 t80 -57.54 -43.45 84.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.849 176.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' ' 6' ' ' THR . 8.0 p -70.38 -28.66 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 121.055 0.455 . . . . 0.0 110.518 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -70.12 -37.93 75.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.592 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -64.82 -43.71 92.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.166 174.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 8' ' ' PHE . 74.2 mt -54.93 -48.53 74.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.285 176.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.98 91.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.098 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -65.58 -49.79 67.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.75 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.04 -20.23 63.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.023 0.44 . . . . 0.0 110.838 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.413 ' SD ' HG22 ' A' ' 35' ' ' VAL . 51.2 ttm -70.58 -48.44 55.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.552 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.5 mt -75.08 -27.66 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 0.0 110.303 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 73.84 -59.39 0.56 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.959 0.904 . . . . 0.0 111.954 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.412 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 14.0 t -142.16 -170.04 3.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -175.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -89.53 108.53 25.59 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 19' ' ' THR . 92.3 Cg_endo -85.98 177.9 4.46 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.695 2.263 . . . . 0.0 112.615 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.41 -9.58 64.81 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.844 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.04 101.65 10.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.882 0.372 . . . . 0.0 110.601 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -113.98 26.26 10.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.45 0.643 . . . . 0.0 109.991 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.2 m -82.71 120.37 25.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.837 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -81.56 9.6 7.3 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -171.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 29' ' ' ASP . 12.4 t70 -75.66 136.35 40.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.448 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 70.4 m-85 -64.35 -21.76 66.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.413 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 2.1 t70 -64.29 -30.85 71.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.327 0.584 . . . . 0.0 110.368 175.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.3 m -65.14 -61.73 1.97 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.156 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.538 ' O ' HG21 ' A' ' 35' ' ' VAL . 2.6 p-10 -64.23 -28.52 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 -178.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.9 -42.79 98.71 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.61 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -73.18 -27.5 61.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.973 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.8 mt -68.12 -47.19 68.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.371 177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 31' ' ' ASN . 89.2 t -55.3 -57.56 7.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -64.99 -28.12 69.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.755 -173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.46 -48.4 67.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.922 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -85.55 -73.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.107 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 t -140.19 108.7 5.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -79.35 -34.43 42.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.252 -173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.504 HG13 HG23 ' A' ' 43' ' ' THR . 50.2 t 61.76 104.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.218 0.532 . . . . 0.0 111.405 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t -62.88 103.15 0.42 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.215 0.531 . . . . 0.0 110.371 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.504 HG23 HG13 ' A' ' 41' ' ' VAL . 15.0 p -141.24 149.16 41.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.653 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -52.03 -64.12 0.92 Allowed 'General case' 0 N--CA 1.461 0.11 0 O-C-N 123.502 0.501 . . . . 0.0 110.326 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -154.86 21.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.77 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.3 tp -65.77 -29.48 69.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -54.29 -34.11 60.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.072 175.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -66.4 -35.38 80.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.768 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -69.19 -41.3 77.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.182 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 54' ' ' ILE . 57.2 mt -63.41 -47.92 89.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.046 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.465 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . . . -60.53 -44.41 96.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.174 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -63.01 -34.21 89.34 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.075 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.497 ' O ' HG13 ' A' ' 57' ' ' ILE . 34.9 t80 -67.04 -37.78 84.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 50' ' ' ILE . 75.0 mt -56.85 -50.03 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.489 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -53.12 -43.23 66.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.978 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.546 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 96.9 mtt180 -64.0 -41.71 97.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.395 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 53' ' ' TYR . 79.9 mt -59.17 -40.8 81.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.706 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 54' ' ' ILE . 76.2 mt -57.36 -43.13 81.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.072 0.463 . . . . 0.0 110.548 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.7 t -65.8 -29.47 69.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.974 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 72.5 mt-30 -82.18 -30.7 30.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.992 0.425 . . . . 0.0 110.556 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -64.77 -62.33 1.64 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.464 -171.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.238 -177.896 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.58 -175.51 48.47 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.823 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.4 m120 62.55 -144.74 0.39 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.875 HG13 ' HD2' ' A' ' 5' ' ' ARG . 40.7 pt 48.04 -155.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.376 1.07 . . . . 0.0 113.061 174.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.875 ' HD2' HG13 ' A' ' 4' ' ' ILE . 5.3 mpt_? 71.97 -158.92 0.11 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.182 0.593 . . . . 0.0 109.677 -173.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.9 t -161.47 21.83 0.12 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.893 0.854 . . . . 0.0 110.09 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m -66.11 -17.44 64.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.403 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.459 ' O ' HG13 ' A' ' 12' ' ' ILE . 9.1 m-85 -64.24 -65.74 0.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.229 0.538 . . . . 0.0 110.736 -176.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' HA ' HD11 ' A' ' 12' ' ' ILE . 40.0 t -65.57 -32.25 57.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.586 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.58 -43.46 97.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.836 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -74.04 -26.39 60.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.663 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 8' ' ' PHE . 75.0 mt -60.44 -43.27 93.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.879 0.371 . . . . 0.0 110.211 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.44 84.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.373 176.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.483 ' HD3' ' C ' ' A' ' 14' ' ' LYS . 12.0 tmtt? -61.12 -41.95 97.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.349 176.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -70.35 -27.14 64.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.184 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.472 ' HE3' HG13 ' A' ' 35' ' ' VAL . 42.7 ttm -70.17 -52.23 25.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.105 0.479 . . . . 0.0 110.538 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 mt -77.38 -1.37 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.074 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.406 ' O ' ' HB ' ' A' ' 19' ' ' THR . 14.1 tp10 -58.8 126.46 27.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.861 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 18' ' ' GLU . 93.1 m 76.62 -54.5 0.58 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.525 173.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 82.6 t60 -138.73 103.02 7.66 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.191 -176.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 20' ' ' HIS . 45.9 Cg_endo -72.09 139.62 32.99 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.326 2.017 . . . . 0.0 110.77 170.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.15 71.75 2.59 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.691 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.645 ' HZ3' ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER 60.28 92.28 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.31 0.576 . . . . 0.0 109.87 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -84.72 63.94 8.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.602 0.715 . . . . 0.0 112.379 -169.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.2 m -92.82 127.57 38.38 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -72.04 79.03 0.93 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.062 0.934 . . . . 0.0 111.778 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.67 132.89 33.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.906 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.631 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 70.5 m-85 -61.5 -19.39 62.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -172.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 18.1 t0 -63.77 -45.45 89.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.084 0.469 . . . . 0.0 109.763 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.574 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 96.8 m -65.31 -56.25 13.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.844 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.679 HD21 ' HB1' ' A' ' 51' ' ' ALA . 2.9 p-10 -61.94 -41.93 98.53 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -70.52 -31.29 68.32 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.462 -179.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.462 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 33.5 ttmt -74.83 -28.19 60.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.612 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 30' ' ' THR . 84.2 mt -67.32 -49.54 63.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.119 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.508 ' HB ' ' HG3' ' A' ' 47' ' ' ARG . 14.9 t -63.07 -26.62 41.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.129 0.49 . . . . 0.0 110.447 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -64.11 -16.47 61.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.569 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -156.68 53.51 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.485 0.659 . . . . 0.0 111.11 -173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.491 ' HE2' HD22 ' A' ' 34' ' ' LEU . 12.8 m-85 -148.55 -89.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.342 172.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.0 m -87.4 58.2 4.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 0.0 110.087 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 m -94.01 86.45 5.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.362 0.601 . . . . 0.0 110.922 -176.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 p -157.26 109.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.8 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.6 m 64.77 2.31 1.66 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.54 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.596 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . 3.2 p -89.95 47.92 1.52 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.176 0.512 . . . . 0.0 111.261 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -60.96 -75.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.881 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -84.45 -13.87 50.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.027 0.442 . . . . 0.0 110.053 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.596 ' HB2' ' HA ' ' A' ' 43' ' ' THR . 3.2 mm? -67.93 -27.48 66.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.824 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.508 ' HG3' ' HB ' ' A' ' 35' ' ' VAL . 42.1 ttp180 -56.62 -35.04 67.84 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.559 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -65.63 -45.62 82.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.257 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.34 -45.17 48.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.545 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.461 ' O ' HG13 ' A' ' 54' ' ' ILE . 76.1 mt -61.65 -41.25 89.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.799 0.333 . . . . 0.0 110.535 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.679 ' HB1' HD21 ' A' ' 31' ' ' ASN . . . -60.13 -41.5 92.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.239 176.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.49 -42.63 99.14 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.985 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.445 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.2 m-85 -58.32 -42.87 87.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.009 -0.096 . . . . 0.0 110.898 176.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 50' ' ' ILE . 62.5 mt -55.92 -53.53 37.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.112 0.257 . . . . 0.0 110.769 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -40.32 73.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.641 0.257 . . . . 0.0 111.531 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -65.91 -41.86 90.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.945 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 53' ' ' TYR . 76.1 mt -65.84 -45.54 91.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.727 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.518 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 86.5 mt -58.11 -49.89 80.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.569 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.9 t -65.19 -29.03 69.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.38 -29.32 65.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.048 0.451 . . . . 0.0 110.23 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.867 HE21 ' HA ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -83.95 -30.92 25.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.309 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 17.8 ptpt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.948 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.669 0.271 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.45 87.0 0.82 Allowed Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.571 ' HB2' ' HG3' ' A' ' 5' ' ' ARG . 7.6 p30 -99.19 117.9 34.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.506 0.67 . . . . 0.0 112.232 -173.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.4 tt -80.09 -27.41 12.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 170.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.571 ' HG3' ' HB2' ' A' ' 3' ' ' ASN . 18.5 mtp85 64.29 -176.32 0.17 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.11 175.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.418 ' HG1' ' C ' ' A' ' 5' ' ' ARG . 10.6 m -161.41 20.11 0.12 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -68.18 -34.74 76.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.084 -174.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -64.8 -38.6 91.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.141 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.74 -50.93 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.815 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -61.68 -42.29 98.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.095 0.474 . . . . 0.0 110.473 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -58.77 -55.12 39.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.493 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.08 -42.42 94.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.545 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -61.31 -42.52 98.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -59.14 -48.48 81.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.953 0.406 . . . . 0.0 110.701 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.69 -25.81 64.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.261 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.9 ttm -72.13 -40.42 68.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.798 0.332 . . . . 0.0 110.932 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 13' ' ' ALA . 50.5 mm -66.0 -46.99 86.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.09 161.92 20.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.953 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.5 m 72.53 -57.37 0.63 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.399 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -129.08 78.08 76.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.858 0.361 . . . . 0.0 110.929 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -88.84 22.17 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.09 2.527 . . . . 0.0 112.887 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.89 93.69 1.18 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.502 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.587 ' HZ3' HD23 ' A' ' 34' ' ' LEU . 67.8 mttm -127.83 147.11 50.43 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -94.67 -70.47 0.71 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.645 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 27' ' ' ASP . 9.8 p -138.7 -165.7 1.87 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.826 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.09 19.96 0.14 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.911 0.484 . . . . 0.0 111.776 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 25' ' ' THR . 31.6 t70 -71.43 127.9 34.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.865 0.364 . . . . 0.0 111.228 -176.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -62.78 -41.34 99.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.408 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.18 -38.17 89.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.123 0.487 . . . . 0.0 110.317 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.46 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 54.5 m -62.4 -45.88 91.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.91 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.558 ' O ' HG23 ' A' ' 35' ' ' VAL . 77.0 m-20 -65.02 -37.28 87.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.506 176.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -60.12 -39.5 86.48 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.07 0.462 . . . . 0.0 110.478 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 30' ' ' THR . 6.8 tmtm? -56.07 -43.04 77.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.171 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.587 HD23 ' HZ3' ' A' ' 23' ' ' LYS . 8.0 mp -73.61 -31.74 63.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.571 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 31' ' ' ASN . 59.4 t -66.99 -32.23 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 109.975 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.5 -45.87 92.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.061 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -70.36 -52.18 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.304 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -110.99 -141.94 0.38 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.563 -172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t 71.4 174.02 0.3 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.308 0.643 . . . . 0.0 109.701 -172.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 m -112.48 -81.17 0.59 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.024 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.78 90.89 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.958 0.885 . . . . 0.0 110.291 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 m -106.19 110.58 22.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.047 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.66 162.58 26.11 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 171.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -63.86 -31.81 73.11 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -169.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -95.64 -21.99 17.86 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.721 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.9 tp -70.88 -27.57 63.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.86 0.362 . . . . 0.0 110.245 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 ttm-85 -55.14 -41.39 71.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.518 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.06 -40.0 95.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.666 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -64.55 -46.93 80.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.851 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.541 ' O ' HG13 ' A' ' 54' ' ' ILE . 64.4 mt -61.77 -43.07 96.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.438 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.28 94.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.764 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.49 -37.28 92.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.182 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -60.05 -46.6 89.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.71 0.29 . . . . 0.0 110.515 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 50' ' ' ILE . 34.7 mt -60.89 -50.74 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.425 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 m -47.18 -44.13 21.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.561 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.586 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 13.1 ttm180 -61.08 -45.82 93.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.966 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.2 mt -56.81 -41.02 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.433 . . . . 0.0 110.383 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.3 mt -59.58 -49.94 81.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.82 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.1 p -65.69 -16.63 63.94 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.82 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 84.3 mm-40 -85.11 -40.09 17.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.029 0.442 . . . . 0.0 110.522 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -81.75 -33.54 30.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.711 -176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.5 mptt . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.167 175.506 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 121.026 0.441 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.02 151.04 31.29 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.427 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 t30 73.38 -53.34 0.7 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.337 0.655 . . . . 0.0 111.182 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.5 tt -91.47 100.78 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.636 0.731 . . . . 0.0 109.758 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -88.97 -67.43 0.84 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.085 -172.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.3 m -164.66 -42.66 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.106 0.479 . . . . 0.0 110.157 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 p -52.29 -42.9 64.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.944 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -57.85 -39.99 79.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.082 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.06 -44.11 78.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.975 0.416 . . . . 0.0 110.662 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.14 -28.75 67.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.416 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 37.0 ttt180 -61.82 -52.87 62.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.523 175.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.432 HG21 ' HE3' ' A' ' 16' ' ' MET . 63.5 mt -58.05 -37.73 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 0.0 110.455 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.41 -46.75 88.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.256 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.438 ' HG3' ' N ' ' A' ' 15' ' ' GLU . 36.4 pttt -69.09 -33.87 74.21 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.72 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 35.1 mt-10 -70.25 -23.05 62.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.142 0.496 . . . . 0.0 110.476 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.952 ' HB3' ' HB3' ' A' ' 38' ' ' PHE . 67.5 mtt -70.78 -48.85 52.1 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 169.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 69.6 mt -65.47 -31.6 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.271 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 10.5 pt-20 -60.89 -15.71 33.79 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -175.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.4 p -74.33 -26.76 60.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.936 0.398 . . . . 0.0 111.053 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.602 ' HB3' ' HE1' ' A' ' 38' ' ' PHE . 17.7 t-160 -148.77 89.41 5.01 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.213 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.84 42.91 1.16 Allowed 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.641 2.894 . . . . 0.0 112.39 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.4 103.24 0.78 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.915 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.539 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -131.44 157.82 42.46 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.526 ' HD2' HG22 ' A' ' 25' ' ' THR . 60.5 t80 -85.99 -68.01 0.77 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.526 HG22 ' HD2' ' A' ' 24' ' ' PHE . 14.4 t -156.0 -165.37 1.92 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -77.35 66.48 3.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.032 0.92 . . . . 0.0 109.729 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.31 143.25 46.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.654 -173.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.671 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 73.4 m-85 -74.03 -33.7 63.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.76 -173.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.67 -36.23 83.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.422 0.629 . . . . 0.0 109.649 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.539 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 96.4 m -61.72 -58.98 5.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.269 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.671 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.5 p-10 -63.69 -28.68 70.07 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.753 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -56.68 -54.18 49.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.179 0.514 . . . . 0.0 110.142 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -70.66 -27.27 63.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.864 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 30' ' ' THR . 69.8 mt -64.97 -51.05 63.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.761 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 31' ' ' ASN . 66.6 t -60.54 -33.09 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 110.528 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -59.25 -37.95 78.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.418 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.29 -53.82 6.02 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.19 0.519 . . . . 0.0 110.793 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.952 ' HB3' ' HB3' ' A' ' 16' ' ' MET . 14.2 m-30 -67.13 106.0 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.118 -173.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 p -144.35 98.49 3.21 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.335 0.588 . . . . 0.0 111.571 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 51.9 m -101.47 -41.93 6.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.403 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.3 m -136.15 155.7 35.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.972 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.5 t -75.15 99.37 3.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.163 0.506 . . . . 0.0 110.267 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 p -77.19 109.85 11.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.249 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -85.62 -78.04 0.28 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.03 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -101.55 -25.7 13.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -68.72 -14.58 63.11 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.356 177.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 47' ' ' ARG . 43.7 ttp180 -59.21 -34.41 72.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.442 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -63.75 -43.87 95.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.411 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HB2' HD12 ' A' ' 46' ' ' LEU . 62.1 mttp -66.4 -43.74 85.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.549 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.482 ' O ' HG13 ' A' ' 54' ' ' ILE . 42.6 mm -57.46 -46.39 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.375 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.454 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . . . -57.45 -47.5 81.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.866 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.46 -35.41 91.92 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.323 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.446 ' O ' HG13 ' A' ' 57' ' ' ILE . 7.8 m-85 -71.37 -33.16 69.29 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.743 -0.269 . . . . 0.0 111.384 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 50' ' ' ILE . 58.4 mt -60.21 -49.3 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.511 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.82 -32.07 70.31 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.558 0.218 . . . . 0.0 111.348 175.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -70.07 -39.56 75.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.615 0.245 . . . . 0.0 110.988 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 53' ' ' TYR . 82.3 mt -64.03 -45.46 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.17 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.05 -38.19 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.995 0.426 . . . . 0.0 110.149 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -65.33 -30.88 71.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.799 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -73.49 -34.35 65.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 110.173 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -81.22 -6.45 58.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.634 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.169 -176.423 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.409 ' O ' ' HG2' ' A' ' 5' ' ' ARG . . . 64.79 24.44 69.85 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.268 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 59.85 20.92 9.82 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.752 0.276 . . . . 0.0 111.168 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.5 pt 45.87 27.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.631 1.172 . . . . 0.0 113.449 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 2' ' ' GLY . 4.8 ptt180 -76.01 97.5 4.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.849 0.833 . . . . 0.0 109.79 174.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.677 HG21 ' HH ' ' A' ' 53' ' ' TYR . 85.8 m -160.59 -27.24 0.06 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.884 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -61.84 -23.76 66.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.917 0.865 . . . . 0.0 109.092 169.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.486 ' HA ' ' HB3' ' A' ' 11' ' ' ARG . 80.3 m-85 -71.21 -11.78 61.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.314 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.909 HG11 HD13 ' A' ' 50' ' ' ILE . 93.4 t -69.05 -38.84 78.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 173.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -66.19 -39.06 89.42 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 17.5 tpt180 -56.19 -51.95 66.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.808 173.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 8' ' ' PHE . 45.5 mm -65.87 -44.66 92.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.268 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.35 98.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.739 0.305 . . . . 0.0 111.222 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -61.03 -51.08 70.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.06 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.17 -23.08 61.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.531 ' HG3' ' HB2' ' A' ' 38' ' ' PHE . 49.0 ttm -68.65 -52.44 31.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.317 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.469 HG12 HD21 ' A' ' 34' ' ' LEU . 57.2 mt -75.81 -25.2 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.864 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 61.94 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.256 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 m -153.04 11.96 0.48 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.341 0.591 . . . . 0.0 109.43 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -144.63 101.8 4.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.413 -172.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.508 ' CG ' ' HB2' ' A' ' 24' ' ' PHE . 93.8 Cg_endo -84.48 166.89 12.03 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.87 2.38 . . . . 0.0 112.487 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -88.28 -25.77 30.14 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.445 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.62 ' HD3' ' HA ' ' A' ' 30' ' ' THR . 51.5 mtpt -129.67 -51.89 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.496 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.508 ' HB2' ' CG ' ' A' ' 21' ' ' PRO . 44.9 t80 64.56 81.63 0.2 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.272 -174.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.1 m -155.79 143.97 19.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.274 177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -74.84 62.0 1.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.97 0.891 . . . . 0.0 109.626 173.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.05 148.37 46.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.729 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -71.82 -28.95 63.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.78 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.2 -37.39 85.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.144 0.497 . . . . 0.0 109.779 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.62 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 85.6 m -59.1 -48.76 80.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.406 173.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.39 -53.68 50.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.278 174.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -49.86 -55.21 15.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.521 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 59.4 tttm -65.09 -39.58 93.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.329 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.469 HD21 HG12 ' A' ' 17' ' ' ILE . 9.2 mp -71.76 -44.64 63.72 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.273 -0.171 . . . . 0.0 111.395 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 39' ' ' SER . 84.6 t -60.94 -50.56 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.83 0.348 . . . . 0.0 110.475 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -73.97 -7.76 53.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.647 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.588 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 5.1 tp10 -80.53 -47.39 14.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.058 0.456 . . . . 0.0 110.059 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.531 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 83.0 m-85 -110.52 -90.22 0.48 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.676 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.589 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 21.4 t 57.16 -169.37 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.509 0.671 . . . . 0.0 112.012 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.1 m -143.41 -62.25 0.41 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.4 t -137.03 93.54 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.573 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.1 p -98.57 94.22 6.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.386 0.612 . . . . 0.0 112.137 -173.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.0 p -86.18 171.87 10.97 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 169.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -61.07 -54.79 40.32 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.29 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.473 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 16.0 t-160 -67.32 -25.92 66.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.814 -175.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 tt -77.25 -41.52 40.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -59.34 -39.46 83.25 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.459 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -58.09 -37.33 74.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.266 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 45' ' ' HIS . 28.1 mmmt -70.15 -49.69 48.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.909 HD13 HG11 ' A' ' 9' ' ' VAL . 41.9 mm -61.71 -53.49 47.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.174 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.43 77.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.178 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -59.14 -45.32 95.49 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.113 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.677 ' HH ' HG21 ' A' ' 6' ' ' THR . 26.9 m-85 -71.68 -37.19 70.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 50' ' ' ILE . 64.3 mt -57.71 -55.9 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.316 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 m -50.67 -44.73 57.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.055 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 98.3 mtt180 -58.82 -51.69 68.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.02 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 53' ' ' TYR . 78.8 mt -57.05 -47.11 84.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.622 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.37 -34.32 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.993 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.0 m -64.59 -40.28 95.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.775 0.322 . . . . 0.0 110.754 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -77.45 -28.34 52.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.059 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -85.18 2.67 42.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 0.0 111.0 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 62' ' ' LYS . 13.2 tppt? . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.859 -0.591 . . . . 0.0 109.426 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.8 mtp . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.78 0.324 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.96 -4.38 27.74 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -77.57 -158.62 0.12 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.26 -0.47 . . . . 0.0 109.966 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.1 pt -53.44 125.53 7.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.183 0.516 . . . . 0.0 111.008 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -146.71 152.51 38.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.715 -175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 6' ' ' THR . 6.6 m 67.1 28.98 8.12 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.674 0.749 . . . . 0.0 110.704 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m -64.2 -8.31 12.02 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.431 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.406 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.5 m-85 -57.97 -37.2 73.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.519 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.1 t -64.39 -37.94 81.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.567 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -60.03 -46.78 88.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.6 ttm-85 -64.64 -41.84 95.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.385 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 8' ' ' PHE . 77.3 mt -63.36 -44.13 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.414 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.87 -44.06 90.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.944 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -58.63 -49.86 75.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.255 0.55 . . . . 0.0 110.696 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.2 -26.77 65.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.702 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.5 ' O ' HG23 ' A' ' 19' ' ' THR . 37.2 tpp -70.36 -39.71 74.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.633 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 13' ' ' ALA . 87.3 mt -74.88 -42.12 46.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.276 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.21 -10.08 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 16' ' ' MET . 15.0 t -80.14 -27.51 39.05 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.193 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -130.41 97.65 21.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 111.137 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -91.39 40.07 0.33 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.262 2.641 . . . . 0.0 112.051 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.93 -56.02 3.93 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.639 -173.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.508 ' HB2' HG23 ' A' ' 30' ' ' THR . 49.6 mtpt -118.33 156.41 28.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.682 0.241 . . . . 0.0 111.162 -174.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -146.39 86.95 1.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.123 0.487 . . . . 0.0 110.323 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.494 ' C ' ' H ' ' A' ' 27' ' ' ASP . 14.0 m -155.81 162.89 40.4 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -76.72 30.66 0.13 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.51 0.671 . . . . 0.0 110.729 176.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -98.91 144.6 27.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.704 -176.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.493 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 81.4 m-85 -74.76 -24.86 58.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.126 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.414 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 25.5 t70 -66.0 -33.95 76.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 109.697 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.517 ' O ' HD11 ' A' ' 34' ' ' LEU . 99.6 m -54.59 -59.68 4.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.438 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 3.3 p-10 -65.13 -28.12 69.21 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.688 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.25 -43.05 96.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.856 0.36 . . . . 0.0 110.458 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 75.0 mmtt -65.25 -32.98 74.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.661 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.517 HD11 ' O ' ' A' ' 30' ' ' THR . 8.4 mp -72.02 -43.19 65.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.754 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.509 HG12 ' HD2' ' A' ' 47' ' ' ARG . 84.4 t -72.49 -18.86 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.289 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -55.09 -39.18 69.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.271 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -76.52 -34.81 58.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.411 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 54.5 p90 48.25 114.47 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.152 1.381 . . . . 0.0 113.71 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 t -71.35 -29.98 65.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.298 177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.3 t -152.71 -169.12 3.25 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.288 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.09 178.02 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.173 0.511 . . . . 0.0 112.261 -175.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.651 ' HB3' ' HB2' ' A' ' 47' ' ' ARG . 19.7 m -96.54 -51.98 4.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.622 -174.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.579 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 55.1 m 69.17 136.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.273 -170.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -33.92 -60.12 0.39 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -167.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -120.77 16.61 11.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 0.0 111.74 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.579 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 36.9 tp -90.88 -33.8 15.5 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.969 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.651 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 22.6 tpp180 -55.12 -46.89 75.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.472 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -69.44 -32.11 70.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 110.702 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.58 -44.65 70.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.431 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.449 ' O ' HG13 ' A' ' 54' ' ' ILE . 44.0 mm -60.22 -45.63 95.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.772 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.436 ' HB2' ' ND2' ' A' ' 31' ' ' ASN . . . -58.12 -45.91 86.5 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.477 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.662 ' O ' ' HG2' ' A' ' 56' ' ' ARG . . . -62.55 -42.73 99.67 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.054 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.5 ' CE2' HD11 ' A' ' 57' ' ' ILE . 66.9 t80 -57.62 -40.31 78.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.14 0.176 . . . . 0.0 110.626 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 50' ' ' ILE . 78.7 mt -56.14 -54.3 29.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.672 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -61.89 -35.77 79.31 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.662 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 52.8 mmm-85 -62.52 -41.83 99.11 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.68 0.276 . . . . 0.0 110.416 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.536 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 78.0 mt -58.66 -46.05 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.411 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.7 mt -57.73 -49.13 81.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -65.79 -37.0 85.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.579 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -71.62 -25.47 62.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.395 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.536 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 49.4 mt-30 -72.33 -18.43 61.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.119 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 C--O 1.246 0.897 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.794 179.163 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.0 -125.82 5.69 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.53 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -114.47 30.31 7.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.499 0.666 . . . . 0.0 109.84 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.4 tt -69.22 150.12 10.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.908 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 73.72 23.82 2.28 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.499 0.666 . . . . 0.0 109.909 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -161.7 -30.91 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.22 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m -60.98 -28.15 68.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.106 171.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.42 ' O ' HG13 ' A' ' 12' ' ' ILE . 94.5 t80 -59.69 -48.19 82.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.528 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.7 t -66.21 -40.59 87.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.168 0.509 . . . . 0.0 110.194 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -60.76 -32.59 71.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.72 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -69.63 -35.86 75.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.682 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 16' ' ' MET . 29.4 mt -61.63 -40.38 86.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.99 0.424 . . . . 0.0 109.931 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.37 -35.02 79.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.962 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -64.68 -56.49 13.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.73 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.528 ' HA ' ' HB3' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -68.48 -15.26 63.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.171 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.462 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 6.8 tpt -64.98 -53.67 42.54 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.13 -28.87 21.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.688 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.528 ' HB3' ' HA ' ' A' ' 15' ' ' GLU . 11.4 tp10 -60.15 153.85 20.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.423 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 18' ' ' GLU . 52.2 m 82.08 -47.72 0.2 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.517 0.727 . . . . 0.0 111.18 -176.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -147.64 96.17 4.16 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.597 0.237 . . . . 0.0 110.89 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.69 95.58 0.81 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.778 2.319 . . . . 0.0 111.315 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.692 ' H ' ' HE1' ' A' ' 38' ' ' PHE . . . -68.18 -82.53 0.16 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 116.111 -0.495 . . . . 0.0 113.133 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.54 ' HB2' HD22 ' A' ' 34' ' ' LEU . 67.0 mttm -136.02 152.95 51.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.664 0.269 . . . . 0.0 110.639 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -118.0 61.35 0.77 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.505 0.669 . . . . 0.0 109.338 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.645 ' HB ' HG23 ' A' ' 30' ' ' THR . 21.7 m -121.34 133.71 55.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.346 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.536 ' HA ' HG23 ' A' ' 55' ' ' THR . 8.0 p-10 -88.35 32.09 0.79 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -173.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -94.96 145.43 24.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -66.82 -27.47 67.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.73 0.3 . . . . 0.0 110.953 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.5 -37.95 88.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.521 0.677 . . . . 0.0 109.27 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.645 HG23 ' HB ' ' A' ' 25' ' ' THR . 22.2 m -65.81 -56.27 12.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.202 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -61.54 -27.83 68.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 111.247 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.73 -49.22 69.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.24 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -77.29 -21.02 54.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.877 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 30' ' ' THR . 41.7 mt -66.3 -50.11 64.75 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.18 174.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 68.8 t -56.14 -43.43 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.039 0.447 . . . . 0.0 110.025 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -58.24 -42.21 85.84 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.297 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.01 -48.86 11.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.692 ' HE1' ' H ' ' A' ' 22' ' ' GLY . 17.1 m-30 -56.88 -76.24 0.04 OUTLIER 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -131.77 133.54 44.86 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 t -81.6 -1.15 45.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.729 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.04 109.85 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.837 0.827 . . . . 0.0 110.517 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.7 m -80.61 162.35 24.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.638 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.757 ' HB ' ' HB2' ' A' ' 47' ' ' ARG . 11.1 m -150.06 117.46 6.08 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -21.51 -79.59 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.962 1.305 . . . . 0.0 113.51 -168.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -133.63 13.25 4.08 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.415 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.426 ' O ' HG13 ' A' ' 50' ' ' ILE . 58.6 tp -88.62 -28.37 20.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.361 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.757 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 14.1 tpp180 -66.67 -34.81 78.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.431 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.72 -39.69 85.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.755 175.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -73.66 -31.91 63.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.551 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.505 ' O ' HG13 ' A' ' 54' ' ' ILE . 80.4 mt -62.74 -40.17 87.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.195 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.43 96.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.042 0.449 . . . . 0.0 110.558 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.92 -32.23 83.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.734 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.492 ' O ' HG13 ' A' ' 57' ' ' ILE . 23.5 t80 -71.4 -30.82 66.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 50' ' ' ILE . 79.3 mt -59.4 -49.54 83.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.894 0.378 . . . . 0.0 110.193 175.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -62.35 -29.23 70.31 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.559 176.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.3 ttt85 -68.69 -41.59 78.95 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 110.687 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 53' ' ' TYR . 77.6 mt -59.99 -45.9 94.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.378 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.8 -50.7 79.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.247 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.0 p -66.4 -35.3 79.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.725 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -73.73 -35.99 65.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -72.81 -52.32 15.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.145 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.538 ' NZ ' ' HB3' ' A' ' 62' ' ' LYS . 1.3 ttpm? . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.4 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.632 0.253 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.38 130.11 9.91 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.335 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.551 HD22 ' HB3' ' A' ' 7' ' ' SER . 0.0 OUTLIER 77.01 145.71 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.413 0.685 . . . . 0.0 111.543 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 62.4 mt -103.88 -72.28 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.91 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -120.34 79.69 1.51 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.688 0.756 . . . . 0.0 111.041 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.4 m -161.29 3.42 0.06 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.751 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.564 ' O ' ' HG2' ' A' ' 11' ' ' ARG . 1.5 p -67.88 -17.71 64.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.016 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.514 ' O ' HG13 ' A' ' 12' ' ' ILE . 79.3 t80 -56.27 -40.61 74.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.031 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.87 -34.6 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.254 0.55 . . . . 0.0 110.192 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -68.04 -31.45 71.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.335 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 7' ' ' SER . 22.5 mmt180 -75.34 -31.77 60.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.075 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 8' ' ' PHE . 82.1 mt -61.75 -55.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.01 -39.13 77.53 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.452 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 38.7 tptt -52.78 -56.21 17.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.066 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.92 -28.29 64.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.588 -176.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.473 ' SD ' ' HA ' ' A' ' 39' ' ' SER . 87.1 mtp -66.65 -43.42 84.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.599 0.238 . . . . 0.0 110.979 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.3 mt -77.59 -31.68 17.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.108 0.48 . . . . 0.0 110.995 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -62.15 113.73 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.966 -175.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.608 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 93.1 m 76.31 -39.49 0.36 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.802 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -91.11 98.3 1.62 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.394 . . . . 0.0 110.149 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 19' ' ' THR . 27.5 Cg_endo -94.92 102.63 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.269 2.646 . . . . 0.0 112.69 -175.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.628 ' HA3' HD13 ' A' ' 34' ' ' LEU . . . -91.7 -125.06 3.35 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 173.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.476 ' HA ' HG22 ' A' ' 30' ' ' THR . 36.5 ttmt 61.54 77.71 0.32 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.188 0.518 . . . . 0.0 111.603 173.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.418 ' C ' ' HG1' ' A' ' 25' ' ' THR . 41.2 t80 -86.8 -37.54 17.71 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.418 ' HG1' ' C ' ' A' ' 24' ' ' PHE . 19.2 m -154.42 168.34 26.99 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -82.32 28.0 0.47 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.149 0.5 . . . . 0.0 111.035 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.37 162.12 14.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.716 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.3 -30.44 68.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.687 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.99 -30.63 71.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.211 0.529 . . . . 0.0 110.316 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 23' ' ' LYS . 97.5 m -64.94 -52.86 54.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.393 176.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.74 ' OD1' ' HB ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -61.34 -37.98 85.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.074 178.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -50.1 -49.27 52.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.573 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.68 -39.16 73.69 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.997 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.628 HD13 ' HA3' ' A' ' 22' ' ' GLY . 8.5 mp -58.77 -39.24 80.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.471 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.464 HG11 ' HG3' ' A' ' 47' ' ' ARG . 57.0 t -75.49 -37.11 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.267 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.14 -49.21 76.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.877 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -63.54 -65.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.067 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -101.6 -84.46 0.44 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.637 -168.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.473 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 90.3 p 51.33 -172.65 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.915 0.886 . . . . 0.0 112.308 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.9 m -145.85 112.22 5.81 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.1 t 65.67 82.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -169.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.8 m -72.33 91.95 1.37 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.124 -174.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.564 ' OG1' ' HB2' ' A' ' 46' ' ' LEU . 2.9 p -92.71 -175.61 3.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.285 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -102.01 -59.33 1.72 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.468 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -31.23 50.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 110.501 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.564 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 7.2 mp -73.18 -18.7 61.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.49 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.464 ' HG3' HG11 ' A' ' 35' ' ' VAL . 41.5 ttp180 -57.43 -43.66 84.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.4 0.619 . . . . 0.0 110.205 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -72.71 -23.17 60.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.574 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -71.23 -46.44 61.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.969 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.0 mt -63.24 -33.15 59.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.928 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.58 84.3 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.915 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.85 -41.22 88.84 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.76 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.441 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.0 m-85 -62.03 -61.45 2.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.496 0.189 . . . . 0.0 111.483 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.74 ' HB ' ' OD1' ' A' ' 31' ' ' ASN . 62.8 mt -60.84 -44.82 98.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -172.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 p -54.26 -45.76 72.5 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.243 0.474 . . . . 0.0 111.473 176.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -60.0 -43.83 94.93 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.418 176.095 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 53' ' ' TYR . 78.1 mt -62.76 -38.63 82.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.081 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 54' ' ' ILE . 75.7 mt -59.7 -51.36 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.865 0.364 . . . . 0.0 110.855 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.2 p -65.24 -22.3 66.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.573 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -84.99 -52.09 6.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.726 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -71.54 -36.31 70.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.085 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm . . . . . 0 C--O 1.25 1.097 0 O-C-N 123.838 0.711 . . . . 0.0 109.688 -172.539 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.92 148.22 41.03 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.966 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -90.69 125.56 35.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 tt -155.86 147.16 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.703 0.287 . . . . 0.0 111.538 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 75.85 130.51 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.995 171.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.2 21.54 0.1 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.271 176.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -75.17 -21.73 58.55 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.631 -166.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.461 ' O ' HG13 ' A' ' 12' ' ' ILE . 25.3 m-85 -65.58 -60.55 2.81 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.834 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.87 -34.64 71.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.214 0.531 . . . . 0.0 110.479 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -66.29 -33.66 76.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.545 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -72.86 -35.76 67.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.687 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 8' ' ' PHE . 72.4 mt -57.14 -49.95 78.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.208 177.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.3 -39.58 94.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -64.84 -34.51 78.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.77 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -69.86 -35.51 74.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.665 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.559 ' HA ' ' HD2' ' A' ' 38' ' ' PHE . 48.8 ttm -70.4 -42.63 71.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.684 177.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.577 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 53.5 mt -75.55 -5.84 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.385 0.612 . . . . 0.0 110.982 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' HG3' ' HG1' ' A' ' 19' ' ' THR . 5.5 tp10 -65.38 134.65 53.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.53 -177.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.516 ' HG1' ' HG3' ' A' ' 18' ' ' GLU . 53.0 m 76.19 -66.74 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 170.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.586 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . 1.2 t-160 -89.64 -57.01 0.27 Allowed Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 120.483 -0.487 . . . . 0.0 112.219 -168.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.941 ' HB3' HD21 ' A' ' 34' ' ' LEU . 43.1 Cg_exo -60.54 133.67 50.11 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.151 1.901 . . . . 0.0 112.631 178.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.56 -7.01 34.99 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.641 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 57.4 pttt 41.17 86.03 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.889 0.875 . . . . 0.0 112.415 -176.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -129.19 1.91 5.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.018 -0.426 . . . . 0.0 111.981 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.441 ' HB ' ' OG1' ' A' ' 30' ' ' THR . 11.6 m -139.94 146.61 39.41 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -105.02 29.42 6.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.7 0.286 . . . . 0.0 111.382 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -100.05 160.34 14.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -71.96 -24.21 61.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.681 0.277 . . . . 0.0 111.618 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.43 -29.17 69.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.338 0.59 . . . . 0.0 109.462 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.605 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 14.3 m -65.59 -52.18 54.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.424 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.454 ' O ' HG21 ' A' ' 35' ' ' VAL . 27.2 p30 -65.87 -28.34 68.89 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.755 -177.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -64.19 -44.02 93.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.949 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -65.2 -34.39 78.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.812 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.941 HD21 ' HB3' ' A' ' 21' ' ' PRO . 59.8 mt -70.6 -43.8 68.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.291 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.528 HG12 ' HG3' ' A' ' 47' ' ' ARG . 56.4 t -69.74 -30.81 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.378 0.609 . . . . 0.0 110.301 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.83 -23.29 60.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.327 0.584 . . . . 0.0 109.928 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -80.01 -55.66 4.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.164 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.559 ' HD2' ' HA ' ' A' ' 16' ' ' MET . 34.2 t80 -132.57 148.19 52.37 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.1 p -162.55 153.74 17.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.773 0.32 . . . . 0.0 110.848 -173.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.554 HG21 HG22 ' A' ' 41' ' ' VAL . 37.5 m -133.92 119.87 19.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.581 177.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.554 HG22 HG21 ' A' ' 40' ' ' THR . 66.1 t 73.63 153.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 123.514 0.509 . . . . 0.0 110.969 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.1 m -66.89 100.58 0.74 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.006 0.431 . . . . 0.0 109.877 175.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 47' ' ' ARG . 37.3 p -85.43 111.59 20.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.692 -175.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -98.63 -77.43 0.51 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -101.59 13.65 34.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.398 0.618 . . . . 0.0 109.953 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.8 tp -95.15 -27.78 15.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.762 173.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.547 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 51.2 ttp180 -67.09 -47.64 70.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.586 -174.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -61.64 -34.98 76.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.996 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 72.2 mmtt -65.57 -51.16 61.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.528 ' O ' HG13 ' A' ' 54' ' ' ILE . 66.3 mt -65.28 -51.34 66.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.8 -48.83 77.05 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.926 0.394 . . . . 0.0 111.144 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.92 -37.94 95.75 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.96 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 57' ' ' ILE . 2.0 t80 -69.95 -33.13 71.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 50' ' ' ILE . 80.9 mt -56.84 -55.58 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.863 0.363 . . . . 0.0 110.265 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.17 -32.31 73.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -62.05 -46.64 88.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.958 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 53' ' ' TYR . 84.1 mt -62.57 -39.01 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.671 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 54' ' ' ILE . 71.8 mt -58.25 -51.87 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.526 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.9 p -65.86 -18.9 65.66 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.785 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -84.89 -38.96 18.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 0.0 110.372 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -73.84 -38.37 64.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.32 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.471 -179.395 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtm . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.779 0.324 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -90.92 95.77 2.12 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.521 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -149.79 -160.5 1.18 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.892 HG13 ' H ' ' A' ' 5' ' ' ARG . 9.6 tp -130.05 -166.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.892 ' H ' HG13 ' A' ' 4' ' ' ILE . 9.6 ptp85 -51.89 133.25 32.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.95 0.405 . . . . 0.0 111.368 176.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 m -67.41 -24.23 65.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.307 0.575 . . . . 0.0 110.601 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.9 m -67.8 -9.33 43.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.501 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.437 ' O ' HG13 ' A' ' 12' ' ' ILE . 75.6 t80 -65.62 -37.19 85.88 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.7 t -66.12 -37.29 79.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.672 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -64.93 -33.33 75.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.448 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -28.24 62.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 8' ' ' PHE . 72.9 mt -70.71 -39.23 75.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.265 0.555 . . . . 0.0 109.547 173.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.31 90.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.484 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -63.03 -42.92 99.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.071 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -55.55 -45.73 77.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.503 ' SD ' ' HB3' ' A' ' 34' ' ' LEU . 46.3 tpp -55.77 -52.44 63.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.222 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.32 -49.73 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.236 -173.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -66.09 -33.08 74.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.728 0.299 . . . . 0.0 111.792 -173.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 m -84.11 -16.87 42.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.246 0.546 . . . . 0.0 110.579 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.433 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . 47.2 t-80 -132.55 69.39 79.75 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.064 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.31 0.45 9.41 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.12 2.547 . . . . 0.0 112.716 -174.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -97.02 147.06 18.56 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 70.43 20.88 5.84 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.915 0.486 . . . . 0.0 110.775 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -71.38 120.52 17.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.186 0.517 . . . . 0.0 109.923 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.2 m -153.97 144.93 22.7 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.719 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -77.95 41.93 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.616 0.722 . . . . 0.0 110.191 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -103.9 139.93 38.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.712 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.643 ' HA ' ' ND2' ' A' ' 31' ' ' ASN . 99.5 m-85 -72.14 -40.27 68.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.777 -174.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.56 -38.35 90.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.245 0.545 . . . . 0.0 110.358 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.434 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 67.3 m -62.71 -55.03 30.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.564 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.643 ' ND2' ' HA ' ' A' ' 28' ' ' PHE . 20.9 p30 -60.87 -30.05 69.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.702 0.287 . . . . 0.0 110.997 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.567 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 14.3 tmtt? -66.93 -52.13 46.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.082 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 52.3 mtmt -67.4 -26.8 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.727 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.503 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 95.2 mt -69.33 -48.17 62.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.65 0.262 . . . . 0.0 110.713 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.824 HG12 HG23 ' A' ' 43' ' ' THR . 17.8 t -68.15 -24.58 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.429 . . . . 0.0 110.11 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 7.3 mm-40 -57.42 -38.51 74.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.245 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -159.09 89.76 0.94 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 -174.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.433 ' CZ ' ' HB2' ' A' ' 20' ' ' HIS . 51.3 t80 -175.65 -78.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.266 171.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.6 m -104.07 51.04 0.78 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.454 0.645 . . . . 0.0 109.347 173.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.443 HG21 ' HB ' ' A' ' 43' ' ' THR . 10.8 m -78.79 113.2 16.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.585 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.22 96.79 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.922 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.7 m 53.14 34.59 17.73 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.631 0.729 . . . . 0.0 109.786 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.824 HG23 HG12 ' A' ' 35' ' ' VAL . 38.2 m -86.5 89.08 7.78 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.8 -168.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -104.31 -66.31 0.97 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.066 168.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -98.18 -19.62 17.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.14 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.6 tp -64.87 -14.19 58.75 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.13 0.491 . . . . 0.0 110.589 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.563 ' HA ' HG13 ' A' ' 35' ' ' VAL . 38.1 ttm180 -49.49 -57.73 6.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.801 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -69.6 -18.33 63.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.538 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -75.32 -54.04 7.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.034 0.445 . . . . 0.0 110.109 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.452 ' O ' HG13 ' A' ' 54' ' ' ILE . 62.2 mt -64.69 -41.76 93.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.048 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB1' ' OD1' ' A' ' 31' ' ' ASN . . . -59.31 -38.64 80.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.172 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.86 -44.24 97.27 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.718 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -60.88 -49.83 75.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.952 -0.124 . . . . 0.0 111.08 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 50' ' ' ILE . 78.0 mt -49.05 -57.81 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 O-C-N 123.527 0.517 . . . . 0.0 111.111 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -47.32 -58.27 4.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.222 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 75.2 mtt-85 -70.8 -33.06 70.33 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -172.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.0 mt -65.26 -40.37 88.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.974 0.416 . . . . 0.0 110.118 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.35 -32.29 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.229 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.1 m -65.52 -24.62 67.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 176.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 83.4 mm-40 -75.38 -54.01 7.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.308 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.49 -51.38 8.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.637 0.256 . . . . 0.0 111.663 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.3 tttt . . . . . 0 C--O 1.249 1.071 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.329 -174.211 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tmm? . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 121.013 0.435 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.07 92.27 1.55 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.58 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -75.26 69.07 2.06 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.4 mt 68.45 -72.88 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 O-C-N 123.725 0.641 . . . . 0.0 110.03 -173.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 62.76 177.03 0.14 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.414 0.685 . . . . 0.0 112.112 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.2 m -162.82 -30.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.407 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 m -49.16 -44.21 42.6 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.207 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -61.65 -48.57 80.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.5 t -63.59 -44.8 98.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.772 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.15 -29.7 67.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.817 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.516 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 8.6 tpt180 -64.49 -42.32 95.92 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 176.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.5 mm -59.24 -43.1 89.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.254 177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.33 97.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.284 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -58.49 -41.66 85.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.779 178.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 11' ' ' ARG . 76.2 mm-40 -56.67 -47.08 80.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.829 0.347 . . . . 0.0 110.493 178.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.458 ' CE ' ' HB3' ' A' ' 39' ' ' SER . 42.0 ttm -65.83 -50.29 65.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.739 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.447 ' HA ' ' HZ3' ' A' ' 23' ' ' LYS . 85.0 mt -57.72 -46.29 86.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.602 -177.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.452 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 5.2 tp10 -66.22 -46.48 77.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 m -69.19 -41.62 76.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.236 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -121.44 92.91 48.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 110.952 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.99 -2.95 11.53 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.589 2.86 . . . . 0.0 112.334 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.31 62.27 2.65 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.329 -0.462 . . . . 0.0 113.038 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.447 ' HZ3' ' HA ' ' A' ' 17' ' ' ILE . 2.0 pptp? -169.61 142.84 2.62 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -167.23 48.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.651 0.738 . . . . 0.0 110.225 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.457 ' HB ' ' OD2' ' A' ' 27' ' ' ASP . 0.6 OUTLIER -139.0 146.01 40.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.488 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -106.14 21.4 17.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 111.503 -173.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.463 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 4.3 p30 -89.45 159.3 17.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 176.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.664 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 62.2 m-85 -71.36 -28.24 63.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.118 -176.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.97 -36.76 85.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.121 0.486 . . . . 0.0 110.305 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.463 ' HG1' ' CG ' ' A' ' 27' ' ' ASP . 53.1 m -61.1 -56.81 16.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.661 176.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.664 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.7 p-10 -65.65 -23.97 66.92 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.395 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 20.6 ttpp -62.12 -52.06 65.36 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -56.58 -38.59 72.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.274 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.461 ' HA ' ' HD2' ' A' ' 38' ' ' PHE . 7.7 mp -60.15 -51.53 69.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.4 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.419 HG11 ' HB3' ' A' ' 51' ' ' ALA . 35.7 m -82.46 -9.2 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 122.047 -0.408 . . . . 0.0 111.011 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.606 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 2.8 tp10 -76.08 -2.61 31.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -158.5 -48.14 0.06 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.854 0.359 . . . . 0.0 111.374 -171.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.461 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 36.9 m-85 -84.66 -165.98 1.34 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.809 -174.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.458 ' HB3' ' CE ' ' A' ' 16' ' ' MET . 93.3 p 62.23 174.42 0.13 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.397 1.079 . . . . 0.0 112.29 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.548 HG23 HG21 ' A' ' 41' ' ' VAL . 13.9 t -160.88 -161.13 0.8 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -178.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.548 HG21 HG23 ' A' ' 40' ' ' THR . 67.6 t 79.01 149.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 123.693 0.621 . . . . 0.0 110.345 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.3 t -78.6 -171.6 2.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.117 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.6 m 69.76 82.6 0.16 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.877 0.846 . . . . 0.0 109.95 -174.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.4 pttm -62.5 -25.74 68.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.316 -175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -78.71 -13.18 59.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.955 0.407 . . . . 0.0 110.64 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -77.04 -39.6 49.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.044 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -69.78 -10.16 57.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.854 0.359 . . . . 0.0 111.682 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -69.59 -41.96 75.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.402 0.62 . . . . 0.0 109.635 172.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -73.24 -38.89 65.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.69 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.555 ' O ' HG13 ' A' ' 54' ' ' ILE . 50.4 mm -57.16 -49.18 80.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.487 177.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.541 ' HB1' HD21 ' A' ' 31' ' ' ASN . . . -57.85 -50.94 71.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.414 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.62 -28.48 73.65 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.767 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.503 ' O ' HG13 ' A' ' 57' ' ' ILE . 22.7 t80 -73.93 -37.27 64.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 50' ' ' ILE . 84.6 mt -58.63 -47.64 88.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 110.124 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.76 -42.23 75.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.414 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -66.22 -44.47 83.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.032 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 53' ' ' TYR . 80.9 mt -57.53 -49.36 80.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.68 -49.95 81.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.095 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 p -65.82 -25.39 67.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.709 0.29 . . . . 0.0 111.535 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -70.27 -34.19 72.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.044 0.449 . . . . 0.0 110.327 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.729 HE21 ' HA ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -86.39 -33.02 20.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.754 177.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.5 tttm . . . . . 0 C--O 1.253 1.275 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.811 -176.036 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.796 0.332 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.15 -110.34 3.77 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.874 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -100.94 86.98 3.17 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.1 mt 66.55 -74.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.469 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -138.5 -63.47 0.54 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.157 0.503 . . . . 0.0 110.079 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -167.39 21.11 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.866 0.841 . . . . 0.0 109.042 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m -67.61 -14.07 62.62 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.259 -172.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.525 ' O ' HG13 ' A' ' 12' ' ' ILE . 55.0 t80 -64.16 -35.84 82.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.4 -48.78 85.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.095 0.474 . . . . 0.0 110.7 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -58.78 -40.2 83.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.544 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -59.44 -46.31 89.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.439 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 8' ' ' PHE . 73.3 mt -57.17 -53.5 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.745 0.307 . . . . 0.0 111.094 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.482 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -63.82 -45.78 88.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.432 -177.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.2 -39.51 94.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.42 -176.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.883 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 31.0 mt-10 -71.06 -30.62 66.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.748 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.502 ' HE2' HG21 ' A' ' 12' ' ' ILE . 59.9 mtt -55.34 -42.45 73.84 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.515 HD12 HG21 ' A' ' 54' ' ' ILE . 57.8 mt -65.23 -54.18 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.25 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.883 ' HG2' ' HA ' ' A' ' 15' ' ' GLU . 8.8 pt-20 -67.0 -6.01 15.19 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.5 m -57.59 -43.08 84.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.147 0.498 . . . . 0.0 110.662 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -150.44 120.09 3.73 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.959 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.68 100.33 0.11 Allowed 'Trans proline' 0 CA--C 1.515 -0.429 0 C-N-CA 122.648 2.232 . . . . 0.0 111.914 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.19 171.69 44.69 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.899 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.578 ' HB3' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER 57.83 -113.56 0.73 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -176.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 92.3 t80 70.77 -33.7 0.28 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 165.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 p -82.9 70.25 9.86 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -166.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t70 36.79 66.54 0.4 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.369 1.068 . . . . 0.0 112.786 170.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.543 ' O ' ' HB ' ' A' ' 30' ' ' THR . 7.9 t70 -139.79 147.91 41.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.222 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -77.9 -35.25 50.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 110.633 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 36.2 t70 -65.63 -29.7 70.31 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.578 HG23 ' HB3' ' A' ' 23' ' ' LYS . 2.5 m -61.06 -50.54 72.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.679 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 51' ' ' ALA . 18.5 p30 -64.46 -34.77 78.97 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 110.507 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.6 ttpt -63.41 -48.89 75.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.517 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 25.9 ttmt -69.67 -13.3 62.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.566 -173.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 30' ' ' THR . 96.7 mt -81.92 -49.9 9.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.941 0.4 . . . . 0.0 110.425 173.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.51 HG13 ' HA ' ' A' ' 47' ' ' ARG . 43.4 t -74.98 -28.39 21.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.212 -176.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -76.08 7.03 4.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -175.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 33' ' ' LYS . 12.4 pt-20 -155.98 -43.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.646 -0.421 . . . . 0.0 112.105 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -84.68 -85.45 0.14 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.494 ' HA ' ' HE3' ' A' ' 16' ' ' MET . 11.9 t 54.65 -159.36 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.752 0.787 . . . . 0.0 112.094 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.2 m -153.65 -44.67 0.09 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.689 HG23 HG23 ' A' ' 43' ' ' THR . 7.5 p -161.61 108.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.707 171.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.448 ' C ' ' HG1' ' A' ' 43' ' ' THR . 14.6 m -80.07 -28.17 39.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.813 -172.221 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.689 HG23 HG23 ' A' ' 41' ' ' VAL . 65.9 p 48.53 -131.84 1.61 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.65 0.594 . . . . 0.0 111.311 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -103.39 -64.95 1.04 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 111.361 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -107.35 -9.06 16.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -173.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.7 tp -64.09 -34.85 78.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.51 ' HA ' HG13 ' A' ' 35' ' ' VAL . 14.6 ttm105 -47.17 -52.45 15.61 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.808 0.693 . . . . 0.0 110.992 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -78.36 -30.38 47.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.664 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -74.1 -51.1 16.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.854 0.359 . . . . 0.0 110.209 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.566 ' O ' HG13 ' A' ' 54' ' ' ILE . 10.6 tt -66.37 -34.05 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.447 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 31' ' ' ASN . . . -65.26 -40.32 93.8 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.039 0.447 . . . . 0.0 110.641 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.39 -41.18 99.47 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.415 ' CE2' HD12 ' A' ' 57' ' ' ILE . 61.4 t80 -63.38 -44.28 95.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.607 -0.297 . . . . 0.0 110.631 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 50' ' ' ILE . 91.4 mt -54.62 -57.84 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.753 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -56.24 -40.7 74.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.132 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -59.1 -39.54 82.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.058 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.415 HD12 ' CE2' ' A' ' 53' ' ' TYR . 70.7 mt -68.11 -42.33 84.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 110.436 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.09 -45.74 93.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.868 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -58.72 -37.41 76.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.754 0.311 . . . . 0.0 110.688 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.99 -36.0 81.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.079 0.466 . . . . 0.0 110.777 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -24.79 57.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.527 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.929 -176.044 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.6 t . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.763 0.316 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -64.37 -36.12 83.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.064 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.8 t -66.3 -36.59 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.435 0.636 . . . . 0.0 109.721 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -66.39 -33.94 76.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.529 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -66.75 -41.61 87.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.412 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.62 -40.26 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.345 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -60.54 -47.03 87.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.391 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 27.0 mmmt -56.63 -50.01 73.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.157 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.31 -39.01 78.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.808 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.579 ' SD ' HG13 ' A' ' 35' ' ' VAL . 37.6 ttm -69.82 -45.64 67.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.442 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.625 HG23 HD21 ' A' ' 34' ' ' LEU . 63.8 mt -75.38 -49.75 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.908 0.385 . . . . 0.0 111.481 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 1.7 tp10 -65.61 -8.89 22.58 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -169.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.489 HG21 ' CD1' ' A' ' 38' ' ' PHE . 5.9 t -76.69 -17.32 59.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.273 0.559 . . . . 0.0 109.808 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 18.1 t-160 -142.51 109.08 5.67 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 20' ' ' HIS . 20.7 Cg_exo . . . . . 0 CA--C 1.536 0.622 0 C-N-CA 123.704 2.936 . . . . 0.0 114.161 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -131.62 144.34 50.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -67.42 -36.18 80.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.389 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.523 ' O ' ' HD3' ' A' ' 33' ' ' LYS . 17.0 t70 -65.69 -39.56 91.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.104 0.478 . . . . 0.0 110.173 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 m -61.22 -52.07 66.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.853 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.451 ' O ' HG23 ' A' ' 35' ' ' VAL . 78.3 m-20 -65.06 -32.39 74.09 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.734 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 64.0 tttm -58.93 -53.83 53.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.353 176.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HD3' ' O ' ' A' ' 29' ' ' ASP . 1.2 mptm? -66.48 -36.27 82.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.919 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.625 HD21 HG23 ' A' ' 17' ' ' ILE . 43.4 tp -57.82 -40.63 80.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.609 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.579 HG13 ' SD ' ' A' ' 16' ' ' MET . 76.9 t -69.75 -46.31 74.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.907 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 43.4 mt-10 -70.99 -25.3 62.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -171.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.52 -15.42 58.62 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.117 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.522 ' HD2' ' HG3' ' A' ' 16' ' ' MET . 65.5 t80 -113.83 -80.47 0.59 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.5 m 63.84 103.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.7 0.625 . . . . 0.0 112.143 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 121.951 0.882 . . . . 0.0 109.589 176.38 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -78.78 -12.34 60.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.96 0.41 . . . . 0.0 110.841 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 49' ' ' LYS . 38.7 tp -74.31 -21.75 59.58 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.478 ' HG3' HG11 ' A' ' 35' ' ' VAL . 73.7 ttp85 -59.92 -30.25 68.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.586 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.69 -44.23 97.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.369 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.528 ' HD2' HD12 ' A' ' 46' ' ' LEU . 68.1 mttm -67.62 -34.26 76.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.331 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.532 ' O ' HG13 ' A' ' 54' ' ' ILE . 50.5 mm -65.35 -49.48 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.524 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.05 97.3 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.89 -33.97 81.12 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.771 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 11.5 t80 -63.23 -45.94 89.29 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.502 0.321 . . . . 0.0 110.54 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.569 HG12 HD11 ' A' ' 17' ' ' ILE . 36.2 mt -58.9 -56.64 15.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.169 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -49.69 -40.24 39.42 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.677 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.09 -48.05 75.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.993 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.2 mt -59.21 -43.4 89.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 110.623 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.59 -48.99 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.73 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 p -65.31 -31.22 72.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -84.95 -18.53 34.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.875 0.369 . . . . 0.0 111.408 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -73.37 -37.76 65.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.242 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 65.0 tttp . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.764 -177.716 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 m . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -63.68 -43.53 96.42 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 122.298 -0.251 . . . . 0.0 111.307 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.52 -48.49 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.261 0.553 . . . . 0.0 110.628 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -64.12 -30.78 71.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.633 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.744 ' HA ' ' HE ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -63.2 -52.98 60.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.51 177.087 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 74.5 mt -57.59 -44.41 85.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.809 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.71 -49.16 71.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.169 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -65.2 -44.24 89.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -62.36 -39.03 91.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.906 0.384 . . . . 0.0 110.53 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.511 ' SD ' ' HB2' ' A' ' 38' ' ' PHE . 27.2 tpp -55.97 -47.81 76.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.438 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.613 HD11 HG23 ' A' ' 54' ' ' ILE . 56.1 mt -76.86 -51.92 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.706 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.86 -25.92 67.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -168.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 p -61.29 -22.94 65.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 111.109 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -143.67 90.14 7.16 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.57 0.7 . . . . 0.0 109.324 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 C--O 1.232 0.216 0 C-N-CA 122.975 2.45 . . . . 0.0 113.223 -172.443 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.83 0.824 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -137.12 157.29 47.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.47 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.729 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 94.2 m-85 -62.22 -28.54 69.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.474 -176.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.58 -45.21 94.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.632 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.419 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.5 m -65.94 -51.57 57.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.883 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.729 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.4 p-10 -65.35 -28.92 69.63 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.978 -177.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -60.79 -49.23 78.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 109.88 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -63.65 -34.85 78.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.992 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 17' ' ' ILE . 97.4 mt -68.17 -44.4 76.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.235 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.598 HG11 ' HG3' ' A' ' 47' ' ' ARG . 56.3 t -77.12 -43.75 31.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.504 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.53 -22.15 61.24 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 111.833 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.63 -39.88 91.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.673 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.511 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 81.8 m-85 -124.79 -52.14 1.69 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.6 t -49.47 110.95 0.43 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.229 0.538 . . . . 0.0 111.716 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 121.646 0.736 . . . . 0.0 110.029 179.073 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -129.23 3.45 5.19 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.233 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -71.69 -42.46 67.4 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.624 0.726 . . . . 0.0 109.169 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.598 ' HG3' HG11 ' A' ' 35' ' ' VAL . 18.9 ttt-85 -66.62 -36.98 83.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.86 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.62 -39.99 90.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.618 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -62.18 -47.24 85.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.966 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.474 ' O ' HG12 ' A' ' 54' ' ' ILE . 69.4 mt -61.64 -41.67 91.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.547 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.17 77.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.315 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.07 93.11 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.887 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -68.55 -30.31 69.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 17' ' ' ILE . 40.8 mm -60.29 -50.31 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.892 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -33.02 71.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.882 0.372 . . . . 0.0 110.914 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 -64.46 -48.68 74.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.376 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 54' ' ' ILE . 14.3 tt -69.02 -26.85 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 110.784 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 54' ' ' ILE . 78.8 mt -65.12 -47.75 86.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 174.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.2 p -66.35 -16.49 64.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.828 0.347 . . . . 0.0 111.112 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -76.02 -33.92 59.67 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.909 0.385 . . . . 0.0 110.249 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -76.33 -45.53 31.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.944 0.402 . . . . 0.0 110.4 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 tptm . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.505 -177.697 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.476 ' O ' HG13 ' A' ' 12' ' ' ILE . 64.4 m-85 -61.97 -58.25 8.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.71 -37.22 79.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.25 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -61.85 -42.61 99.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.64 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 8.1 tmm_? -68.39 -40.74 81.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.463 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 8' ' ' PHE . 86.0 mt -58.78 -45.59 91.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.016 0.436 . . . . 0.0 110.132 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.53 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -62.84 -43.63 98.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.42 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.97 -43.39 81.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.452 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 11' ' ' ARG . 49.0 mt-10 -61.33 -41.43 97.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.982 0.42 . . . . 0.0 110.706 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.529 ' SD ' ' HA ' ' A' ' 35' ' ' VAL . 31.8 ttp -70.26 -48.52 56.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.437 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 54' ' ' ILE . 74.6 mt -58.47 -44.82 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.126 0.489 . . . . 0.0 111.441 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.94 -4.18 6.54 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.154 -172.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -77.66 -20.77 53.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.044 0.449 . . . . 0.0 110.416 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.414 ' HB2' HD22 ' A' ' 34' ' ' LEU . 11.1 m-70 -140.44 84.83 13.81 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.487 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.462 -0.332 0 C-N-CA 122.483 2.122 . . . . 0.0 112.136 177.666 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 122.276 1.036 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -133.79 168.29 19.0 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.729 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -77.93 -18.6 55.9 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.905 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.89 -38.27 88.3 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 167.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.637 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 6.4 m -60.72 -62.06 2.13 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.814 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.703 ' O ' HG23 ' A' ' 35' ' ' VAL . 23.1 p30 -65.17 -49.25 70.55 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -173.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -55.5 -46.17 77.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 111.183 -176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -71.37 -27.84 63.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.016 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 30' ' ' THR . 64.5 mt -76.66 -32.57 58.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.979 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 31' ' ' ASN . 32.8 t -66.38 -34.12 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.261 0.553 . . . . 0.0 110.177 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.56 -12.24 61.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.386 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.99 -61.33 2.02 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.606 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.516 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 0.3 OUTLIER -97.92 -157.79 0.62 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.876 -171.299 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.2 t -90.47 126.1 35.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -168.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.812 169.399 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -115.81 -16.04 11.23 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.432 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.98 -23.66 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 166.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.537 ' HG2' HG11 ' A' ' 35' ' ' VAL . 6.2 ttt180 -50.84 -38.93 51.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.175 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.86 -39.0 93.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.763 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' HD1' ' A' ' 53' ' ' TYR . 58.5 mttp -67.18 -40.37 86.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.144 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.487 ' O ' HG13 ' A' ' 54' ' ' ILE . 65.7 mt -60.08 -40.89 84.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.371 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.05 -40.1 84.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.667 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.23 -46.68 93.81 Favored Glycine 0 C--O 1.239 0.458 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.952 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.445 ' HD1' ' O ' ' A' ' 49' ' ' LYS . 57.4 m-85 -55.54 -43.72 76.04 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 176.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.55 ' HA ' HD11 ' A' ' 17' ' ' ILE . 52.9 mt -53.61 -55.32 13.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 O-C-N 123.432 0.457 . . . . 0.0 111.758 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -48.34 57.34 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 111.55 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -67.68 -42.32 82.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.377 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 53' ' ' TYR . 84.1 mt -61.04 -43.46 96.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.745 0.307 . . . . 0.0 110.391 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.6 mt -62.7 -42.04 94.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.323 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.4 p -65.18 -24.68 67.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.019 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.83 -28.25 24.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.029 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -84.73 -35.46 22.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.517 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.672 -178.947 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.535 0.373 0 CA-C-O 121.431 0.634 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.498 ' O ' HG13 ' A' ' 12' ' ' ILE . 52.8 t80 -57.54 -43.45 84.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.849 176.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.38 -28.66 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 121.055 0.455 . . . . 0.0 110.518 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -70.12 -37.93 75.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.592 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -64.82 -43.71 92.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.166 174.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 8' ' ' PHE . 74.2 mt -54.93 -48.53 74.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.285 176.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.98 91.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.098 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -65.58 -49.79 67.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.75 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.04 -20.23 63.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.023 0.44 . . . . 0.0 110.838 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.421 ' SD ' HG22 ' A' ' 35' ' ' VAL . 51.2 ttm -70.58 -48.44 55.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.552 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.5 mt -75.08 -27.66 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 0.0 110.303 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 73.84 -59.39 0.56 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.959 0.904 . . . . 0.0 111.954 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 14.0 t -142.16 -170.04 3.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -175.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -89.53 108.53 25.59 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 19' ' ' THR . 92.3 Cg_endo . . . . . 0 N--CA 1.457 -0.634 0 C-N-CA 122.695 2.263 . . . . 0.0 112.615 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.466 0.346 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.429 ' OD1' ' HB3' ' A' ' 29' ' ' ASP . 12.4 t70 -75.66 136.35 40.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.46 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 70.4 m-85 -64.35 -21.76 66.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.429 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 2.1 t70 -64.29 -30.85 71.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.327 0.584 . . . . 0.0 110.368 175.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.3 m -65.14 -61.73 1.97 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.156 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.6 p-10 -64.23 -28.52 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 -178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.9 -42.79 98.71 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.61 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -73.18 -27.5 61.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.973 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 31' ' ' ASN . 97.8 mt -68.12 -47.19 68.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.371 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 31' ' ' ASN . 89.2 t -55.3 -57.56 7.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -64.99 -28.12 69.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.755 -173.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.46 -48.4 67.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.922 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -85.55 -73.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.107 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 t -140.19 108.7 5.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.252 -173.707 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.0 tptp . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.729 0.299 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -154.86 21.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.77 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.3 tp -65.77 -29.48 69.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 47' ' ' ARG . 41.2 ttm180 -54.29 -34.11 60.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.072 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -66.4 -35.38 80.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.768 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -69.19 -41.3 77.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.182 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 54' ' ' ILE . 57.2 mt -63.41 -47.92 89.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.046 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.486 ' HB1' HD22 ' A' ' 31' ' ' ASN . . . -60.53 -44.41 96.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.174 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -63.01 -34.21 89.34 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.075 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.505 ' O ' HG13 ' A' ' 57' ' ' ILE . 34.9 t80 -67.04 -37.78 84.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 50' ' ' ILE . 75.0 mt -56.85 -50.03 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.489 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -53.12 -43.23 66.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.978 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.552 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 96.9 mtt180 -64.0 -41.71 97.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.395 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 53' ' ' TYR . 79.9 mt -59.17 -40.8 81.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.706 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 54' ' ' ILE . 76.2 mt -57.36 -43.13 81.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.072 0.463 . . . . 0.0 110.548 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.7 t -65.8 -29.47 69.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.974 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 72.5 mt-30 -82.18 -30.7 30.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.992 0.425 . . . . 0.0 110.556 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -64.77 -62.33 1.64 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.464 -171.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.238 -177.896 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.888 0.375 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.465 ' O ' HG13 ' A' ' 12' ' ' ILE . 9.1 m-85 -64.24 -65.74 0.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.229 0.538 . . . . 0.0 110.736 -176.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.462 ' HA ' HD12 ' A' ' 12' ' ' ILE . 40.0 t -65.57 -32.25 57.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.586 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.58 -43.46 97.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.836 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -74.04 -26.39 60.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.663 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 8' ' ' PHE . 75.0 mt -60.44 -43.27 93.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.879 0.371 . . . . 0.0 110.211 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.44 84.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.373 176.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.487 ' HD3' ' C ' ' A' ' 14' ' ' LYS . 12.0 tmtt? -61.12 -41.95 97.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.349 176.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -70.35 -27.14 64.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.184 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.435 ' HE1' HG13 ' A' ' 35' ' ' VAL . 42.7 ttm -70.17 -52.23 25.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.105 0.479 . . . . 0.0 110.538 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 mt -77.38 -1.37 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.074 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.406 ' O ' ' HB ' ' A' ' 19' ' ' THR . 14.1 tp10 -58.8 126.46 27.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.861 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 18' ' ' GLU . 93.1 m 76.62 -54.5 0.58 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.525 173.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 82.6 t60 -138.73 103.02 7.66 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.191 -176.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 20' ' ' HIS . 45.9 Cg_endo . . . . . 0 N--CA 1.46 -0.484 0 C-N-CA 122.326 2.017 . . . . 0.0 110.77 170.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 122.062 0.934 . . . . 0.0 111.778 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.67 132.89 33.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.906 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.649 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 70.5 m-85 -61.5 -19.39 62.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -172.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.481 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 18.1 t0 -63.77 -45.45 89.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.084 0.469 . . . . 0.0 109.763 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.588 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 96.8 m -65.31 -56.25 13.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.844 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.761 HD22 ' HB1' ' A' ' 51' ' ' ALA . 2.9 p-10 -61.94 -41.93 98.53 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -70.52 -31.29 68.32 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.462 -179.219 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 33.5 ttmt -74.83 -28.19 60.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.612 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 30' ' ' THR . 84.2 mt -67.32 -49.54 63.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.119 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.524 ' HB ' ' HG3' ' A' ' 47' ' ' ARG . 14.9 t -63.07 -26.62 41.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.129 0.49 . . . . 0.0 110.447 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.4 tt0 -64.11 -16.47 61.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.569 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -156.68 53.51 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.485 0.659 . . . . 0.0 111.11 -173.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.481 ' HE2' HD22 ' A' ' 34' ' ' LEU . 12.8 m-85 -148.55 -89.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.342 172.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.0 m -87.4 58.2 4.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 0.0 110.087 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.449 -0.514 0 CA-C-O 121.362 0.601 . . . . 0.0 110.922 -176.358 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.3 mttt . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.802 0.334 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -84.45 -13.87 50.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.027 0.442 . . . . 0.0 110.053 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.93 -27.48 66.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.824 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.524 ' HG3' ' HB ' ' A' ' 35' ' ' VAL . 42.1 ttp180 -56.62 -35.04 67.84 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.559 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -65.63 -45.62 82.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.257 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.34 -45.17 48.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.545 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 54' ' ' ILE . 76.1 mt -61.65 -41.25 89.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.799 0.333 . . . . 0.0 110.535 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.761 ' HB1' HD22 ' A' ' 31' ' ' ASN . . . -60.13 -41.5 92.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.239 176.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.49 -42.63 99.14 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.985 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.443 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.2 m-85 -58.32 -42.87 87.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.009 -0.096 . . . . 0.0 110.898 176.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 50' ' ' ILE . 62.5 mt -55.92 -53.53 37.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.112 0.257 . . . . 0.0 110.769 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -40.32 73.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.641 0.257 . . . . 0.0 111.531 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -65.91 -41.86 90.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.945 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 53' ' ' TYR . 76.1 mt -65.84 -45.54 91.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.727 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.534 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 86.5 mt -58.11 -49.89 80.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.569 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.9 t -65.19 -29.03 69.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.38 -29.32 65.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.048 0.451 . . . . 0.0 110.23 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -83.95 -30.92 25.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.309 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 17.8 ptpt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.948 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 120.677 0.275 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -64.8 -38.6 91.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.141 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.74 -50.93 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.815 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -61.68 -42.29 98.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.095 0.474 . . . . 0.0 110.473 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -58.77 -55.12 39.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.493 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.08 -42.42 94.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.558 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -61.31 -42.52 98.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -59.14 -48.48 81.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.953 0.406 . . . . 0.0 110.701 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.69 -25.81 64.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.261 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.9 ttm -72.13 -40.42 68.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.798 0.332 . . . . 0.0 110.932 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 13' ' ' ALA . 50.5 mm -66.0 -46.99 86.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.09 161.92 20.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.953 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.5 m 72.53 -57.37 0.63 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.399 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -129.08 78.08 76.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.858 0.361 . . . . 0.0 110.929 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 N--CA 1.463 -0.315 0 C-N-CA 123.09 2.527 . . . . 0.0 112.887 -177.087 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 120.82 0.343 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -71.43 127.9 34.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.865 0.364 . . . . 0.0 111.228 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -62.78 -41.34 99.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.408 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.18 -38.17 89.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.123 0.487 . . . . 0.0 110.317 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 54.5 m -62.4 -45.88 91.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.91 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.568 ' O ' HG23 ' A' ' 35' ' ' VAL . 77.0 m-20 -65.02 -37.28 87.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.506 176.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -60.12 -39.5 86.48 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.07 0.462 . . . . 0.0 110.478 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 30' ' ' THR . 6.8 tmtm? -56.07 -43.04 77.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.171 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.0 mp -73.61 -31.74 63.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.571 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 31' ' ' ASN . 59.4 t -66.99 -32.23 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 109.975 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.5 -45.87 92.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.061 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -70.36 -52.18 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.304 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -110.99 -141.94 0.38 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.563 -172.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t 71.4 174.02 0.3 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.308 0.643 . . . . 0.0 109.701 -172.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 m . . . . . 0 C--N 1.322 -0.623 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.024 -177.849 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.3 mttp . . . . . 0 CA--C 1.528 0.123 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -95.64 -21.99 17.86 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.721 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.9 tp -70.88 -27.57 63.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.86 0.362 . . . . 0.0 110.245 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 ttm-85 -55.14 -41.39 71.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.518 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.06 -40.0 95.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.666 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -64.55 -46.93 80.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.851 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.543 ' O ' HG13 ' A' ' 54' ' ' ILE . 64.4 mt -61.77 -43.07 96.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.438 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.28 94.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.764 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.49 -37.28 92.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.182 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.4 ' O ' HG13 ' A' ' 57' ' ' ILE . 78.4 t80 -60.05 -46.6 89.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.71 0.29 . . . . 0.0 110.515 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 50' ' ' ILE . 34.7 mt -60.89 -50.74 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.425 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 m -47.18 -44.13 21.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.561 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.595 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 13.1 ttm180 -61.08 -45.82 93.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.966 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 53' ' ' TYR . 69.2 mt -56.81 -41.02 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.433 . . . . 0.0 110.383 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.3 mt -59.58 -49.94 81.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.82 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.1 p -65.69 -16.63 63.94 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.82 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 84.3 mm-40 -85.11 -40.09 17.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.029 0.442 . . . . 0.0 110.522 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -81.75 -33.54 30.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.711 -176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.5 mptt . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.167 175.506 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.528 0.124 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -57.85 -39.99 79.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.082 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.06 -44.11 78.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.975 0.416 . . . . 0.0 110.662 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.14 -28.75 67.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.416 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 37.0 ttt180 -61.82 -52.87 62.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.523 175.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.05 -37.73 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 0.0 110.455 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.41 -46.75 88.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.256 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 15' ' ' GLU . 36.4 pttt -69.09 -33.87 74.21 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.72 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 35.1 mt-10 -70.25 -23.05 62.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.142 0.496 . . . . 0.0 110.476 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.962 ' HB3' ' HB3' ' A' ' 38' ' ' PHE . 67.5 mtt -70.78 -48.85 52.1 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 169.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 69.6 mt -65.47 -31.6 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.271 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 10.5 pt-20 -60.89 -15.71 33.79 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -175.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.4 p -74.33 -26.76 60.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.936 0.398 . . . . 0.0 111.053 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.624 ' HB3' ' HE1' ' A' ' 38' ' ' PHE . 17.7 t-160 -148.77 89.41 5.01 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.213 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 CA--C 1.53 0.287 0 C-N-CA 123.641 2.894 . . . . 0.0 112.39 -178.738 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 122.032 0.92 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.31 143.25 46.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.654 -173.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.682 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 73.4 m-85 -74.03 -33.7 63.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.76 -173.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.67 -36.23 83.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.422 0.629 . . . . 0.0 109.649 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.553 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 96.4 m -61.72 -58.98 5.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.269 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.682 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.5 p-10 -63.69 -28.68 70.07 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.753 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -56.68 -54.18 49.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.179 0.514 . . . . 0.0 110.142 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -70.66 -27.27 63.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.864 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 30' ' ' THR . 69.8 mt -64.97 -51.05 63.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.761 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 31' ' ' ASN . 66.6 t -60.54 -33.09 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 110.528 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -59.25 -37.95 78.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.418 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.29 -53.82 6.02 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.19 0.519 . . . . 0.0 110.793 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.962 ' HB3' ' HB3' ' A' ' 16' ' ' MET . 14.2 m-30 -67.13 106.0 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.118 -173.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 p -144.35 98.49 3.21 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.335 0.588 . . . . 0.0 111.571 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 51.9 m . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.403 173.003 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.2 tptt . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.926 0.393 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -101.55 -25.7 13.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.428 HD13 ' HB2' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -68.72 -14.58 63.11 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.356 177.577 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -59.21 -34.41 72.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.442 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -63.75 -43.87 95.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.411 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HB2' HD13 ' A' ' 46' ' ' LEU . 62.1 mttp -66.4 -43.74 85.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.549 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 54' ' ' ILE . 42.6 mm -57.46 -46.39 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.375 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.451 ' HB1' ' ND2' ' A' ' 31' ' ' ASN . . . -57.45 -47.5 81.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.866 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.46 -35.41 91.92 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.323 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 57' ' ' ILE . 7.8 m-85 -71.37 -33.16 69.29 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.743 -0.269 . . . . 0.0 111.384 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 50' ' ' ILE . 58.4 mt -60.21 -49.3 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.511 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.82 -32.07 70.31 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.558 0.218 . . . . 0.0 111.348 175.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -70.07 -39.56 75.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.615 0.245 . . . . 0.0 110.988 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 53' ' ' TYR . 82.3 mt -64.03 -45.46 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.17 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.05 -38.19 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.995 0.426 . . . . 0.0 110.149 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -65.33 -30.88 71.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.799 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -73.49 -34.35 65.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 110.173 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -81.22 -6.45 58.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.634 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.169 -176.423 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.917 0.865 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.516 ' HA ' ' HB3' ' A' ' 11' ' ' ARG . 80.3 m-85 -71.21 -11.78 61.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.314 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.931 HG13 HD13 ' A' ' 50' ' ' ILE . 93.4 t -69.05 -38.84 78.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 173.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -66.19 -39.06 89.42 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.516 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 17.5 tpt180 -56.19 -51.95 66.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.808 173.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 8' ' ' PHE . 45.5 mm -65.87 -44.66 92.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.268 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.35 98.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.739 0.305 . . . . 0.0 111.222 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -61.03 -51.08 70.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.06 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.17 -23.08 61.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.569 ' HG3' ' HB2' ' A' ' 38' ' ' PHE . 49.0 ttm -68.65 -52.44 31.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.317 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.466 HG12 HD23 ' A' ' 34' ' ' LEU . 57.2 mt -75.81 -25.2 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.864 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 61.94 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.256 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 m -153.04 11.96 0.48 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.341 0.591 . . . . 0.0 109.43 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -144.63 101.8 4.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.413 -172.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo . . . . . 0 N--CA 1.461 -0.432 0 C-N-CA 122.87 2.38 . . . . 0.0 112.487 -179.829 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.97 0.891 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.05 148.37 46.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.729 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -71.82 -28.95 63.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.78 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.2 -37.39 85.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.144 0.497 . . . . 0.0 109.779 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.6 m -59.1 -48.76 80.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.406 173.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.39 -53.68 50.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.278 174.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -49.86 -55.21 15.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.521 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 59.4 tttm -65.09 -39.58 93.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.329 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.466 HD23 HG12 ' A' ' 17' ' ' ILE . 9.2 mp -71.76 -44.64 63.72 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.273 -0.171 . . . . 0.0 111.395 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 39' ' ' SER . 84.6 t -60.94 -50.56 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.83 0.348 . . . . 0.0 110.475 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -73.97 -7.76 53.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.647 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 5.1 tp10 -80.53 -47.39 14.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.058 0.456 . . . . 0.0 110.059 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.569 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 83.0 m-85 -110.52 -90.22 0.48 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.676 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.61 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 21.4 t 57.16 -169.37 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.509 0.671 . . . . 0.0 112.012 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.247 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.4 mttt . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.74 0.305 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.494 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 16.0 t-160 -67.32 -25.92 66.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.814 -175.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 tt -77.25 -41.52 40.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -59.34 -39.46 83.25 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.459 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -58.09 -37.33 74.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.266 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 45' ' ' HIS . 28.1 mmmt -70.15 -49.69 48.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.931 HD13 HG13 ' A' ' 9' ' ' VAL . 41.9 mm -61.71 -53.49 47.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.174 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.43 77.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.178 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -59.14 -45.32 95.49 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.113 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.481 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.9 m-85 -71.68 -37.19 70.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 50' ' ' ILE . 64.3 mt -57.71 -55.9 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.316 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 m -50.67 -44.73 57.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.055 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 98.3 mtt180 -58.82 -51.69 68.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.02 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 53' ' ' TYR . 78.8 mt -57.05 -47.11 84.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.622 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.37 -34.32 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.993 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.0 m -64.59 -40.28 95.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.775 0.322 . . . . 0.0 110.754 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -77.45 -28.34 52.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.059 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -85.18 2.67 42.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 0.0 111.0 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' A' ' 62' ' ' LYS . 13.2 tppt? . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.859 -0.591 . . . . 0.0 109.426 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.235 0.317 0 CA-C-O 121.28 0.562 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.405 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.5 m-85 -57.97 -37.2 73.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.519 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.1 t -64.39 -37.94 81.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.567 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -60.03 -46.78 88.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.6 ttm-85 -64.64 -41.84 95.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.385 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 8' ' ' PHE . 77.3 mt -63.36 -44.13 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.87 -44.06 90.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.944 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -58.63 -49.86 75.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.255 0.55 . . . . 0.0 110.696 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.2 -26.77 65.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.702 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.509 ' O ' HG22 ' A' ' 19' ' ' THR . 37.2 tpp -70.36 -39.71 74.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.633 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.435 HG23 HD23 ' A' ' 34' ' ' LEU . 87.3 mt -74.88 -42.12 46.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.276 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.21 -10.08 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 16' ' ' MET . 15.0 t -80.14 -27.51 39.05 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.193 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -130.41 97.65 21.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 111.137 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 C-N-CA 123.262 2.641 . . . . 0.0 112.051 178.957 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.51 0.671 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -98.91 144.6 27.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.704 -176.589 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.509 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 81.4 m-85 -74.76 -24.86 58.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.126 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 25.5 t70 -66.0 -33.95 76.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 109.697 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.538 ' O ' HD13 ' A' ' 34' ' ' LEU . 99.6 m -54.59 -59.68 4.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.438 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.509 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 3.3 p-10 -65.13 -28.12 69.21 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.688 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.25 -43.05 96.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.856 0.36 . . . . 0.0 110.458 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 75.0 mmtt -65.25 -32.98 74.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.661 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 30' ' ' THR . 8.4 mp -72.02 -43.19 65.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.754 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.531 HG11 ' HD2' ' A' ' 47' ' ' ARG . 84.4 t -72.49 -18.86 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.289 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -55.09 -39.18 69.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.271 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -76.52 -34.81 58.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.411 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 54.5 p90 48.25 114.47 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.152 1.381 . . . . 0.0 113.71 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 t -71.35 -29.98 65.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.298 177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.3 t . . . . . 0 C--O 1.24 0.599 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.288 -178.093 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -120.77 16.61 11.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 0.0 111.74 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.438 ' O ' HG12 ' A' ' 50' ' ' ILE . 36.9 tp -90.88 -33.8 15.5 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.969 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.531 ' HD2' HG11 ' A' ' 35' ' ' VAL . 22.6 tpp180 -55.12 -46.89 75.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.472 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -69.44 -32.11 70.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 110.702 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.58 -44.65 70.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.431 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 54' ' ' ILE . 44.0 mm -60.22 -45.63 95.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.772 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' HB1' ' ND2' ' A' ' 31' ' ' ASN . . . -58.12 -45.91 86.5 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.477 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.672 ' O ' ' HG2' ' A' ' 56' ' ' ARG . . . -62.55 -42.73 99.67 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.054 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CE2' HD11 ' A' ' 57' ' ' ILE . 66.9 t80 -57.62 -40.31 78.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.14 0.176 . . . . 0.0 110.626 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 50' ' ' ILE . 78.7 mt -56.14 -54.3 29.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.672 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -61.89 -35.77 79.31 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 52.8 mmm-85 -62.52 -41.83 99.11 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.68 0.276 . . . . 0.0 110.416 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.534 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 78.0 mt -58.66 -46.05 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.411 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.7 mt -57.73 -49.13 81.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -65.79 -37.0 85.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.579 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -71.62 -25.47 62.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.395 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 57.6 mt-30 -72.33 -18.43 61.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.119 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 C--O 1.246 0.897 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.794 179.163 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.846 0.355 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.434 ' O ' HG13 ' A' ' 12' ' ' ILE . 94.5 t80 -59.69 -48.19 82.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.528 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.7 t -66.21 -40.59 87.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.168 0.509 . . . . 0.0 110.194 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -60.76 -32.59 71.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.72 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -69.63 -35.86 75.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.682 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 16' ' ' MET . 29.4 mt -61.63 -40.38 86.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.99 0.424 . . . . 0.0 109.931 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.37 -35.02 79.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.962 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -64.68 -56.49 13.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.73 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.55 ' HA ' ' HB3' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -68.48 -15.26 63.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.171 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.482 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 6.8 tpt -64.98 -53.67 42.54 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.13 -28.87 21.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.688 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 15' ' ' GLU . 11.4 tp10 -60.15 153.85 20.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.423 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 18' ' ' GLU . 52.2 m 82.08 -47.72 0.2 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.517 0.727 . . . . 0.0 111.18 -176.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -147.64 96.17 4.16 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.597 0.237 . . . . 0.0 110.89 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo . . . . . 0 N--CA 1.463 -0.308 0 C-N-CA 122.778 2.319 . . . . 0.0 111.315 176.643 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.562 ' HA ' HG22 ' A' ' 55' ' ' THR . 8.0 p-10 . . . . . 0 N--CA 1.464 0.271 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -94.96 145.43 24.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -66.82 -27.47 67.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.73 0.3 . . . . 0.0 110.953 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.5 -37.95 88.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.521 0.677 . . . . 0.0 109.27 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.594 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 22.2 m -65.81 -56.27 12.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.202 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.9 p30 -61.54 -27.83 68.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 111.247 -175.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.73 -49.22 69.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.24 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -77.29 -21.02 54.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.877 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 30' ' ' THR . 41.7 mt -66.3 -50.11 64.75 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.18 174.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 31' ' ' ASN . 68.8 t -56.14 -43.43 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.039 0.447 . . . . 0.0 110.025 176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -58.24 -42.21 85.84 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.297 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.01 -48.86 11.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE2' ' HB3' ' A' ' 34' ' ' LEU . 17.1 m-30 -56.88 -76.24 0.04 OUTLIER 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -131.77 133.54 44.86 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 t . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.729 -175.048 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -133.63 13.25 4.08 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.415 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 50' ' ' ILE . 58.6 tp -88.62 -28.37 20.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.361 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -66.67 -34.81 78.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.431 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.72 -39.69 85.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.755 175.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 33.0 mmtp -73.66 -31.91 63.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.551 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 54' ' ' ILE . 80.4 mt -62.74 -40.17 87.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.195 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.43 96.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.042 0.449 . . . . 0.0 110.558 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.92 -32.23 83.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.734 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.494 ' O ' HG13 ' A' ' 57' ' ' ILE . 23.5 t80 -71.4 -30.82 66.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 50' ' ' ILE . 79.3 mt -59.4 -49.54 83.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.894 0.378 . . . . 0.0 110.193 175.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.562 HG22 ' HA ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -62.35 -29.23 70.31 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.559 176.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.3 ttt85 -68.69 -41.59 78.95 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 110.687 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 53' ' ' TYR . 77.6 mt -59.99 -45.9 94.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.378 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.8 -50.7 79.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.247 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.0 p -66.4 -35.3 79.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.725 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.73 -35.99 65.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -72.81 -52.32 15.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.145 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.53 ' HB3' ' NZ ' ' A' ' 62' ' ' LYS . 1.3 ttpm? . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.4 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.569 ' O ' ' HG2' ' A' ' 11' ' ' ARG . 1.5 p . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 120.45 0.167 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.516 ' O ' HG13 ' A' ' 12' ' ' ILE . 79.3 t80 -56.27 -40.61 74.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.031 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.87 -34.6 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.254 0.55 . . . . 0.0 110.192 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -68.04 -31.45 71.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.335 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 7' ' ' SER . 22.5 mmt180 -75.34 -31.77 60.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.075 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 8' ' ' PHE . 82.1 mt -61.75 -55.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.01 -39.13 77.53 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.452 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 38.7 tptt -52.78 -56.21 17.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.066 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.92 -28.29 64.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.588 -176.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 39' ' ' SER . 87.1 mtp -66.65 -43.42 84.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.599 0.238 . . . . 0.0 110.979 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.3 mt -77.59 -31.68 17.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.108 0.48 . . . . 0.0 110.995 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -62.15 113.73 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.966 -175.526 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.6 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 93.1 m 76.31 -39.49 0.36 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.802 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -91.11 98.3 1.62 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.394 . . . . 0.0 110.149 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 19' ' ' THR . 27.5 Cg_endo . . . . . 0 N--CA 1.446 -1.272 0 C-N-CA 123.269 2.646 . . . . 0.0 112.69 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 121.149 0.5 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.37 162.12 14.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.716 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.3 -30.44 68.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.687 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.99 -30.63 71.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.211 0.529 . . . . 0.0 110.316 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.403 ' O ' HD13 ' A' ' 34' ' ' LEU . 97.5 m -64.94 -52.86 54.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.393 176.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.749 ' OD1' ' HB ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -61.34 -37.98 85.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.074 178.411 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -50.1 -49.27 52.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.573 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.68 -39.16 73.69 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.997 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 30' ' ' THR . 8.5 mp -58.77 -39.24 80.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.471 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.528 HG11 ' HG3' ' A' ' 47' ' ' ARG . 57.0 t -75.49 -37.11 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.267 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.14 -49.21 76.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.877 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -63.54 -65.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.067 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -101.6 -84.46 0.44 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.637 -168.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.482 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 90.3 p 51.33 -172.65 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.915 0.886 . . . . 0.0 112.308 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.9 m . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 173.989 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.6 tttt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.648 0.261 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -31.23 50.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 110.501 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 mp -73.18 -18.7 61.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.49 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.528 ' HG3' HG11 ' A' ' 35' ' ' VAL . 41.5 ttp180 -57.43 -43.66 84.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.4 0.619 . . . . 0.0 110.205 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -72.71 -23.17 60.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.574 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -71.23 -46.44 61.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.969 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.0 mt -63.24 -33.15 59.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.928 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.58 84.3 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.915 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.85 -41.22 88.84 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.76 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.442 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.0 m-85 -62.03 -61.45 2.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.496 0.189 . . . . 0.0 111.483 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.749 ' HB ' ' OD1' ' A' ' 31' ' ' ASN . 62.8 mt -60.84 -44.82 98.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -172.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 p -54.26 -45.76 72.5 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.243 0.474 . . . . 0.0 111.473 176.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -60.0 -43.83 94.93 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.418 176.095 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 53' ' ' TYR . 78.1 mt -62.76 -38.63 82.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.081 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 54' ' ' ILE . 75.7 mt -59.7 -51.36 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.865 0.364 . . . . 0.0 110.855 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.2 p -65.24 -22.3 66.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.573 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -84.99 -52.09 6.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.726 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -71.54 -36.31 70.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.085 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm . . . . . 0 C--O 1.25 1.097 0 O-C-N 123.838 0.711 . . . . 0.0 109.688 -172.539 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.464 ' O ' HG13 ' A' ' 12' ' ' ILE . 25.3 m-85 -65.58 -60.55 2.81 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.834 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.87 -34.64 71.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.214 0.531 . . . . 0.0 110.479 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -66.29 -33.66 76.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.545 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -72.86 -35.76 67.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.687 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 8' ' ' PHE . 72.4 mt -57.14 -49.95 78.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.208 177.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.3 -39.58 94.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -64.84 -34.51 78.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.77 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -69.86 -35.51 74.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.665 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.567 ' HA ' ' HD2' ' A' ' 38' ' ' PHE . 48.8 ttm -70.4 -42.63 71.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.684 177.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.569 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 53.5 mt -75.55 -5.84 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.385 0.612 . . . . 0.0 110.982 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.38 134.65 53.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.53 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m 76.19 -66.74 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.598 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . 1.2 t-160 -89.64 -57.01 0.27 Allowed Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 120.483 -0.487 . . . . 0.0 112.219 -168.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.951 ' HB3' HD22 ' A' ' 34' ' ' LEU . 43.1 Cg_exo . . . . . 0 C--N 1.352 0.739 0 C-N-CA 122.151 1.901 . . . . 0.0 112.631 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 C--O 1.234 0.247 0 CA-C-O 120.7 0.286 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -100.05 160.34 14.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -71.96 -24.21 61.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.681 0.277 . . . . 0.0 111.618 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.43 -29.17 69.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.338 0.59 . . . . 0.0 109.462 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.617 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 14.3 m -65.59 -52.18 54.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.424 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.452 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.2 p30 -65.87 -28.34 68.89 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.755 -177.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -64.19 -44.02 93.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.949 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -65.2 -34.39 78.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.812 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.951 HD22 ' HB3' ' A' ' 21' ' ' PRO . 59.8 mt -70.6 -43.8 68.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.291 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.541 HG11 ' HG3' ' A' ' 47' ' ' ARG . 56.4 t -69.74 -30.81 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.378 0.609 . . . . 0.0 110.301 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.83 -23.29 60.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.327 0.584 . . . . 0.0 109.928 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -80.01 -55.66 4.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.164 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.567 ' HD2' ' HA ' ' A' ' 16' ' ' MET . 34.2 t80 -132.57 148.19 52.37 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.1 p -162.55 153.74 17.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.773 0.32 . . . . 0.0 110.848 -173.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.5 m . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.581 177.66 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.2 tptm . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -101.59 13.65 34.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.398 0.618 . . . . 0.0 109.953 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.8 tp -95.15 -27.78 15.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.762 173.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.541 ' HG3' HG11 ' A' ' 35' ' ' VAL . 51.2 ttp180 -67.09 -47.64 70.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.586 -174.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -61.64 -34.98 76.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.996 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 72.2 mmtt -65.57 -51.16 61.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.532 ' O ' HG13 ' A' ' 54' ' ' ILE . 66.3 mt -65.28 -51.34 66.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.8 -48.83 77.05 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.926 0.394 . . . . 0.0 111.144 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.92 -37.94 95.75 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.96 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.448 ' O ' HG13 ' A' ' 57' ' ' ILE . 2.0 t80 -69.95 -33.13 71.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 50' ' ' ILE . 80.9 mt -56.84 -55.58 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.863 0.363 . . . . 0.0 110.265 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.17 -32.31 73.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -62.05 -46.64 88.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.958 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 53' ' ' TYR . 84.1 mt -62.57 -39.01 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.671 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 54' ' ' ILE . 71.8 mt -58.25 -51.87 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.526 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.9 p -65.86 -18.9 65.66 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.785 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -84.89 -38.96 18.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 0.0 110.372 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -73.84 -38.37 64.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.32 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.471 -179.395 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.667 0.27 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.439 ' O ' HG13 ' A' ' 12' ' ' ILE . 75.6 t80 -65.62 -37.19 85.88 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.7 t -66.12 -37.29 79.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.672 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -64.93 -33.33 75.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.448 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -28.24 62.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 8' ' ' PHE . 72.9 mt -70.71 -39.23 75.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.265 0.555 . . . . 0.0 109.547 173.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.31 90.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.484 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -63.03 -42.92 99.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.071 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -55.55 -45.73 77.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.516 ' SD ' ' HB3' ' A' ' 34' ' ' LEU . 46.3 tpp -55.77 -52.44 63.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.222 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.32 -49.73 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.236 -173.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -66.09 -33.08 74.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.728 0.299 . . . . 0.0 111.792 -173.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 m -84.11 -16.87 42.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.246 0.546 . . . . 0.0 110.579 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . 47.2 t-80 -132.55 69.39 79.75 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.064 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 C--N 1.344 0.321 0 C-N-CA 123.12 2.547 . . . . 0.0 112.716 -174.904 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 121.616 0.722 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -103.9 139.93 38.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.712 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.654 ' HA ' ' ND2' ' A' ' 31' ' ' ASN . 99.5 m-85 -72.14 -40.27 68.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.777 -174.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.56 -38.35 90.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.245 0.545 . . . . 0.0 110.358 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.443 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 67.3 m -62.71 -55.03 30.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.564 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.654 ' ND2' ' HA ' ' A' ' 28' ' ' PHE . 20.9 p30 -60.87 -30.05 69.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.702 0.287 . . . . 0.0 110.997 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.586 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 14.3 tmtt? -66.93 -52.13 46.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.082 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 52.3 mtmt -67.4 -26.8 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.727 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.516 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 95.2 mt -69.33 -48.17 62.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.65 0.262 . . . . 0.0 110.713 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.572 HG11 ' HA ' ' A' ' 47' ' ' ARG . 17.8 t -68.15 -24.58 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.429 . . . . 0.0 110.11 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 7.3 mm-40 -57.42 -38.51 74.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.245 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -159.09 89.76 0.94 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 -174.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 20' ' ' HIS . 51.3 t80 -175.65 -78.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.266 171.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.424 ' HB2' ' HE2' ' A' ' 16' ' ' MET . 66.6 m -104.07 51.04 0.78 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.454 0.645 . . . . 0.0 109.347 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.8 m . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.585 -176.247 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.4 tttt . . . . . 0 N--CA 1.447 -0.581 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -98.18 -19.62 17.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.14 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.6 tp -64.87 -14.19 58.75 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.13 0.491 . . . . 0.0 110.589 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.572 ' HA ' HG11 ' A' ' 35' ' ' VAL . 38.1 ttm180 -49.49 -57.73 6.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.801 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -69.6 -18.33 63.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.538 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -75.32 -54.04 7.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.034 0.445 . . . . 0.0 110.109 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 54' ' ' ILE . 62.2 mt -64.69 -41.76 93.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.048 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.478 ' HB1' ' OD1' ' A' ' 31' ' ' ASN . . . -59.31 -38.64 80.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.172 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.86 -44.24 97.27 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.718 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -60.88 -49.83 75.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.952 -0.124 . . . . 0.0 111.08 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 50' ' ' ILE . 78.0 mt -49.05 -57.81 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 O-C-N 123.527 0.517 . . . . 0.0 111.111 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -47.32 -58.27 4.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.222 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 75.2 mtt-85 -70.8 -33.06 70.33 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -172.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.0 mt -65.26 -40.37 88.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.974 0.416 . . . . 0.0 110.118 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.35 -32.29 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.229 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.1 m -65.52 -24.62 67.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 176.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 83.4 mm-40 -75.38 -54.01 7.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.308 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.49 -51.38 8.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.637 0.256 . . . . 0.0 111.663 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.3 tttt . . . . . 0 C--O 1.249 1.071 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.329 -174.211 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.411 ' O ' HG12 ' A' ' 12' ' ' ILE . 74.9 t80 -61.65 -48.57 80.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.5 t -63.59 -44.8 98.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.772 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.15 -29.7 67.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.817 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.521 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 8.6 tpt180 -64.49 -42.32 95.92 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 176.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 8' ' ' PHE . 49.5 mm -59.24 -43.1 89.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.254 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.33 97.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.284 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -58.49 -41.66 85.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.779 178.57 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 11' ' ' ARG . 76.2 mm-40 -56.67 -47.08 80.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.829 0.347 . . . . 0.0 110.493 178.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.481 ' HE2' ' HB3' ' A' ' 39' ' ' SER . 42.0 ttm -65.83 -50.29 65.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.739 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.72 -46.29 86.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.602 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.472 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 5.2 tp10 -66.22 -46.48 77.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 m -69.19 -41.62 76.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.236 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -121.44 92.91 48.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 110.952 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo . . . . . 0 N--CA 1.46 -0.475 0 C-N-CA 123.589 2.86 . . . . 0.0 112.334 -179.643 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.97 0.414 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -89.45 159.3 17.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.68 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 62.2 m-85 -71.36 -28.24 63.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.118 -176.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.97 -36.76 85.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.121 0.486 . . . . 0.0 110.305 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 53.1 m -61.1 -56.81 16.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.661 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.68 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.7 p-10 -65.65 -23.97 66.92 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.395 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.617 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 20.6 ttpp -62.12 -52.06 65.36 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -56.58 -38.59 72.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.274 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.482 ' HA ' ' HD2' ' A' ' 38' ' ' PHE . 7.7 mp -60.15 -51.53 69.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.4 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 51' ' ' ALA . 35.7 m -82.46 -9.2 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 122.047 -0.408 . . . . 0.0 111.011 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 2.8 tp10 -76.08 -2.61 31.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -158.5 -48.14 0.06 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.854 0.359 . . . . 0.0 111.374 -171.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.482 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 36.9 m-85 -84.66 -165.98 1.34 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.809 -174.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.481 ' HB3' ' HE2' ' A' ' 16' ' ' MET . 93.3 p 62.23 174.42 0.13 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.397 1.079 . . . . 0.0 112.29 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -178.517 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.4 pttm . . . . . 0 CA--C 1.529 0.139 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -78.71 -13.18 59.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.955 0.407 . . . . 0.0 110.64 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -77.04 -39.6 49.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.044 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -69.78 -10.16 57.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.854 0.359 . . . . 0.0 111.682 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -69.59 -41.96 75.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.402 0.62 . . . . 0.0 109.635 172.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -73.24 -38.89 65.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.69 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.558 ' O ' HG13 ' A' ' 54' ' ' ILE . 50.4 mm -57.16 -49.18 80.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.487 177.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.591 ' HB1' HD22 ' A' ' 31' ' ' ASN . . . -57.85 -50.94 71.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.414 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.62 -28.48 73.65 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.767 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.501 ' O ' HG13 ' A' ' 57' ' ' ILE . 22.7 t80 -73.93 -37.27 64.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 50' ' ' ILE . 84.6 mt -58.63 -47.64 88.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 110.124 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.76 -42.23 75.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.414 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -66.22 -44.47 83.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.032 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 53' ' ' TYR . 80.9 mt -57.53 -49.36 80.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.68 -49.95 81.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.095 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 p -65.82 -25.39 67.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.709 0.29 . . . . 0.0 111.535 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -70.27 -34.19 72.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.044 0.449 . . . . 0.0 110.327 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -86.39 -33.02 20.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.754 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.5 tttm . . . . . 0 C--O 1.253 1.275 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.811 -176.036 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.53 ' O ' HG13 ' A' ' 12' ' ' ILE . 55.0 t80 -64.16 -35.84 82.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.4 -48.78 85.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.095 0.474 . . . . 0.0 110.7 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 53' ' ' TYR . 87.8 tttt -58.78 -40.2 83.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.544 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -59.44 -46.31 89.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.439 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 8' ' ' PHE . 73.3 mt -57.17 -53.5 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.745 0.307 . . . . 0.0 111.094 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.503 ' HB1' HG12 ' A' ' 54' ' ' ILE . . . -63.82 -45.78 88.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.432 -177.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.2 -39.51 94.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.42 -176.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.886 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 31.0 mt-10 -71.06 -30.62 66.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.748 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.453 ' HG3' ' O ' ' A' ' 12' ' ' ILE . 59.9 mtt -55.34 -42.45 73.84 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.535 HD11 HG23 ' A' ' 54' ' ' ILE . 57.8 mt -65.23 -54.18 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.25 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.886 ' HG2' ' HA ' ' A' ' 15' ' ' GLU . 8.8 pt-20 -67.0 -6.01 15.19 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.5 m -57.59 -43.08 84.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.147 0.498 . . . . 0.0 110.662 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -150.44 120.09 3.73 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.959 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 CA--C 1.515 -0.429 0 C-N-CA 122.648 2.232 . . . . 0.0 111.914 177.364 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.694 0.759 . . . . 0.0 112.786 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.556 ' O ' ' HB ' ' A' ' 30' ' ' THR . 7.9 t70 -139.79 147.91 41.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.222 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -77.9 -35.25 50.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 110.633 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.433 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 36.2 t70 -65.63 -29.7 70.31 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 27' ' ' ASP . 2.5 m -61.06 -50.54 72.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.679 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.409 ' HB2' ' HB1' ' A' ' 51' ' ' ALA . 18.5 p30 -64.46 -34.77 78.97 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 110.507 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 19.6 ttpt -63.41 -48.89 75.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.517 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 25.9 ttmt -69.67 -13.3 62.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.566 -173.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 30' ' ' THR . 96.7 mt -81.92 -49.9 9.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.941 0.4 . . . . 0.0 110.425 173.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.526 HG11 ' HA ' ' A' ' 47' ' ' ARG . 43.4 t -74.98 -28.39 21.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.212 -176.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 4.4 tp10 -76.08 7.03 4.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 33' ' ' LYS . 12.4 pt-20 -155.98 -43.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.646 -0.421 . . . . 0.0 112.105 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -84.68 -85.45 0.14 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 11.9 t 54.65 -159.36 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.752 0.787 . . . . 0.0 112.094 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.2 m . . . . . 0 C--N 1.319 -0.752 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.703 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.892 0.377 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -107.35 -9.06 16.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -173.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.7 tp -64.09 -34.85 78.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HA ' HG11 ' A' ' 35' ' ' VAL . 14.6 ttm105 -47.17 -52.45 15.61 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.808 0.693 . . . . 0.0 110.992 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -78.36 -30.38 47.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.664 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -74.1 -51.1 16.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.854 0.359 . . . . 0.0 110.209 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.566 ' O ' HG13 ' A' ' 54' ' ' ILE . 10.6 tt -66.37 -34.05 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.447 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 31' ' ' ASN . . . -65.26 -40.32 93.8 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.039 0.447 . . . . 0.0 110.641 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.39 -41.18 99.47 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.419 ' CE2' HD11 ' A' ' 57' ' ' ILE . 61.4 t80 -63.38 -44.28 95.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.607 -0.297 . . . . 0.0 110.631 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 50' ' ' ILE . 91.4 mt -54.62 -57.84 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.753 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -56.24 -40.7 74.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.132 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -59.1 -39.54 82.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.058 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.419 HD11 ' CE2' ' A' ' 53' ' ' TYR . 70.7 mt -68.11 -42.33 84.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 110.436 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.09 -45.74 93.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.868 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -58.72 -37.41 76.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.754 0.311 . . . . 0.0 110.688 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -66.99 -36.0 81.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.079 0.466 . . . . 0.0 110.777 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -75.41 -24.79 57.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.527 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.929 -176.044 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptp . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 120.929 0.395 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -128.6 -150.78 7.3 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -85.73 151.28 23.97 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 58.6 mt -72.47 -66.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.171 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 58.43 88.61 0.06 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.477 0.656 . . . . 0.0 112.317 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.1 t -164.73 -26.09 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.645 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.6 t -60.87 -30.48 70.16 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.658 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -64.37 -36.12 83.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.064 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.8 t -66.3 -36.59 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.435 0.636 . . . . 0.0 109.721 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -66.39 -33.94 76.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.529 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -66.75 -41.61 87.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.412 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.62 -40.26 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.345 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -60.54 -47.03 87.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.391 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 27.0 mmmt -56.63 -50.01 73.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.157 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.31 -39.01 78.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.808 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.579 ' SD ' HG13 ' A' ' 35' ' ' VAL . 37.6 ttm -69.82 -45.64 67.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.442 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.625 HG23 HD21 ' A' ' 34' ' ' LEU . 63.8 mt -75.38 -49.75 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.908 0.385 . . . . 0.0 111.481 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 1.7 tp10 -65.61 -8.89 22.58 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -169.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.489 HG21 ' CD1' ' A' ' 38' ' ' PHE . 5.9 t -76.69 -17.32 59.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.273 0.559 . . . . 0.0 109.808 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 18.1 t-160 -142.51 109.08 5.67 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 20' ' ' HIS . 20.7 Cg_exo -67.7 25.83 0.12 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.704 2.936 . . . . 0.0 114.161 -176.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.19 60.06 4.88 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 174.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -107.88 158.43 17.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.707 -169.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.5 ' CD1' HG23 ' A' ' 58' ' ' ILE . 54.9 t80 65.07 54.91 1.18 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.562 0.696 . . . . 0.0 111.455 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.48 ' CB ' HG21 ' A' ' 30' ' ' THR . 6.1 m -105.75 0.43 26.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.502 0.668 . . . . 0.0 109.27 172.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.94 35.59 1.17 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.211 -1.359 . . . . 0.0 113.709 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -131.62 144.34 50.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -67.42 -36.18 80.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.389 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.523 ' O ' ' HD3' ' A' ' 33' ' ' LYS . 17.0 t70 -65.69 -39.56 91.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.104 0.478 . . . . 0.0 110.173 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.48 HG21 ' CB ' ' A' ' 25' ' ' THR . 8.7 m -61.22 -52.07 66.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.853 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.451 ' O ' HG23 ' A' ' 35' ' ' VAL . 78.3 m-20 -65.06 -32.39 74.09 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.734 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 64.0 tttm -58.93 -53.83 53.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.353 176.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HD3' ' O ' ' A' ' 29' ' ' ASP . 1.2 mptm? -66.48 -36.27 82.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.919 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.625 HD21 HG23 ' A' ' 17' ' ' ILE . 43.4 tp -57.82 -40.63 80.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.609 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.579 HG13 ' SD ' ' A' ' 16' ' ' MET . 76.9 t -69.75 -46.31 74.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.907 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 43.4 mt-10 -70.99 -25.3 62.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -171.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.52 -15.42 58.62 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.117 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.522 ' HD2' ' HG3' ' A' ' 16' ' ' MET . 65.5 t80 -113.83 -80.47 0.59 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.5 m 63.84 103.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.7 0.625 . . . . 0.0 112.143 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.9 t -132.16 17.16 4.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.951 0.882 . . . . 0.0 109.589 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.0 p -107.75 138.61 33.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.83 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.6 m -87.8 164.93 15.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.898 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.3 m 72.38 107.53 0.07 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.462 0.648 . . . . 0.0 110.054 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -66.09 -35.25 80.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.595 -169.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -78.78 -12.34 60.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.96 0.41 . . . . 0.0 110.841 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 49' ' ' LYS . 38.7 tp -74.31 -21.75 59.58 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.478 ' HG3' HG11 ' A' ' 35' ' ' VAL . 73.7 ttp85 -59.92 -30.25 68.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.586 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.69 -44.23 97.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.369 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.528 ' HD2' HD12 ' A' ' 46' ' ' LEU . 68.1 mttm -67.62 -34.26 76.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.331 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.532 ' O ' HG13 ' A' ' 54' ' ' ILE . 50.5 mm -65.35 -49.48 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.524 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.05 97.3 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.89 -33.97 81.12 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.771 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 11.5 t80 -63.23 -45.94 89.29 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.502 0.321 . . . . 0.0 110.54 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.569 HG12 HD11 ' A' ' 17' ' ' ILE . 36.2 mt -58.9 -56.64 15.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.169 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -49.69 -40.24 39.42 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.677 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.09 -48.05 75.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.993 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.2 mt -59.21 -43.4 89.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 110.623 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.5 HG23 ' CD1' ' A' ' 24' ' ' PHE . 68.2 mt -62.59 -48.99 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.73 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 p -65.31 -31.22 72.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -84.95 -18.53 34.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.875 0.369 . . . . 0.0 111.408 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -73.37 -37.76 65.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.242 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 65.0 tttp . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.764 -177.716 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.984 0.421 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.15 31.75 2.5 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.747 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -62.2 -27.76 69.2 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.476 0.31 . . . . 0.0 111.792 -176.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.8 tp -85.13 -21.64 7.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.294 0.569 . . . . 0.0 110.477 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.8 mtm-85 -93.77 96.05 9.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.405 0.621 . . . . 0.0 110.336 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -164.48 -19.3 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.135 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 m -76.16 6.09 5.89 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.415 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -63.68 -43.53 96.42 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 122.298 -0.251 . . . . 0.0 111.307 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.52 -48.49 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.261 0.553 . . . . 0.0 110.628 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -64.12 -30.78 71.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.633 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.744 ' HA ' ' HE ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -63.2 -52.98 60.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.51 177.087 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 74.5 mt -57.59 -44.41 85.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.809 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.71 -49.16 71.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.169 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -65.2 -44.24 89.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -62.36 -39.03 91.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.906 0.384 . . . . 0.0 110.53 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.511 ' SD ' ' HB2' ' A' ' 38' ' ' PHE . 27.2 tpp -55.97 -47.81 76.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.438 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.637 HG21 ' HE3' ' A' ' 23' ' ' LYS . 56.1 mt -76.86 -51.92 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.706 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.86 -25.92 67.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -168.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 p -61.29 -22.94 65.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 111.109 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -143.67 90.14 7.16 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.57 0.7 . . . . 0.0 109.324 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.4 163.4 34.77 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.975 2.45 . . . . 0.0 113.223 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.69 -61.29 0.66 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.485 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.637 ' HE3' HG21 ' A' ' 17' ' ' ILE . 54.1 mttp 62.32 -158.39 0.33 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -174.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -158.76 -72.7 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.907 0.384 . . . . 0.0 110.386 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.6 m -154.02 160.77 42.16 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -77.92 71.57 4.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.83 0.824 . . . . 0.0 110.722 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -137.12 157.29 47.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.47 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.729 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 94.2 m-85 -62.22 -28.54 69.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.474 -176.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.58 -45.21 94.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.632 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.419 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.5 m -65.94 -51.57 57.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.883 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.729 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.4 p-10 -65.35 -28.92 69.63 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.978 -177.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -60.79 -49.23 78.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 109.88 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -63.65 -34.85 78.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.992 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 17' ' ' ILE . 97.4 mt -68.17 -44.4 76.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.235 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.598 HG11 ' HG3' ' A' ' 47' ' ' ARG . 56.3 t -77.12 -43.75 31.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.504 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.53 -22.15 61.24 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 111.833 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.63 -39.88 91.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.673 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.511 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 81.8 m-85 -124.79 -52.14 1.69 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.6 t -49.47 110.95 0.43 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.229 0.538 . . . . 0.0 111.716 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 t -124.33 11.74 8.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.646 0.736 . . . . 0.0 110.029 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.875 HG22 ' H ' ' A' ' 42' ' ' SER . 8.9 p -83.95 -163.22 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.596 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.875 ' H ' HG22 ' A' ' 41' ' ' VAL . 14.0 m -47.65 108.25 0.15 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.407 0.622 . . . . 0.0 110.921 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.784 HG23 ' HD3' ' A' ' 47' ' ' ARG . 18.9 m -88.0 -40.42 13.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.084 -170.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -24.19 -83.14 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.616 1.198 . . . . 0.0 113.667 -167.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -129.23 3.45 5.19 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.233 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -71.69 -42.46 67.4 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.624 0.726 . . . . 0.0 109.169 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.784 ' HD3' HG23 ' A' ' 43' ' ' THR . 18.9 ttt-85 -66.62 -36.98 83.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.86 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.62 -39.99 90.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.618 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -62.18 -47.24 85.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.966 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.474 ' O ' HG12 ' A' ' 54' ' ' ILE . 69.4 mt -61.64 -41.67 91.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.547 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.17 77.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.315 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.07 93.11 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.887 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -68.55 -30.31 69.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 17' ' ' ILE . 40.8 mm -60.29 -50.31 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.892 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -33.02 71.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.882 0.372 . . . . 0.0 110.914 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 -64.46 -48.68 74.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.376 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 54' ' ' ILE . 14.3 tt -69.02 -26.85 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 110.784 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 54' ' ' ILE . 78.8 mt -65.12 -47.75 86.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 174.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.2 p -66.35 -16.49 64.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.828 0.347 . . . . 0.0 111.112 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -76.02 -33.92 59.67 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.909 0.385 . . . . 0.0 110.249 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -76.33 -45.53 31.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.944 0.402 . . . . 0.0 110.4 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 tptm . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.505 -177.697 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtm . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 120.651 0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.49 82.11 0.16 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.98 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.22 100.18 1.26 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.394 0.616 . . . . 0.0 110.7 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.444 HG23 ' H ' ' A' ' 5' ' ' ARG . 6.9 tt -98.12 -62.06 2.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.509 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.444 ' H ' HG23 ' A' ' 4' ' ' ILE . 42.2 ttp180 -87.41 65.15 8.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.322 0.582 . . . . 0.0 111.331 -171.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.9 t -170.18 -39.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.325 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.9 m -73.56 -4.62 35.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.978 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.476 ' O ' HG13 ' A' ' 12' ' ' ILE . 64.4 m-85 -61.97 -58.25 8.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.71 -37.22 79.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.25 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -61.85 -42.61 99.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.64 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 8.1 tmm_? -68.39 -40.74 81.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.463 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 8' ' ' PHE . 86.0 mt -58.78 -45.59 91.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.016 0.436 . . . . 0.0 110.132 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.53 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -62.84 -43.63 98.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.42 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.97 -43.39 81.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.452 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 11' ' ' ARG . 49.0 mt-10 -61.33 -41.43 97.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.982 0.42 . . . . 0.0 110.706 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.529 ' SD ' ' HA ' ' A' ' 35' ' ' VAL . 31.8 ttp -70.26 -48.52 56.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.437 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 54' ' ' ILE . 74.6 mt -58.47 -44.82 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.126 0.489 . . . . 0.0 111.441 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.94 -4.18 6.54 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.154 -172.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -77.66 -20.77 53.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.044 0.449 . . . . 0.0 110.416 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.414 ' HB2' HD22 ' A' ' 34' ' ' LEU . 11.1 m-70 -140.44 84.83 13.81 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.487 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.49 -16.13 21.75 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.483 2.122 . . . . 0.0 112.136 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -83.34 63.07 4.53 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.94 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' HB3' HG23 ' A' ' 30' ' ' THR . 30.2 mmmt -145.76 -71.42 0.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.443 ' HA ' ' CG2' ' A' ' 58' ' ' ILE . 42.3 p90 42.5 28.63 0.12 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 172.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.7 m -85.62 -21.86 28.25 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.13 -0.356 . . . . 0.0 111.196 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 61.12 59.59 1.97 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 122.276 1.036 . . . . 0.0 109.53 -173.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -133.79 168.29 19.0 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.729 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -77.93 -18.6 55.9 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.905 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.89 -38.27 88.3 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 167.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.637 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 6.4 m -60.72 -62.06 2.13 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.814 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.703 ' O ' HG23 ' A' ' 35' ' ' VAL . 23.1 p30 -65.17 -49.25 70.55 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -173.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -55.5 -46.17 77.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 111.183 -176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -71.37 -27.84 63.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.016 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 30' ' ' THR . 64.5 mt -76.66 -32.57 58.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.979 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 31' ' ' ASN . 32.8 t -66.38 -34.12 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.261 0.553 . . . . 0.0 110.177 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.56 -12.24 61.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.386 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.99 -61.33 2.02 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.606 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.516 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 0.3 OUTLIER -97.92 -157.79 0.62 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.876 -171.299 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.2 t -90.47 126.1 35.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -168.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.9 p -144.23 114.44 7.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.812 169.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.62 125.97 73.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.113 0.483 . . . . 0.0 112.125 -172.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.9 m 62.45 16.58 8.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.906 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 16.1 p -115.81 37.51 3.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.18 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.409 ' H ' ' CD ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -53.72 -34.93 60.47 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -169.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -115.81 -16.04 11.23 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.432 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.98 -23.66 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 166.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.537 ' HG2' HG11 ' A' ' 35' ' ' VAL . 6.2 ttt180 -50.84 -38.93 51.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.175 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.86 -39.0 93.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.763 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' HD1' ' A' ' 53' ' ' TYR . 58.5 mttp -67.18 -40.37 86.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.144 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.487 ' O ' HG13 ' A' ' 54' ' ' ILE . 65.7 mt -60.08 -40.89 84.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.371 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.05 -40.1 84.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.667 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.23 -46.68 93.81 Favored Glycine 0 C--O 1.239 0.458 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.952 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.445 ' HD1' ' O ' ' A' ' 49' ' ' LYS . 57.4 m-85 -55.54 -43.72 76.04 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 176.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.55 ' HA ' HD11 ' A' ' 17' ' ' ILE . 52.9 mt -53.61 -55.32 13.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 O-C-N 123.432 0.457 . . . . 0.0 111.758 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -48.34 57.34 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 111.55 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -67.68 -42.32 82.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.377 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 53' ' ' TYR . 84.1 mt -61.04 -43.46 96.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.745 0.307 . . . . 0.0 110.391 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 24' ' ' PHE . 72.6 mt -62.7 -42.04 94.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.323 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.4 p -65.18 -24.68 67.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.019 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -85.83 -28.25 24.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.029 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -84.73 -35.46 22.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.517 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.672 -178.947 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.944 0.402 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 161.04 109.75 0.25 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -84.79 99.6 10.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.007 0.432 . . . . 0.0 112.035 -172.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.809 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -94.67 157.95 2.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.33 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.506 ' C ' ' HD2' ' A' ' 5' ' ' ARG . 2.3 tmm_? 68.19 112.78 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -169.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.604 ' O ' HG12 ' A' ' 9' ' ' VAL . 12.6 t -163.21 30.21 0.09 Allowed 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.624 -173.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t -65.21 -13.87 59.29 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.431 0.634 . . . . 0.0 109.728 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.498 ' O ' HG13 ' A' ' 12' ' ' ILE . 52.8 t80 -57.54 -43.45 84.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.849 176.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 6' ' ' THR . 8.0 p -70.38 -28.66 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 121.055 0.455 . . . . 0.0 110.518 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -70.12 -37.93 75.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.592 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -64.82 -43.71 92.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.166 174.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 8' ' ' PHE . 74.2 mt -54.93 -48.53 74.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.285 176.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.98 91.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.098 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -65.58 -49.79 67.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.75 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.04 -20.23 63.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.023 0.44 . . . . 0.0 110.838 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.421 ' SD ' HG22 ' A' ' 35' ' ' VAL . 51.2 ttm -70.58 -48.44 55.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.552 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.5 mt -75.08 -27.66 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 0.0 110.303 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 73.84 -59.39 0.56 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.959 0.904 . . . . 0.0 111.954 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 14.0 t -142.16 -170.04 3.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -175.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -89.53 108.53 25.59 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 19' ' ' THR . 92.3 Cg_endo -85.98 177.9 4.46 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.695 2.263 . . . . 0.0 112.615 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.41 -9.58 64.81 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.844 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.04 101.65 10.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.882 0.372 . . . . 0.0 110.601 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -113.98 26.26 10.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.45 0.643 . . . . 0.0 109.991 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.2 m -82.71 120.37 25.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.837 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -81.56 9.6 7.3 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -171.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.429 ' OD1' ' HB3' ' A' ' 29' ' ' ASP . 12.4 t70 -75.66 136.35 40.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.46 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 70.4 m-85 -64.35 -21.76 66.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.429 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 2.1 t70 -64.29 -30.85 71.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.327 0.584 . . . . 0.0 110.368 175.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.3 m -65.14 -61.73 1.97 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.156 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.6 p-10 -64.23 -28.52 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 -178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.9 -42.79 98.71 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.61 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -73.18 -27.5 61.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.973 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 31' ' ' ASN . 97.8 mt -68.12 -47.19 68.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.371 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 31' ' ' ASN . 89.2 t -55.3 -57.56 7.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -64.99 -28.12 69.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.755 -173.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.46 -48.4 67.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.922 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -85.55 -73.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.107 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 t -140.19 108.7 5.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -79.35 -34.43 42.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.252 -173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.514 HG12 HG23 ' A' ' 43' ' ' THR . 50.2 t 61.76 104.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.218 0.532 . . . . 0.0 111.405 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t -62.88 103.15 0.42 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.215 0.531 . . . . 0.0 110.371 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.514 HG23 HG12 ' A' ' 41' ' ' VAL . 15.0 p -141.24 149.16 41.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.653 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -52.03 -64.12 0.92 Allowed 'General case' 0 N--CA 1.461 0.11 0 O-C-N 123.502 0.501 . . . . 0.0 110.326 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -154.86 21.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.77 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.3 tp -65.77 -29.48 69.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 47' ' ' ARG . 41.2 ttm180 -54.29 -34.11 60.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.072 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -66.4 -35.38 80.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.768 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -69.19 -41.3 77.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.182 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 54' ' ' ILE . 57.2 mt -63.41 -47.92 89.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.046 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.486 ' HB1' HD22 ' A' ' 31' ' ' ASN . . . -60.53 -44.41 96.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.174 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -63.01 -34.21 89.34 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.075 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.505 ' O ' HG13 ' A' ' 57' ' ' ILE . 34.9 t80 -67.04 -37.78 84.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 50' ' ' ILE . 75.0 mt -56.85 -50.03 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.489 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -53.12 -43.23 66.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.978 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.552 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 96.9 mtt180 -64.0 -41.71 97.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.395 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 53' ' ' TYR . 79.9 mt -59.17 -40.8 81.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.706 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 54' ' ' ILE . 76.2 mt -57.36 -43.13 81.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.072 0.463 . . . . 0.0 110.548 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.7 t -65.8 -29.47 69.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.974 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 72.5 mt-30 -82.18 -30.7 30.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.992 0.425 . . . . 0.0 110.556 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -64.77 -62.33 1.64 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.464 -171.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.238 -177.896 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.58 -175.51 48.47 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.823 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.4 m120 62.55 -144.74 0.39 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.9 HG13 ' HD2' ' A' ' 5' ' ' ARG . 40.7 pt 48.04 -155.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.376 1.07 . . . . 0.0 113.061 174.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.9 ' HD2' HG13 ' A' ' 4' ' ' ILE . 5.3 mpt_? 71.97 -158.92 0.11 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.182 0.593 . . . . 0.0 109.677 -173.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.9 t -161.47 21.83 0.12 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.893 0.854 . . . . 0.0 110.09 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m -66.11 -17.44 64.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.403 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.465 ' O ' HG13 ' A' ' 12' ' ' ILE . 9.1 m-85 -64.24 -65.74 0.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.229 0.538 . . . . 0.0 110.736 -176.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.462 ' HA ' HD12 ' A' ' 12' ' ' ILE . 40.0 t -65.57 -32.25 57.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.586 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.58 -43.46 97.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.836 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -74.04 -26.39 60.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.663 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 8' ' ' PHE . 75.0 mt -60.44 -43.27 93.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.879 0.371 . . . . 0.0 110.211 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.44 84.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.373 176.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' C ' ' HD3' ' A' ' 14' ' ' LYS . 12.0 tmtt? -61.12 -41.95 97.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.349 176.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -70.35 -27.14 64.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.184 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.435 ' HE1' HG13 ' A' ' 35' ' ' VAL . 42.7 ttm -70.17 -52.23 25.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.105 0.479 . . . . 0.0 110.538 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 mt -77.38 -1.37 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.074 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.406 ' O ' ' HB ' ' A' ' 19' ' ' THR . 14.1 tp10 -58.8 126.46 27.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.861 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 18' ' ' GLU . 93.1 m 76.62 -54.5 0.58 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.525 173.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 82.6 t60 -138.73 103.02 7.66 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.191 -176.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 20' ' ' HIS . 45.9 Cg_endo -72.09 139.62 32.99 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.326 2.017 . . . . 0.0 110.77 170.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.15 71.75 2.59 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.691 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.613 ' NZ ' ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER 60.28 92.28 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.31 0.576 . . . . 0.0 109.87 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -84.72 63.94 8.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.602 0.715 . . . . 0.0 112.379 -169.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.2 m -92.82 127.57 38.38 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -72.04 79.03 0.93 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.062 0.934 . . . . 0.0 111.778 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.67 132.89 33.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.906 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.649 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 70.5 m-85 -61.5 -19.39 62.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -172.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.481 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 18.1 t0 -63.77 -45.45 89.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.084 0.469 . . . . 0.0 109.763 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.588 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 96.8 m -65.31 -56.25 13.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.844 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.761 HD22 ' HB1' ' A' ' 51' ' ' ALA . 2.9 p-10 -61.94 -41.93 98.53 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -70.52 -31.29 68.32 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.462 -179.219 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 33.5 ttmt -74.83 -28.19 60.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.612 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 30' ' ' THR . 84.2 mt -67.32 -49.54 63.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.119 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.524 ' HB ' ' HG3' ' A' ' 47' ' ' ARG . 14.9 t -63.07 -26.62 41.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.129 0.49 . . . . 0.0 110.447 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 33.4 tt0 -64.11 -16.47 61.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.569 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -156.68 53.51 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.485 0.659 . . . . 0.0 111.11 -173.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.481 ' HE2' HD22 ' A' ' 34' ' ' LEU . 12.8 m-85 -148.55 -89.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.342 172.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.0 m -87.4 58.2 4.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 0.0 110.087 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 m -94.01 86.45 5.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.362 0.601 . . . . 0.0 110.922 -176.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 p -157.26 109.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.8 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.6 m 64.77 2.31 1.66 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.54 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.611 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . 3.2 p -89.95 47.92 1.52 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.176 0.512 . . . . 0.0 111.261 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -60.96 -75.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.881 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -84.45 -13.87 50.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.027 0.442 . . . . 0.0 110.053 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 43' ' ' THR . 3.2 mm? -67.93 -27.48 66.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.824 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.524 ' HG3' ' HB ' ' A' ' 35' ' ' VAL . 42.1 ttp180 -56.62 -35.04 67.84 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.559 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -65.63 -45.62 82.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.257 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.34 -45.17 48.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.545 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 54' ' ' ILE . 76.1 mt -61.65 -41.25 89.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.799 0.333 . . . . 0.0 110.535 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.761 ' HB1' HD22 ' A' ' 31' ' ' ASN . . . -60.13 -41.5 92.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.239 176.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.49 -42.63 99.14 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.985 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.443 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.2 m-85 -58.32 -42.87 87.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.009 -0.096 . . . . 0.0 110.898 176.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 50' ' ' ILE . 62.5 mt -55.92 -53.53 37.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.112 0.257 . . . . 0.0 110.769 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -40.32 73.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.641 0.257 . . . . 0.0 111.531 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -65.91 -41.86 90.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.945 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 53' ' ' TYR . 76.1 mt -65.84 -45.54 91.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.727 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.534 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 86.5 mt -58.11 -49.89 80.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.569 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.9 t -65.19 -29.03 69.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.38 -29.32 65.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.048 0.451 . . . . 0.0 110.23 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -83.95 -30.92 25.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.309 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 17.8 ptpt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.948 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.669 0.271 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.45 87.0 0.82 Allowed Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.584 ' HB2' ' HG3' ' A' ' 5' ' ' ARG . 7.6 p30 -99.19 117.9 34.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.506 0.67 . . . . 0.0 112.232 -173.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.4 tt -80.09 -27.41 12.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 170.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.584 ' HG3' ' HB2' ' A' ' 3' ' ' ASN . 18.5 mtp85 64.29 -176.32 0.17 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.11 175.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 m -161.41 20.11 0.12 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -68.18 -34.74 76.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.084 -174.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -64.8 -38.6 91.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.141 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.74 -50.93 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.815 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -61.68 -42.29 98.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.095 0.474 . . . . 0.0 110.473 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -58.77 -55.12 39.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.493 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.08 -42.42 94.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.558 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -61.31 -42.52 98.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -59.14 -48.48 81.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.953 0.406 . . . . 0.0 110.701 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.69 -25.81 64.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.261 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.9 ttm -72.13 -40.42 68.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.798 0.332 . . . . 0.0 110.932 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 13' ' ' ALA . 50.5 mm -66.0 -46.99 86.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.09 161.92 20.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.953 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.5 m 72.53 -57.37 0.63 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.399 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -129.08 78.08 76.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.858 0.361 . . . . 0.0 110.929 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -88.84 22.17 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.09 2.527 . . . . 0.0 112.887 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.89 93.69 1.18 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.502 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.463 ' HZ3' HD22 ' A' ' 34' ' ' LEU . 67.8 mttm -127.83 147.11 50.43 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -94.67 -70.47 0.71 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.645 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 27' ' ' ASP . 9.8 p -138.7 -165.7 1.87 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.826 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.09 19.96 0.14 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.911 0.484 . . . . 0.0 111.776 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 25' ' ' THR . 31.6 t70 -71.43 127.9 34.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.865 0.364 . . . . 0.0 111.228 -176.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -62.78 -41.34 99.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.408 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.18 -38.17 89.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.123 0.487 . . . . 0.0 110.317 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 54.5 m -62.4 -45.88 91.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.91 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.568 ' O ' HG23 ' A' ' 35' ' ' VAL . 77.0 m-20 -65.02 -37.28 87.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.506 176.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -60.12 -39.5 86.48 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.07 0.462 . . . . 0.0 110.478 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 30' ' ' THR . 6.8 tmtm? -56.07 -43.04 77.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.171 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.463 HD22 ' HZ3' ' A' ' 23' ' ' LYS . 8.0 mp -73.61 -31.74 63.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.571 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 31' ' ' ASN . 59.4 t -66.99 -32.23 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 109.975 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.5 -45.87 92.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.061 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -70.36 -52.18 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.304 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -110.99 -141.94 0.38 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.563 -172.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t 71.4 174.02 0.3 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.308 0.643 . . . . 0.0 109.701 -172.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 m -112.48 -81.17 0.59 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.024 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.78 90.89 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.958 0.885 . . . . 0.0 110.291 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 m -106.19 110.58 22.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.047 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.66 162.58 26.11 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 171.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -63.86 -31.81 73.11 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -169.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -95.64 -21.99 17.86 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.721 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.9 tp -70.88 -27.57 63.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.86 0.362 . . . . 0.0 110.245 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 ttm-85 -55.14 -41.39 71.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.518 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.06 -40.0 95.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.666 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -64.55 -46.93 80.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.851 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.543 ' O ' HG13 ' A' ' 54' ' ' ILE . 64.4 mt -61.77 -43.07 96.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.438 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.28 94.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.764 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.49 -37.28 92.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.182 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.4 ' O ' HG13 ' A' ' 57' ' ' ILE . 78.4 t80 -60.05 -46.6 89.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.71 0.29 . . . . 0.0 110.515 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 50' ' ' ILE . 34.7 mt -60.89 -50.74 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.425 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 m -47.18 -44.13 21.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.561 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.595 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 13.1 ttm180 -61.08 -45.82 93.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.966 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 53' ' ' TYR . 69.2 mt -56.81 -41.02 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.433 . . . . 0.0 110.383 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.3 mt -59.58 -49.94 81.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.82 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.1 p -65.69 -16.63 63.94 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.82 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 84.3 mm-40 -85.11 -40.09 17.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.029 0.442 . . . . 0.0 110.522 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -81.75 -33.54 30.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.711 -176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.5 mptt . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.167 175.506 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 121.026 0.441 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.02 151.04 31.29 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.427 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 t30 73.38 -53.34 0.7 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.337 0.655 . . . . 0.0 111.182 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.5 tt -91.47 100.78 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.636 0.731 . . . . 0.0 109.758 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 5' ' ' ARG . 29.8 ttt180 -88.97 -67.43 0.84 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.085 -172.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.3 m -164.66 -42.66 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.106 0.479 . . . . 0.0 110.157 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 p -52.29 -42.9 64.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.944 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -57.85 -39.99 79.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.082 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.06 -44.11 78.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.975 0.416 . . . . 0.0 110.662 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.14 -28.75 67.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.416 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 37.0 ttt180 -61.82 -52.87 62.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.523 175.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.05 -37.73 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 0.0 110.455 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.41 -46.75 88.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.256 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 15' ' ' GLU . 36.4 pttt -69.09 -33.87 74.21 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.72 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 35.1 mt-10 -70.25 -23.05 62.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.142 0.496 . . . . 0.0 110.476 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.962 ' HB3' ' HB3' ' A' ' 38' ' ' PHE . 67.5 mtt -70.78 -48.85 52.1 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 169.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 69.6 mt -65.47 -31.6 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.271 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 10.5 pt-20 -60.89 -15.71 33.79 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -175.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.4 p -74.33 -26.76 60.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.936 0.398 . . . . 0.0 111.053 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.624 ' HB3' ' HE1' ' A' ' 38' ' ' PHE . 17.7 t-160 -148.77 89.41 5.01 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.213 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.84 42.91 1.16 Allowed 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.641 2.894 . . . . 0.0 112.39 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.4 103.24 0.78 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.915 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -131.44 157.82 42.46 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.548 ' HD2' HG22 ' A' ' 25' ' ' THR . 60.5 t80 -85.99 -68.01 0.77 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.548 HG22 ' HD2' ' A' ' 24' ' ' PHE . 14.4 t -156.0 -165.37 1.92 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -77.35 66.48 3.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.032 0.92 . . . . 0.0 109.729 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.31 143.25 46.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.654 -173.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.682 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 73.4 m-85 -74.03 -33.7 63.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.76 -173.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.67 -36.23 83.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.422 0.629 . . . . 0.0 109.649 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.553 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 96.4 m -61.72 -58.98 5.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.269 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.682 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.5 p-10 -63.69 -28.68 70.07 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.753 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -56.68 -54.18 49.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.179 0.514 . . . . 0.0 110.142 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -70.66 -27.27 63.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.864 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 30' ' ' THR . 69.8 mt -64.97 -51.05 63.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.761 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 31' ' ' ASN . 66.6 t -60.54 -33.09 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 110.528 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -59.25 -37.95 78.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.418 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.29 -53.82 6.02 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.19 0.519 . . . . 0.0 110.793 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.962 ' HB3' ' HB3' ' A' ' 16' ' ' MET . 14.2 m-30 -67.13 106.0 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.118 -173.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 p -144.35 98.49 3.21 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.335 0.588 . . . . 0.0 111.571 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 51.9 m -101.47 -41.93 6.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.403 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.3 m -136.15 155.7 35.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.972 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.5 t -75.15 99.37 3.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.163 0.506 . . . . 0.0 110.267 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 p -77.19 109.85 11.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.249 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -85.62 -78.04 0.28 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.03 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -101.55 -25.7 13.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.428 HD13 ' HB2' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -68.72 -14.58 63.11 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.356 177.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -59.21 -34.41 72.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.442 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -63.75 -43.87 95.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.411 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HB2' HD13 ' A' ' 46' ' ' LEU . 62.1 mttp -66.4 -43.74 85.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.549 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 54' ' ' ILE . 42.6 mm -57.46 -46.39 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.375 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.451 ' HB1' ' ND2' ' A' ' 31' ' ' ASN . . . -57.45 -47.5 81.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.866 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.46 -35.41 91.92 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.323 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 57' ' ' ILE . 7.8 m-85 -71.37 -33.16 69.29 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.743 -0.269 . . . . 0.0 111.384 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 50' ' ' ILE . 58.4 mt -60.21 -49.3 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.511 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.82 -32.07 70.31 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.558 0.218 . . . . 0.0 111.348 175.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -70.07 -39.56 75.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.615 0.245 . . . . 0.0 110.988 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 53' ' ' TYR . 82.3 mt -64.03 -45.46 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.17 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.05 -38.19 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.995 0.426 . . . . 0.0 110.149 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -65.33 -30.88 71.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.799 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -73.49 -34.35 65.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 110.173 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -81.22 -6.45 58.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.634 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.169 -176.423 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 5' ' ' ARG . . . 64.79 24.44 69.85 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.268 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 59.85 20.92 9.82 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.752 0.276 . . . . 0.0 111.168 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.5 pt 45.87 27.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.631 1.172 . . . . 0.0 113.449 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 2' ' ' GLY . 4.8 ptt180 -76.01 97.5 4.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.849 0.833 . . . . 0.0 109.79 174.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.8 m -160.59 -27.24 0.06 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.884 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -61.84 -23.76 66.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.917 0.865 . . . . 0.0 109.092 169.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.516 ' HA ' ' HB3' ' A' ' 11' ' ' ARG . 80.3 m-85 -71.21 -11.78 61.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.314 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.931 HG13 HD13 ' A' ' 50' ' ' ILE . 93.4 t -69.05 -38.84 78.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 173.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -66.19 -39.06 89.42 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.516 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 17.5 tpt180 -56.19 -51.95 66.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.808 173.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 8' ' ' PHE . 45.5 mm -65.87 -44.66 92.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.268 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.35 98.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.739 0.305 . . . . 0.0 111.222 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -61.03 -51.08 70.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.06 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.17 -23.08 61.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.569 ' HG3' ' HB2' ' A' ' 38' ' ' PHE . 49.0 ttm -68.65 -52.44 31.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.317 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.466 HG12 HD23 ' A' ' 34' ' ' LEU . 57.2 mt -75.81 -25.2 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.864 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 61.94 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.256 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 m -153.04 11.96 0.48 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.341 0.591 . . . . 0.0 109.43 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -144.63 101.8 4.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.413 -172.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.511 ' CG ' ' HB2' ' A' ' 24' ' ' PHE . 93.8 Cg_endo -84.48 166.89 12.03 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.87 2.38 . . . . 0.0 112.487 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -88.28 -25.77 30.14 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.445 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.646 ' HD3' ' HA ' ' A' ' 30' ' ' THR . 51.5 mtpt -129.67 -51.89 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.496 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.511 ' HB2' ' CG ' ' A' ' 21' ' ' PRO . 44.9 t80 64.56 81.63 0.2 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.272 -174.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.401 ' H ' HG21 ' A' ' 30' ' ' THR . 16.1 m -155.79 143.97 19.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.274 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -74.84 62.0 1.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.97 0.891 . . . . 0.0 109.626 173.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.05 148.37 46.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.729 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -71.82 -28.95 63.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.78 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.2 -37.39 85.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.144 0.497 . . . . 0.0 109.779 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.646 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 85.6 m -59.1 -48.76 80.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.406 173.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.39 -53.68 50.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.278 174.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -49.86 -55.21 15.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.521 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 59.4 tttm -65.09 -39.58 93.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.329 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.466 HD23 HG12 ' A' ' 17' ' ' ILE . 9.2 mp -71.76 -44.64 63.72 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.273 -0.171 . . . . 0.0 111.395 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 39' ' ' SER . 84.6 t -60.94 -50.56 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.83 0.348 . . . . 0.0 110.475 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -73.97 -7.76 53.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.647 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 5.1 tp10 -80.53 -47.39 14.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.058 0.456 . . . . 0.0 110.059 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.569 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 83.0 m-85 -110.52 -90.22 0.48 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.676 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.61 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 21.4 t 57.16 -169.37 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.509 0.671 . . . . 0.0 112.012 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.1 m -143.41 -62.25 0.41 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.4 t -137.03 93.54 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.573 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.1 p -98.57 94.22 6.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.386 0.612 . . . . 0.0 112.137 -173.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.0 p -86.18 171.87 10.97 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 169.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -61.07 -54.79 40.32 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.29 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.494 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 16.0 t-160 -67.32 -25.92 66.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.814 -175.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 tt -77.25 -41.52 40.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -59.34 -39.46 83.25 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.459 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -58.09 -37.33 74.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.266 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 45' ' ' HIS . 28.1 mmmt -70.15 -49.69 48.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.931 HD13 HG13 ' A' ' 9' ' ' VAL . 41.9 mm -61.71 -53.49 47.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.174 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.43 77.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.178 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -59.14 -45.32 95.49 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.113 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.481 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.9 m-85 -71.68 -37.19 70.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 50' ' ' ILE . 64.3 mt -57.71 -55.9 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.316 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 m -50.67 -44.73 57.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.055 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 98.3 mtt180 -58.82 -51.69 68.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.02 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 53' ' ' TYR . 78.8 mt -57.05 -47.11 84.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.622 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.37 -34.32 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.993 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.0 m -64.59 -40.28 95.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.775 0.322 . . . . 0.0 110.754 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -77.45 -28.34 52.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.059 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -85.18 2.67 42.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 0.0 111.0 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' A' ' 62' ' ' LYS . 13.2 tppt? . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.859 -0.591 . . . . 0.0 109.426 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.8 mtp . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.78 0.324 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.96 -4.38 27.74 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -77.57 -158.62 0.12 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.26 -0.47 . . . . 0.0 109.966 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.1 pt -53.44 125.53 7.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.183 0.516 . . . . 0.0 111.008 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -146.71 152.51 38.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.715 -175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m 67.1 28.98 8.12 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.674 0.749 . . . . 0.0 110.704 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m -64.2 -8.31 12.02 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.431 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.405 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.5 m-85 -57.97 -37.2 73.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.519 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.1 t -64.39 -37.94 81.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.567 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -60.03 -46.78 88.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.6 ttm-85 -64.64 -41.84 95.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.385 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 8' ' ' PHE . 77.3 mt -63.36 -44.13 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.87 -44.06 90.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.944 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -58.63 -49.86 75.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.255 0.55 . . . . 0.0 110.696 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.2 -26.77 65.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.702 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.509 ' O ' HG22 ' A' ' 19' ' ' THR . 37.2 tpp -70.36 -39.71 74.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.633 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.435 HG23 HD23 ' A' ' 34' ' ' LEU . 87.3 mt -74.88 -42.12 46.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.276 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.21 -10.08 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 16' ' ' MET . 15.0 t -80.14 -27.51 39.05 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.193 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -130.41 97.65 21.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 111.137 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -91.39 40.07 0.33 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.262 2.641 . . . . 0.0 112.051 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.93 -56.02 3.93 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.639 -173.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.543 ' HB2' HG23 ' A' ' 30' ' ' THR . 49.6 mtpt -118.33 156.41 28.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.682 0.241 . . . . 0.0 111.162 -174.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -146.39 86.95 1.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.123 0.487 . . . . 0.0 110.323 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 27' ' ' ASP . 14.0 m -155.81 162.89 40.4 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -76.72 30.66 0.13 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.51 0.671 . . . . 0.0 110.729 176.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -98.91 144.6 27.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.704 -176.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.509 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 81.4 m-85 -74.76 -24.86 58.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.126 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 25.5 t70 -66.0 -33.95 76.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 109.697 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.543 HG23 ' HB2' ' A' ' 23' ' ' LYS . 99.6 m -54.59 -59.68 4.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.438 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.509 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 3.3 p-10 -65.13 -28.12 69.21 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.688 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.25 -43.05 96.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.856 0.36 . . . . 0.0 110.458 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 75.0 mmtt -65.25 -32.98 74.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.661 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 30' ' ' THR . 8.4 mp -72.02 -43.19 65.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.754 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.531 HG11 ' HD2' ' A' ' 47' ' ' ARG . 84.4 t -72.49 -18.86 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.289 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -55.09 -39.18 69.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.271 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -76.52 -34.81 58.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.411 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 54.5 p90 48.25 114.47 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.152 1.381 . . . . 0.0 113.71 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 t -71.35 -29.98 65.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.298 177.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.3 t -152.71 -169.12 3.25 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.288 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.09 178.02 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.173 0.511 . . . . 0.0 112.261 -175.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.657 ' HB3' ' HB2' ' A' ' 47' ' ' ARG . 19.7 m -96.54 -51.98 4.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.622 -174.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 55.1 m 69.17 136.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.273 -170.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -33.92 -60.12 0.39 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -167.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -120.77 16.61 11.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 0.0 111.74 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.622 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 36.9 tp -90.88 -33.8 15.5 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.969 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.657 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 22.6 tpp180 -55.12 -46.89 75.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.472 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -69.44 -32.11 70.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 110.702 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.58 -44.65 70.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.431 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 54' ' ' ILE . 44.0 mm -60.22 -45.63 95.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.772 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' HB1' ' ND2' ' A' ' 31' ' ' ASN . . . -58.12 -45.91 86.5 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.477 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.672 ' O ' ' HG2' ' A' ' 56' ' ' ARG . . . -62.55 -42.73 99.67 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.054 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CE2' HD11 ' A' ' 57' ' ' ILE . 66.9 t80 -57.62 -40.31 78.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.14 0.176 . . . . 0.0 110.626 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 50' ' ' ILE . 78.7 mt -56.14 -54.3 29.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.672 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -61.89 -35.77 79.31 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 52.8 mmm-85 -62.52 -41.83 99.11 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.68 0.276 . . . . 0.0 110.416 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.534 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 78.0 mt -58.66 -46.05 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.411 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.7 mt -57.73 -49.13 81.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -65.79 -37.0 85.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.579 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -71.62 -25.47 62.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.395 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 57.6 mt-30 -72.33 -18.43 61.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.119 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 C--O 1.246 0.897 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.794 179.163 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.0 -125.82 5.69 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.53 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -114.47 30.31 7.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.499 0.666 . . . . 0.0 109.84 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.4 tt -69.22 150.12 10.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.908 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 73.72 23.82 2.28 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.499 0.666 . . . . 0.0 109.909 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -161.7 -30.91 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.22 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m -60.98 -28.15 68.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.106 171.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.434 ' O ' HG13 ' A' ' 12' ' ' ILE . 94.5 t80 -59.69 -48.19 82.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.528 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.7 t -66.21 -40.59 87.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.168 0.509 . . . . 0.0 110.194 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -60.76 -32.59 71.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.72 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -69.63 -35.86 75.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.682 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 16' ' ' MET . 29.4 mt -61.63 -40.38 86.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.99 0.424 . . . . 0.0 109.931 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.37 -35.02 79.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.962 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -64.68 -56.49 13.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.73 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.55 ' HA ' ' HB3' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -68.48 -15.26 63.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.171 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.482 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 6.8 tpt -64.98 -53.67 42.54 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.13 -28.87 21.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.688 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 15' ' ' GLU . 11.4 tp10 -60.15 153.85 20.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.423 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 18' ' ' GLU . 52.2 m 82.08 -47.72 0.2 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.517 0.727 . . . . 0.0 111.18 -176.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -147.64 96.17 4.16 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.597 0.237 . . . . 0.0 110.89 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.69 95.58 0.81 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.778 2.319 . . . . 0.0 111.315 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.753 ' H ' ' HE1' ' A' ' 38' ' ' PHE . . . -68.18 -82.53 0.16 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 116.111 -0.495 . . . . 0.0 113.133 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.565 ' HB2' HD21 ' A' ' 34' ' ' LEU . 67.0 mttm -136.02 152.95 51.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.664 0.269 . . . . 0.0 110.639 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -118.0 61.35 0.77 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.505 0.669 . . . . 0.0 109.338 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.657 ' HB ' HG21 ' A' ' 30' ' ' THR . 21.7 m -121.34 133.71 55.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.346 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.562 ' HA ' HG22 ' A' ' 55' ' ' THR . 8.0 p-10 -88.35 32.09 0.79 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -173.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -94.96 145.43 24.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -66.82 -27.47 67.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.73 0.3 . . . . 0.0 110.953 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.5 -37.95 88.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.521 0.677 . . . . 0.0 109.27 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.657 HG21 ' HB ' ' A' ' 25' ' ' THR . 22.2 m -65.81 -56.27 12.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.202 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.9 p30 -61.54 -27.83 68.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 111.247 -175.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.73 -49.22 69.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.24 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -77.29 -21.02 54.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.877 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 30' ' ' THR . 41.7 mt -66.3 -50.11 64.75 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.18 174.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 31' ' ' ASN . 68.8 t -56.14 -43.43 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.039 0.447 . . . . 0.0 110.025 176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -58.24 -42.21 85.84 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.297 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.01 -48.86 11.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.753 ' HE1' ' H ' ' A' ' 22' ' ' GLY . 17.1 m-30 -56.88 -76.24 0.04 OUTLIER 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -131.77 133.54 44.86 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 t -81.6 -1.15 45.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.729 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.04 109.85 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.837 0.827 . . . . 0.0 110.517 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.7 m -80.61 162.35 24.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.638 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.769 ' HB ' ' HB2' ' A' ' 47' ' ' ARG . 11.1 m -150.06 117.46 6.08 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -21.51 -79.59 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.962 1.305 . . . . 0.0 113.51 -168.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -133.63 13.25 4.08 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.415 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 50' ' ' ILE . 58.6 tp -88.62 -28.37 20.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.361 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.769 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 14.1 tpp180 -66.67 -34.81 78.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.431 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.72 -39.69 85.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.755 175.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 33.0 mmtp -73.66 -31.91 63.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.551 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 54' ' ' ILE . 80.4 mt -62.74 -40.17 87.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.195 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.43 96.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.042 0.449 . . . . 0.0 110.558 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.92 -32.23 83.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.734 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.494 ' O ' HG13 ' A' ' 57' ' ' ILE . 23.5 t80 -71.4 -30.82 66.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 50' ' ' ILE . 79.3 mt -59.4 -49.54 83.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.894 0.378 . . . . 0.0 110.193 175.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.562 HG22 ' HA ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -62.35 -29.23 70.31 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.559 176.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.3 ttt85 -68.69 -41.59 78.95 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 110.687 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 53' ' ' TYR . 77.6 mt -59.99 -45.9 94.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.378 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.8 -50.7 79.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.247 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.0 p -66.4 -35.3 79.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.725 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.73 -35.99 65.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -72.81 -52.32 15.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.145 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.53 ' HB3' ' NZ ' ' A' ' 62' ' ' LYS . 1.3 ttpm? . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.4 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.632 0.253 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.38 130.11 9.91 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.335 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.587 HD21 ' HB3' ' A' ' 7' ' ' SER . 0.0 OUTLIER 77.01 145.71 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.413 0.685 . . . . 0.0 111.543 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 62.4 mt -103.88 -72.28 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.91 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -120.34 79.69 1.51 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.688 0.756 . . . . 0.0 111.041 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.416 ' H ' ' H ' ' A' ' 7' ' ' SER . 14.4 m -161.29 3.42 0.06 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.751 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.587 ' HB3' HD21 ' A' ' 3' ' ' ASN . 1.5 p -67.88 -17.71 64.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.016 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.516 ' O ' HG13 ' A' ' 12' ' ' ILE . 79.3 t80 -56.27 -40.61 74.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.031 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.87 -34.6 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.254 0.55 . . . . 0.0 110.192 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -68.04 -31.45 71.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.335 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 7' ' ' SER . 22.5 mmt180 -75.34 -31.77 60.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.075 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 8' ' ' PHE . 82.1 mt -61.75 -55.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.01 -39.13 77.53 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.452 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 38.7 tptt -52.78 -56.21 17.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.066 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.92 -28.29 64.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.588 -176.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 39' ' ' SER . 87.1 mtp -66.65 -43.42 84.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.599 0.238 . . . . 0.0 110.979 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.3 mt -77.59 -31.68 17.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.108 0.48 . . . . 0.0 110.995 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -62.15 113.73 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.966 -175.526 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.6 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 93.1 m 76.31 -39.49 0.36 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.802 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -91.11 98.3 1.62 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.394 . . . . 0.0 110.149 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 19' ' ' THR . 27.5 Cg_endo -94.92 102.63 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.269 2.646 . . . . 0.0 112.69 -175.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.639 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -91.7 -125.06 3.35 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 173.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.494 ' HA ' HG21 ' A' ' 30' ' ' THR . 36.5 ttmt 61.54 77.71 0.32 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.188 0.518 . . . . 0.0 111.603 173.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -86.8 -37.54 17.71 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.42 HG22 ' N ' ' A' ' 26' ' ' ASP . 19.2 m -154.42 168.34 26.99 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.42 ' N ' HG22 ' A' ' 25' ' ' THR . 12.2 p-10 -82.32 28.0 0.47 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.149 0.5 . . . . 0.0 111.035 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.37 162.12 14.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.716 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.3 -30.44 68.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.687 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.99 -30.63 71.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.211 0.529 . . . . 0.0 110.316 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.494 HG21 ' HA ' ' A' ' 23' ' ' LYS . 97.5 m -64.94 -52.86 54.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.393 176.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.749 ' OD1' ' HB ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -61.34 -37.98 85.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.074 178.411 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -50.1 -49.27 52.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.573 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.68 -39.16 73.69 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.997 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.639 HD11 ' HA3' ' A' ' 22' ' ' GLY . 8.5 mp -58.77 -39.24 80.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.471 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.528 HG11 ' HG3' ' A' ' 47' ' ' ARG . 57.0 t -75.49 -37.11 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.267 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.14 -49.21 76.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.877 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -63.54 -65.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.067 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -101.6 -84.46 0.44 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.637 -168.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.482 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 90.3 p 51.33 -172.65 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.915 0.886 . . . . 0.0 112.308 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.9 m -145.85 112.22 5.81 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.1 t 65.67 82.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -169.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.8 m -72.33 91.95 1.37 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.124 -174.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.578 ' OG1' ' HB2' ' A' ' 46' ' ' LEU . 2.9 p -92.71 -175.61 3.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.285 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -102.01 -59.33 1.72 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.468 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -31.23 50.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 110.501 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.578 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 7.2 mp -73.18 -18.7 61.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.49 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.528 ' HG3' HG11 ' A' ' 35' ' ' VAL . 41.5 ttp180 -57.43 -43.66 84.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.4 0.619 . . . . 0.0 110.205 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -72.71 -23.17 60.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.574 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -71.23 -46.44 61.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.969 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.0 mt -63.24 -33.15 59.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.928 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.58 84.3 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.915 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.85 -41.22 88.84 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.76 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.442 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.0 m-85 -62.03 -61.45 2.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.496 0.189 . . . . 0.0 111.483 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.749 ' HB ' ' OD1' ' A' ' 31' ' ' ASN . 62.8 mt -60.84 -44.82 98.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -172.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 p -54.26 -45.76 72.5 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.243 0.474 . . . . 0.0 111.473 176.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -60.0 -43.83 94.93 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.418 176.095 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 53' ' ' TYR . 78.1 mt -62.76 -38.63 82.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.081 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 54' ' ' ILE . 75.7 mt -59.7 -51.36 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.865 0.364 . . . . 0.0 110.855 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.2 p -65.24 -22.3 66.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.573 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -84.99 -52.09 6.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.726 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -71.54 -36.31 70.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.085 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm . . . . . 0 C--O 1.25 1.097 0 O-C-N 123.838 0.711 . . . . 0.0 109.688 -172.539 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.92 148.22 41.03 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.966 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -90.69 125.56 35.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 tt -155.86 147.16 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.703 0.287 . . . . 0.0 111.538 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 75.85 130.51 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.995 171.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.2 21.54 0.1 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.271 176.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -75.17 -21.73 58.55 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.631 -166.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.464 ' O ' HG13 ' A' ' 12' ' ' ILE . 25.3 m-85 -65.58 -60.55 2.81 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.834 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.87 -34.64 71.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.214 0.531 . . . . 0.0 110.479 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -66.29 -33.66 76.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.545 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -72.86 -35.76 67.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.687 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 8' ' ' PHE . 72.4 mt -57.14 -49.95 78.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.208 177.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.3 -39.58 94.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -64.84 -34.51 78.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.77 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -69.86 -35.51 74.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.665 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.567 ' HA ' ' HD2' ' A' ' 38' ' ' PHE . 48.8 ttm -70.4 -42.63 71.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.684 177.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.569 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 53.5 mt -75.55 -5.84 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.385 0.612 . . . . 0.0 110.982 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.38 134.65 53.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.53 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m 76.19 -66.74 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.598 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . 1.2 t-160 -89.64 -57.01 0.27 Allowed Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 120.483 -0.487 . . . . 0.0 112.219 -168.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.951 ' HB3' HD22 ' A' ' 34' ' ' LEU . 43.1 Cg_exo -60.54 133.67 50.11 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.151 1.901 . . . . 0.0 112.631 178.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.56 -7.01 34.99 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.641 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 57.4 pttt 41.17 86.03 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.889 0.875 . . . . 0.0 112.415 -176.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -129.19 1.91 5.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.018 -0.426 . . . . 0.0 111.981 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.454 ' HB ' ' OG1' ' A' ' 30' ' ' THR . 11.6 m -139.94 146.61 39.41 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -105.02 29.42 6.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.7 0.286 . . . . 0.0 111.382 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -100.05 160.34 14.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -71.96 -24.21 61.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.681 0.277 . . . . 0.0 111.618 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.43 -29.17 69.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.338 0.59 . . . . 0.0 109.462 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.617 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 14.3 m -65.59 -52.18 54.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.424 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.452 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.2 p30 -65.87 -28.34 68.89 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.755 -177.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -64.19 -44.02 93.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.949 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -65.2 -34.39 78.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.812 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.951 HD22 ' HB3' ' A' ' 21' ' ' PRO . 59.8 mt -70.6 -43.8 68.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.291 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.541 HG11 ' HG3' ' A' ' 47' ' ' ARG . 56.4 t -69.74 -30.81 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.378 0.609 . . . . 0.0 110.301 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.83 -23.29 60.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.327 0.584 . . . . 0.0 109.928 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -80.01 -55.66 4.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.164 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.567 ' HD2' ' HA ' ' A' ' 16' ' ' MET . 34.2 t80 -132.57 148.19 52.37 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.1 p -162.55 153.74 17.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.773 0.32 . . . . 0.0 110.848 -173.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.594 HG22 HG23 ' A' ' 41' ' ' VAL . 37.5 m -133.92 119.87 19.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.581 177.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.594 HG23 HG22 ' A' ' 40' ' ' THR . 66.1 t 73.63 153.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 123.514 0.509 . . . . 0.0 110.969 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.1 m -66.89 100.58 0.74 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.006 0.431 . . . . 0.0 109.877 175.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 47' ' ' ARG . 37.3 p -85.43 111.59 20.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.692 -175.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -98.63 -77.43 0.51 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -101.59 13.65 34.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.398 0.618 . . . . 0.0 109.953 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.401 HD23 HG22 ' A' ' 43' ' ' THR . 59.8 tp -95.15 -27.78 15.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.762 173.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.542 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 51.2 ttp180 -67.09 -47.64 70.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.586 -174.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -61.64 -34.98 76.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.996 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 72.2 mmtt -65.57 -51.16 61.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.532 ' O ' HG13 ' A' ' 54' ' ' ILE . 66.3 mt -65.28 -51.34 66.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.8 -48.83 77.05 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.926 0.394 . . . . 0.0 111.144 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.92 -37.94 95.75 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.96 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.448 ' O ' HG13 ' A' ' 57' ' ' ILE . 2.0 t80 -69.95 -33.13 71.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 50' ' ' ILE . 80.9 mt -56.84 -55.58 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.863 0.363 . . . . 0.0 110.265 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.17 -32.31 73.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -62.05 -46.64 88.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.958 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 53' ' ' TYR . 84.1 mt -62.57 -39.01 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.671 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 54' ' ' ILE . 71.8 mt -58.25 -51.87 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.526 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.9 p -65.86 -18.9 65.66 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.785 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -84.89 -38.96 18.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 0.0 110.372 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -73.84 -38.37 64.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.32 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.471 -179.395 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtm . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.779 0.324 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -90.92 95.77 2.12 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.521 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -149.79 -160.5 1.18 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.892 HG13 ' H ' ' A' ' 5' ' ' ARG . 9.6 tp -130.05 -166.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.892 ' H ' HG13 ' A' ' 4' ' ' ILE . 9.6 ptp85 -51.89 133.25 32.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.95 0.405 . . . . 0.0 111.368 176.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 m -67.41 -24.23 65.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.307 0.575 . . . . 0.0 110.601 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.9 m -67.8 -9.33 43.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.501 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.439 ' O ' HG13 ' A' ' 12' ' ' ILE . 75.6 t80 -65.62 -37.19 85.88 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.7 t -66.12 -37.29 79.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.672 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -64.93 -33.33 75.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.448 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -28.24 62.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 8' ' ' PHE . 72.9 mt -70.71 -39.23 75.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.265 0.555 . . . . 0.0 109.547 173.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.31 90.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.484 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -63.03 -42.92 99.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.071 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -55.55 -45.73 77.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.516 ' SD ' ' HB3' ' A' ' 34' ' ' LEU . 46.3 tpp -55.77 -52.44 63.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.222 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.32 -49.73 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.236 -173.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -66.09 -33.08 74.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.728 0.299 . . . . 0.0 111.792 -173.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 m -84.11 -16.87 42.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.246 0.546 . . . . 0.0 110.579 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . 47.2 t-80 -132.55 69.39 79.75 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.064 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.31 0.45 9.41 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.12 2.547 . . . . 0.0 112.716 -174.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -97.02 147.06 18.56 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 70.43 20.88 5.84 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.915 0.486 . . . . 0.0 110.775 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -71.38 120.52 17.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.186 0.517 . . . . 0.0 109.923 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.2 m -153.97 144.93 22.7 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.719 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -77.95 41.93 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.616 0.722 . . . . 0.0 110.191 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -103.9 139.93 38.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.712 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.654 ' HA ' ' ND2' ' A' ' 31' ' ' ASN . 99.5 m-85 -72.14 -40.27 68.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.777 -174.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.56 -38.35 90.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.245 0.545 . . . . 0.0 110.358 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.443 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 67.3 m -62.71 -55.03 30.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.564 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.654 ' ND2' ' HA ' ' A' ' 28' ' ' PHE . 20.9 p30 -60.87 -30.05 69.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.702 0.287 . . . . 0.0 110.997 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.586 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 14.3 tmtt? -66.93 -52.13 46.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.082 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 52.3 mtmt -67.4 -26.8 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.727 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.516 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 95.2 mt -69.33 -48.17 62.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.65 0.262 . . . . 0.0 110.713 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.86 HG12 HG21 ' A' ' 43' ' ' THR . 17.8 t -68.15 -24.58 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.429 . . . . 0.0 110.11 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 7.3 mm-40 -57.42 -38.51 74.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.245 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -159.09 89.76 0.94 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 -174.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 20' ' ' HIS . 51.3 t80 -175.65 -78.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.266 171.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.424 ' HB2' ' HE2' ' A' ' 16' ' ' MET . 66.6 m -104.07 51.04 0.78 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.454 0.645 . . . . 0.0 109.347 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.448 HG23 ' HB ' ' A' ' 43' ' ' THR . 10.8 m -78.79 113.2 16.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.585 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.22 96.79 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.922 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.7 m 53.14 34.59 17.73 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.631 0.729 . . . . 0.0 109.786 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.86 HG21 HG12 ' A' ' 35' ' ' VAL . 38.2 m -86.5 89.08 7.78 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.8 -168.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -104.31 -66.31 0.97 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.066 168.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -98.18 -19.62 17.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.14 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.6 tp -64.87 -14.19 58.75 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.13 0.491 . . . . 0.0 110.589 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.572 ' HA ' HG11 ' A' ' 35' ' ' VAL . 38.1 ttm180 -49.49 -57.73 6.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.801 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -69.6 -18.33 63.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.538 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -75.32 -54.04 7.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.034 0.445 . . . . 0.0 110.109 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 54' ' ' ILE . 62.2 mt -64.69 -41.76 93.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.048 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.478 ' HB1' ' OD1' ' A' ' 31' ' ' ASN . . . -59.31 -38.64 80.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.172 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.86 -44.24 97.27 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.718 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -60.88 -49.83 75.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.952 -0.124 . . . . 0.0 111.08 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 50' ' ' ILE . 78.0 mt -49.05 -57.81 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 O-C-N 123.527 0.517 . . . . 0.0 111.111 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -47.32 -58.27 4.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.222 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 75.2 mtt-85 -70.8 -33.06 70.33 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -172.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.0 mt -65.26 -40.37 88.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.974 0.416 . . . . 0.0 110.118 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.35 -32.29 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.229 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.1 m -65.52 -24.62 67.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 176.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 83.4 mm-40 -75.38 -54.01 7.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.308 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.49 -51.38 8.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.637 0.256 . . . . 0.0 111.663 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.3 tttt . . . . . 0 C--O 1.249 1.071 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.329 -174.211 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tmm? . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 121.013 0.435 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.07 92.27 1.55 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.58 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -75.26 69.07 2.06 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.4 mt 68.45 -72.88 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 O-C-N 123.725 0.641 . . . . 0.0 110.03 -173.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 62.76 177.03 0.14 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.414 0.685 . . . . 0.0 112.112 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.2 m -162.82 -30.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.407 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 m -49.16 -44.21 42.6 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.207 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.411 ' O ' HG12 ' A' ' 12' ' ' ILE . 74.9 t80 -61.65 -48.57 80.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.5 t -63.59 -44.8 98.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.772 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.15 -29.7 67.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.817 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.521 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 8.6 tpt180 -64.49 -42.32 95.92 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 176.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 8' ' ' PHE . 49.5 mm -59.24 -43.1 89.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.254 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.33 97.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.284 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -58.49 -41.66 85.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.779 178.57 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 11' ' ' ARG . 76.2 mm-40 -56.67 -47.08 80.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.829 0.347 . . . . 0.0 110.493 178.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.481 ' HE2' ' HB3' ' A' ' 39' ' ' SER . 42.0 ttm -65.83 -50.29 65.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.739 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.478 HG23 ' HZ1' ' A' ' 23' ' ' LYS . 85.0 mt -57.72 -46.29 86.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.602 -177.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.472 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 5.2 tp10 -66.22 -46.48 77.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 m -69.19 -41.62 76.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.236 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -121.44 92.91 48.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 110.952 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.99 -2.95 11.53 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.589 2.86 . . . . 0.0 112.334 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.31 62.27 2.65 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.329 -0.462 . . . . 0.0 113.038 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.478 ' HZ1' HG23 ' A' ' 17' ' ' ILE . 2.0 pptp? -169.61 142.84 2.62 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -167.23 48.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.651 0.738 . . . . 0.0 110.225 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.461 ' HB ' ' OD2' ' A' ' 27' ' ' ASP . 0.6 OUTLIER -139.0 146.01 40.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.488 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -106.14 21.4 17.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 111.503 -173.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' OD2' ' HB ' ' A' ' 25' ' ' THR . 4.3 p30 -89.45 159.3 17.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 176.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.68 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 62.2 m-85 -71.36 -28.24 63.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.118 -176.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.97 -36.76 85.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.121 0.486 . . . . 0.0 110.305 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 53.1 m -61.1 -56.81 16.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.661 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.68 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.7 p-10 -65.65 -23.97 66.92 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.395 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.617 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 20.6 ttpp -62.12 -52.06 65.36 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -56.58 -38.59 72.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.274 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.482 ' HA ' ' HD2' ' A' ' 38' ' ' PHE . 7.7 mp -60.15 -51.53 69.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.4 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 51' ' ' ALA . 35.7 m -82.46 -9.2 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 122.047 -0.408 . . . . 0.0 111.011 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 2.8 tp10 -76.08 -2.61 31.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -158.5 -48.14 0.06 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.854 0.359 . . . . 0.0 111.374 -171.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.482 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 36.9 m-85 -84.66 -165.98 1.34 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.809 -174.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.481 ' HB3' ' HE2' ' A' ' 16' ' ' MET . 93.3 p 62.23 174.42 0.13 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.397 1.079 . . . . 0.0 112.29 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.559 HG23 HG23 ' A' ' 41' ' ' VAL . 13.9 t -160.88 -161.13 0.8 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -178.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.559 HG23 HG23 ' A' ' 40' ' ' THR . 67.6 t 79.01 149.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 123.693 0.621 . . . . 0.0 110.345 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.3 t -78.6 -171.6 2.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.117 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.6 m 69.76 82.6 0.16 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.877 0.846 . . . . 0.0 109.95 -174.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HG2' ' H ' ' A' ' 44' ' ' LYS . 18.4 pttm -62.5 -25.74 68.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.316 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -78.71 -13.18 59.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.955 0.407 . . . . 0.0 110.64 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -77.04 -39.6 49.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.044 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -69.78 -10.16 57.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.854 0.359 . . . . 0.0 111.682 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -69.59 -41.96 75.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.402 0.62 . . . . 0.0 109.635 172.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -73.24 -38.89 65.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.69 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.558 ' O ' HG13 ' A' ' 54' ' ' ILE . 50.4 mm -57.16 -49.18 80.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.487 177.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.591 ' HB1' HD22 ' A' ' 31' ' ' ASN . . . -57.85 -50.94 71.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.414 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.62 -28.48 73.65 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.767 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.501 ' O ' HG13 ' A' ' 57' ' ' ILE . 22.7 t80 -73.93 -37.27 64.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 50' ' ' ILE . 84.6 mt -58.63 -47.64 88.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 110.124 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.76 -42.23 75.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.414 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -66.22 -44.47 83.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.032 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 53' ' ' TYR . 80.9 mt -57.53 -49.36 80.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.68 -49.95 81.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.095 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 p -65.82 -25.39 67.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.709 0.29 . . . . 0.0 111.535 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -70.27 -34.19 72.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.044 0.449 . . . . 0.0 110.327 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -86.39 -33.02 20.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.754 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.5 tttm . . . . . 0 C--O 1.253 1.275 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.811 -176.036 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.796 0.332 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.15 -110.34 3.77 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.874 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -100.94 86.98 3.17 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.1 mt 66.55 -74.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.469 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -138.5 -63.47 0.54 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.157 0.503 . . . . 0.0 110.079 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -167.39 21.11 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.866 0.841 . . . . 0.0 109.042 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m -67.61 -14.07 62.62 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.259 -172.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.53 ' O ' HG13 ' A' ' 12' ' ' ILE . 55.0 t80 -64.16 -35.84 82.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.4 -48.78 85.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.095 0.474 . . . . 0.0 110.7 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 53' ' ' TYR . 87.8 tttt -58.78 -40.2 83.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.544 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -59.44 -46.31 89.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.439 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 8' ' ' PHE . 73.3 mt -57.17 -53.5 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.745 0.307 . . . . 0.0 111.094 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.503 ' HB1' HG12 ' A' ' 54' ' ' ILE . . . -63.82 -45.78 88.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.432 -177.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.2 -39.51 94.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.42 -176.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.886 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 31.0 mt-10 -71.06 -30.62 66.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.748 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.453 ' HG3' ' O ' ' A' ' 12' ' ' ILE . 59.9 mtt -55.34 -42.45 73.84 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.535 HD11 HG23 ' A' ' 54' ' ' ILE . 57.8 mt -65.23 -54.18 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.25 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.886 ' HG2' ' HA ' ' A' ' 15' ' ' GLU . 8.8 pt-20 -67.0 -6.01 15.19 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.5 m -57.59 -43.08 84.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.147 0.498 . . . . 0.0 110.662 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -150.44 120.09 3.73 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.959 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.68 100.33 0.11 Allowed 'Trans proline' 0 CA--C 1.515 -0.429 0 C-N-CA 122.648 2.232 . . . . 0.0 111.914 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.19 171.69 44.69 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.899 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.766 ' HB3' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER 57.83 -113.56 0.73 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -176.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 92.3 t80 70.77 -33.7 0.28 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 165.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 p -82.9 70.25 9.86 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -166.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.477 ' H ' HG21 ' A' ' 58' ' ' ILE . 32.5 t70 36.79 66.54 0.4 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.369 1.068 . . . . 0.0 112.786 170.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.556 ' O ' ' HB ' ' A' ' 30' ' ' THR . 7.9 t70 -139.79 147.91 41.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.222 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -77.9 -35.25 50.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 110.633 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.433 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 36.2 t70 -65.63 -29.7 70.31 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.766 HG23 ' HB3' ' A' ' 23' ' ' LYS . 2.5 m -61.06 -50.54 72.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.679 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' HB2' ' HB1' ' A' ' 51' ' ' ALA . 18.5 p30 -64.46 -34.77 78.97 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 110.507 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 19.6 ttpt -63.41 -48.89 75.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.517 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 25.9 ttmt -69.67 -13.3 62.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.566 -173.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 30' ' ' THR . 96.7 mt -81.92 -49.9 9.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.941 0.4 . . . . 0.0 110.425 173.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.526 HG11 ' HA ' ' A' ' 47' ' ' ARG . 43.4 t -74.98 -28.39 21.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.212 -176.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 4.4 tp10 -76.08 7.03 4.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 33' ' ' LYS . 12.4 pt-20 -155.98 -43.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.646 -0.421 . . . . 0.0 112.105 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -84.68 -85.45 0.14 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 11.9 t 54.65 -159.36 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.752 0.787 . . . . 0.0 112.094 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.2 m -153.65 -44.67 0.09 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 HG23 ' A' ' 43' ' ' THR . 7.5 p -161.61 108.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.707 171.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.6 m -80.07 -28.17 39.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.813 -172.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.673 HG23 HG22 ' A' ' 41' ' ' VAL . 65.9 p 48.53 -131.84 1.61 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.65 0.594 . . . . 0.0 111.311 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -103.39 -64.95 1.04 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 111.361 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -107.35 -9.06 16.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -173.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.7 tp -64.09 -34.85 78.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HA ' HG11 ' A' ' 35' ' ' VAL . 14.6 ttm105 -47.17 -52.45 15.61 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.808 0.693 . . . . 0.0 110.992 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -78.36 -30.38 47.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.664 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -74.1 -51.1 16.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.854 0.359 . . . . 0.0 110.209 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.566 ' O ' HG13 ' A' ' 54' ' ' ILE . 10.6 tt -66.37 -34.05 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.447 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 31' ' ' ASN . . . -65.26 -40.32 93.8 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.039 0.447 . . . . 0.0 110.641 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.39 -41.18 99.47 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.419 ' CE2' HD11 ' A' ' 57' ' ' ILE . 61.4 t80 -63.38 -44.28 95.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.607 -0.297 . . . . 0.0 110.631 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 50' ' ' ILE . 91.4 mt -54.62 -57.84 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.753 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -56.24 -40.7 74.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.132 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -59.1 -39.54 82.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.058 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.419 HD11 ' CE2' ' A' ' 53' ' ' TYR . 70.7 mt -68.11 -42.33 84.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 110.436 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.477 HG21 ' H ' ' A' ' 26' ' ' ASP . 49.4 mm -65.09 -45.74 93.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.868 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -58.72 -37.41 76.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.754 0.311 . . . . 0.0 110.688 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -66.99 -36.0 81.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.079 0.466 . . . . 0.0 110.777 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -75.41 -24.79 57.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.527 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.929 -176.044 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.6 t . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.763 0.316 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -64.37 -36.12 83.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.064 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.8 t -66.3 -36.59 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.435 0.636 . . . . 0.0 109.721 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -66.39 -33.94 76.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.529 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -66.75 -41.61 87.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.412 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.62 -40.26 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.345 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -60.54 -47.03 87.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.391 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 27.0 mmmt -56.63 -50.01 73.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.157 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.31 -39.01 78.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.808 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.579 ' SD ' HG13 ' A' ' 35' ' ' VAL . 37.6 ttm -69.82 -45.64 67.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.442 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.625 HG23 HD21 ' A' ' 34' ' ' LEU . 63.8 mt -75.38 -49.75 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.908 0.385 . . . . 0.0 111.481 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 1.7 tp10 -65.61 -8.89 22.58 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -169.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.489 HG21 ' CD1' ' A' ' 38' ' ' PHE . 5.9 t -76.69 -17.32 59.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.273 0.559 . . . . 0.0 109.808 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 18.1 t-160 -142.51 109.08 5.67 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 20' ' ' HIS . 20.7 Cg_exo . . . . . 0 CA--C 1.536 0.622 0 C-N-CA 123.704 2.936 . . . . 0.0 114.161 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -131.62 144.34 50.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -67.42 -36.18 80.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.389 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.523 ' O ' ' HD3' ' A' ' 33' ' ' LYS . 17.0 t70 -65.69 -39.56 91.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.104 0.478 . . . . 0.0 110.173 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 m -61.22 -52.07 66.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.853 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.451 ' O ' HG23 ' A' ' 35' ' ' VAL . 78.3 m-20 -65.06 -32.39 74.09 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.734 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 64.0 tttm -58.93 -53.83 53.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.353 176.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HD3' ' O ' ' A' ' 29' ' ' ASP . 1.2 mptm? -66.48 -36.27 82.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.919 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.625 HD21 HG23 ' A' ' 17' ' ' ILE . 43.4 tp -57.82 -40.63 80.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.609 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.579 HG13 ' SD ' ' A' ' 16' ' ' MET . 76.9 t -69.75 -46.31 74.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.907 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 43.4 mt-10 -70.99 -25.3 62.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -171.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.52 -15.42 58.62 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.117 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.522 ' HD2' ' HG3' ' A' ' 16' ' ' MET . 65.5 t80 -113.83 -80.47 0.59 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.5 m 63.84 103.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.7 0.625 . . . . 0.0 112.143 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 C--N 1.323 -0.548 0 CA-C-O 121.951 0.882 . . . . 0.0 109.589 176.38 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -78.78 -12.34 60.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.96 0.41 . . . . 0.0 110.841 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 49' ' ' LYS . 38.7 tp -74.31 -21.75 59.58 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.478 ' HG3' HG11 ' A' ' 35' ' ' VAL . 73.7 ttp85 -59.92 -30.25 68.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.586 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.69 -44.23 97.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.369 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.528 ' HD2' HD12 ' A' ' 46' ' ' LEU . 68.1 mttm -67.62 -34.26 76.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.331 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.532 ' O ' HG13 ' A' ' 54' ' ' ILE . 50.5 mm -65.35 -49.48 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.524 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.05 97.3 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.89 -33.97 81.12 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.771 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 11.5 t80 -63.23 -45.94 89.29 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.502 0.321 . . . . 0.0 110.54 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.569 HG12 HD11 ' A' ' 17' ' ' ILE . 36.2 mt -58.9 -56.64 15.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.169 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -49.69 -40.24 39.42 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.677 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.09 -48.05 75.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.993 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.2 mt -59.21 -43.4 89.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 110.623 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.59 -48.99 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.73 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 p -65.31 -31.22 72.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -84.95 -18.53 34.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.875 0.369 . . . . 0.0 111.408 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.37 -37.76 65.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.242 -177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 65.0 tttp . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.764 -177.716 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 m . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -63.68 -43.53 96.42 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 122.298 -0.251 . . . . 0.0 111.307 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.52 -48.49 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.261 0.553 . . . . 0.0 110.628 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -64.12 -30.78 71.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.633 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.744 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -63.2 -52.98 60.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.51 177.087 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 74.5 mt -57.59 -44.41 85.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.809 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.71 -49.16 71.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.169 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -65.2 -44.24 89.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -62.36 -39.03 91.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.906 0.384 . . . . 0.0 110.53 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.511 ' SD ' ' HB2' ' A' ' 38' ' ' PHE . 27.2 tpp -55.97 -47.81 76.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.438 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.613 HD11 HG23 ' A' ' 54' ' ' ILE . 56.1 mt -76.86 -51.92 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.706 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.86 -25.92 67.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -168.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 p -61.29 -22.94 65.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 111.109 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -143.67 90.14 7.16 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.57 0.7 . . . . 0.0 109.324 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 C--O 1.232 0.216 0 C-N-CA 122.975 2.45 . . . . 0.0 113.223 -172.443 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.83 0.824 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -137.12 157.29 47.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.47 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.729 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 94.2 m-85 -62.22 -28.54 69.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.474 -176.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.58 -45.21 94.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.632 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.419 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.5 m -65.94 -51.57 57.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.883 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.729 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.4 p-10 -65.35 -28.92 69.63 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.978 -177.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -60.79 -49.23 78.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 109.88 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -63.65 -34.85 78.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.992 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 17' ' ' ILE . 97.4 mt -68.17 -44.4 76.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.235 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.598 HG11 ' HG3' ' A' ' 47' ' ' ARG . 56.3 t -77.12 -43.75 31.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.504 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.53 -22.15 61.24 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 111.833 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.63 -39.88 91.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.673 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.511 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 81.8 m-85 -124.79 -52.14 1.69 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.6 t -49.47 110.95 0.43 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.229 0.538 . . . . 0.0 111.716 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 t . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 121.646 0.736 . . . . 0.0 110.029 179.073 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -129.23 3.45 5.19 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.233 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -71.69 -42.46 67.4 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.624 0.726 . . . . 0.0 109.169 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.598 ' HG3' HG11 ' A' ' 35' ' ' VAL . 18.9 ttt-85 -66.62 -36.98 83.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.86 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.62 -39.99 90.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.618 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -62.18 -47.24 85.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.966 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.474 ' O ' HG12 ' A' ' 54' ' ' ILE . 69.4 mt -61.64 -41.67 91.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.547 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.17 77.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.315 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.07 93.11 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.887 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -68.55 -30.31 69.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 17' ' ' ILE . 40.8 mm -60.29 -50.31 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.892 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -33.02 71.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.882 0.372 . . . . 0.0 110.914 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 -64.46 -48.68 74.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.376 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 54' ' ' ILE . 14.3 tt -69.02 -26.85 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 110.784 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 54' ' ' ILE . 78.8 mt -65.12 -47.75 86.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 174.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.2 p -66.35 -16.49 64.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.828 0.347 . . . . 0.0 111.112 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -76.02 -33.92 59.67 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.909 0.385 . . . . 0.0 110.249 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -76.33 -45.53 31.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.944 0.402 . . . . 0.0 110.4 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 tptm . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.505 -177.697 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.476 ' O ' HG13 ' A' ' 12' ' ' ILE . 64.4 m-85 -61.97 -58.25 8.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.71 -37.22 79.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.25 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -61.85 -42.61 99.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.64 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 8.1 tmm_? -68.39 -40.74 81.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.463 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 8' ' ' PHE . 86.0 mt -58.78 -45.59 91.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.016 0.436 . . . . 0.0 110.132 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.53 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -62.84 -43.63 98.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.42 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.97 -43.39 81.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.452 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 11' ' ' ARG . 49.0 mt-10 -61.33 -41.43 97.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.982 0.42 . . . . 0.0 110.706 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.529 ' SD ' ' HA ' ' A' ' 35' ' ' VAL . 31.8 ttp -70.26 -48.52 56.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.437 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 54' ' ' ILE . 74.6 mt -58.47 -44.82 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.126 0.489 . . . . 0.0 111.441 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.94 -4.18 6.54 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.154 -172.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -77.66 -20.77 53.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.044 0.449 . . . . 0.0 110.416 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.414 ' HB2' HD22 ' A' ' 34' ' ' LEU . 11.1 m-70 -140.44 84.83 13.81 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.487 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.462 -0.332 0 C-N-CA 122.483 2.122 . . . . 0.0 112.136 177.666 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 122.276 1.036 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -133.79 168.29 19.0 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.729 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -77.93 -18.6 55.9 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.905 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.89 -38.27 88.3 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 167.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.637 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 6.4 m -60.72 -62.06 2.13 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.814 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.703 ' O ' HG23 ' A' ' 35' ' ' VAL . 23.1 p30 -65.17 -49.25 70.55 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -173.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -55.5 -46.17 77.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 111.183 -176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -71.37 -27.84 63.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.016 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 30' ' ' THR . 64.5 mt -76.66 -32.57 58.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.979 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 31' ' ' ASN . 32.8 t -66.38 -34.12 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.261 0.553 . . . . 0.0 110.177 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.56 -12.24 61.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.386 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.99 -61.33 2.02 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.606 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.516 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 0.3 OUTLIER -97.92 -157.79 0.62 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.876 -171.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.2 t -90.47 126.1 35.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -168.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.812 169.399 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -115.81 -16.04 11.23 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.432 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.98 -23.66 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 166.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.537 ' HG2' HG11 ' A' ' 35' ' ' VAL . 6.2 ttt180 -50.84 -38.93 51.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.175 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.86 -39.0 93.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.763 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' HD1' ' A' ' 53' ' ' TYR . 58.5 mttp -67.18 -40.37 86.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.144 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.487 ' O ' HG13 ' A' ' 54' ' ' ILE . 65.7 mt -60.08 -40.89 84.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.371 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.05 -40.1 84.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.667 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.23 -46.68 93.81 Favored Glycine 0 C--O 1.239 0.458 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.952 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.445 ' HD1' ' O ' ' A' ' 49' ' ' LYS . 57.4 m-85 -55.54 -43.72 76.04 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 176.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.55 ' HA ' HD11 ' A' ' 17' ' ' ILE . 52.9 mt -53.61 -55.32 13.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 O-C-N 123.432 0.457 . . . . 0.0 111.758 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -48.34 57.34 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 111.55 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -67.68 -42.32 82.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.377 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 53' ' ' TYR . 84.1 mt -61.04 -43.46 96.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.745 0.307 . . . . 0.0 110.391 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.6 mt -62.7 -42.04 94.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.323 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.4 p -65.18 -24.68 67.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.019 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -85.83 -28.25 24.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.029 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -84.73 -35.46 22.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.517 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.672 -178.947 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.535 0.373 0 CA-C-O 121.431 0.634 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.498 ' O ' HG13 ' A' ' 12' ' ' ILE . 52.8 t80 -57.54 -43.45 84.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.849 176.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.38 -28.66 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 121.055 0.455 . . . . 0.0 110.518 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -70.12 -37.93 75.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.592 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -64.82 -43.71 92.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.166 174.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 8' ' ' PHE . 74.2 mt -54.93 -48.53 74.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.285 176.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.98 91.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.098 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -65.58 -49.79 67.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.75 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.04 -20.23 63.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.023 0.44 . . . . 0.0 110.838 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.421 ' SD ' HG22 ' A' ' 35' ' ' VAL . 51.2 ttm -70.58 -48.44 55.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.552 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.5 mt -75.08 -27.66 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 0.0 110.303 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 73.84 -59.39 0.56 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.959 0.904 . . . . 0.0 111.954 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 14.0 t -142.16 -170.04 3.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -175.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -89.53 108.53 25.59 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 19' ' ' THR . 92.3 Cg_endo . . . . . 0 N--CA 1.457 -0.634 0 C-N-CA 122.695 2.263 . . . . 0.0 112.615 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.466 0.346 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.429 ' OD1' ' HB3' ' A' ' 29' ' ' ASP . 12.4 t70 -75.66 136.35 40.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.46 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 70.4 m-85 -64.35 -21.76 66.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.429 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 2.1 t70 -64.29 -30.85 71.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.327 0.584 . . . . 0.0 110.368 175.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.3 m -65.14 -61.73 1.97 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.156 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.6 p-10 -64.23 -28.52 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 -178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.9 -42.79 98.71 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.61 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -73.18 -27.5 61.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.973 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 31' ' ' ASN . 97.8 mt -68.12 -47.19 68.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.371 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 31' ' ' ASN . 89.2 t -55.3 -57.56 7.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -64.99 -28.12 69.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.755 -173.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.46 -48.4 67.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.922 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -85.55 -73.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.107 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 t -140.19 108.7 5.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.252 -173.707 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.0 tptp . . . . . 0 N--CA 1.461 0.11 0 CA-C-O 120.729 0.299 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -154.86 21.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.77 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.3 tp -65.77 -29.48 69.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 47' ' ' ARG . 41.2 ttm180 -54.29 -34.11 60.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.072 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -66.4 -35.38 80.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.768 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -69.19 -41.3 77.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.182 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 54' ' ' ILE . 57.2 mt -63.41 -47.92 89.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.046 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.486 ' HB1' HD22 ' A' ' 31' ' ' ASN . . . -60.53 -44.41 96.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.174 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -63.01 -34.21 89.34 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.075 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.505 ' O ' HG13 ' A' ' 57' ' ' ILE . 34.9 t80 -67.04 -37.78 84.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 50' ' ' ILE . 75.0 mt -56.85 -50.03 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.489 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -53.12 -43.23 66.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.978 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.552 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 96.9 mtt180 -64.0 -41.71 97.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.395 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 53' ' ' TYR . 79.9 mt -59.17 -40.8 81.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.706 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 54' ' ' ILE . 76.2 mt -57.36 -43.13 81.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.072 0.463 . . . . 0.0 110.548 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.7 t -65.8 -29.47 69.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.974 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 72.5 mt-30 -82.18 -30.7 30.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.992 0.425 . . . . 0.0 110.556 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -64.77 -62.33 1.64 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.464 -171.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.238 -177.896 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.888 0.375 . . . . 0.0 111.403 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.465 ' O ' HG13 ' A' ' 12' ' ' ILE . 9.1 m-85 -64.24 -65.74 0.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.229 0.538 . . . . 0.0 110.736 -176.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.462 ' HA ' HD12 ' A' ' 12' ' ' ILE . 40.0 t -65.57 -32.25 57.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.586 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.58 -43.46 97.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.836 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -74.04 -26.39 60.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.663 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 8' ' ' PHE . 75.0 mt -60.44 -43.27 93.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.879 0.371 . . . . 0.0 110.211 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.44 84.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.373 176.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.487 ' HD3' ' C ' ' A' ' 14' ' ' LYS . 12.0 tmtt? -61.12 -41.95 97.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.349 176.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -70.35 -27.14 64.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.184 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.435 ' HE1' HG13 ' A' ' 35' ' ' VAL . 42.7 ttm -70.17 -52.23 25.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.105 0.479 . . . . 0.0 110.538 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 mt -77.38 -1.37 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.074 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.406 ' O ' ' HB ' ' A' ' 19' ' ' THR . 14.1 tp10 -58.8 126.46 27.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.861 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 18' ' ' GLU . 93.1 m 76.62 -54.5 0.58 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.525 173.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 82.6 t60 -138.73 103.02 7.66 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.191 -176.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 20' ' ' HIS . 45.9 Cg_endo . . . . . 0 N--CA 1.46 -0.484 0 C-N-CA 122.326 2.017 . . . . 0.0 110.77 170.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 122.062 0.934 . . . . 0.0 111.778 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.67 132.89 33.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.906 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.649 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 70.5 m-85 -61.5 -19.39 62.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -172.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.481 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 18.1 t0 -63.77 -45.45 89.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.084 0.469 . . . . 0.0 109.763 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.588 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 96.8 m -65.31 -56.25 13.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.844 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.761 HD22 ' HB1' ' A' ' 51' ' ' ALA . 2.9 p-10 -61.94 -41.93 98.53 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -70.52 -31.29 68.32 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.462 -179.219 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 33.5 ttmt -74.83 -28.19 60.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.612 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 30' ' ' THR . 84.2 mt -67.32 -49.54 63.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.119 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.524 ' HB ' ' HG3' ' A' ' 47' ' ' ARG . 14.9 t -63.07 -26.62 41.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.129 0.49 . . . . 0.0 110.447 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 36' ' ' GLU . 33.4 tt0 -64.11 -16.47 61.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.569 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -156.68 53.51 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.485 0.659 . . . . 0.0 111.11 -173.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.481 ' HE2' HD22 ' A' ' 34' ' ' LEU . 12.8 m-85 -148.55 -89.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.342 172.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.0 m -87.4 58.2 4.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 0.0 110.087 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.449 -0.514 0 CA-C-O 121.362 0.601 . . . . 0.0 110.922 -176.358 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.3 mttt . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.802 0.334 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -84.45 -13.87 50.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.027 0.442 . . . . 0.0 110.053 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -67.93 -27.48 66.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.824 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.524 ' HG3' ' HB ' ' A' ' 35' ' ' VAL . 42.1 ttp180 -56.62 -35.04 67.84 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.559 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -65.63 -45.62 82.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.257 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.34 -45.17 48.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.545 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 54' ' ' ILE . 76.1 mt -61.65 -41.25 89.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.799 0.333 . . . . 0.0 110.535 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.761 ' HB1' HD22 ' A' ' 31' ' ' ASN . . . -60.13 -41.5 92.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.239 176.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.49 -42.63 99.14 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.985 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.443 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.2 m-85 -58.32 -42.87 87.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.009 -0.096 . . . . 0.0 110.898 176.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 50' ' ' ILE . 62.5 mt -55.92 -53.53 37.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.112 0.257 . . . . 0.0 110.769 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -40.32 73.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.641 0.257 . . . . 0.0 111.531 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -65.91 -41.86 90.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.945 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 53' ' ' TYR . 76.1 mt -65.84 -45.54 91.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.727 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.534 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 86.5 mt -58.11 -49.89 80.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.569 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.9 t -65.19 -29.03 69.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.38 -29.32 65.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.048 0.451 . . . . 0.0 110.23 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.9 HE21 ' HA ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -83.95 -30.92 25.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.309 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 17.8 ptpt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.948 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 120.677 0.275 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -64.8 -38.6 91.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.141 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.74 -50.93 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.815 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -61.68 -42.29 98.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.095 0.474 . . . . 0.0 110.473 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -58.77 -55.12 39.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.493 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.08 -42.42 94.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.558 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -61.31 -42.52 98.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -59.14 -48.48 81.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.953 0.406 . . . . 0.0 110.701 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.69 -25.81 64.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.261 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.9 ttm -72.13 -40.42 68.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.798 0.332 . . . . 0.0 110.932 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 13' ' ' ALA . 50.5 mm -66.0 -46.99 86.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.09 161.92 20.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.953 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.5 m 72.53 -57.37 0.63 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.399 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -129.08 78.08 76.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.858 0.361 . . . . 0.0 110.929 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 N--CA 1.463 -0.315 0 C-N-CA 123.09 2.527 . . . . 0.0 112.887 -177.087 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 120.82 0.343 . . . . 0.0 111.776 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -71.43 127.9 34.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.865 0.364 . . . . 0.0 111.228 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -62.78 -41.34 99.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.408 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.18 -38.17 89.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.123 0.487 . . . . 0.0 110.317 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 54.5 m -62.4 -45.88 91.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.91 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.568 ' O ' HG23 ' A' ' 35' ' ' VAL . 77.0 m-20 -65.02 -37.28 87.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.506 176.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -60.12 -39.5 86.48 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.07 0.462 . . . . 0.0 110.478 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 30' ' ' THR . 6.8 tmtm? -56.07 -43.04 77.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.171 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.0 mp -73.61 -31.74 63.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.571 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 31' ' ' ASN . 59.4 t -66.99 -32.23 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 109.975 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.5 -45.87 92.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.061 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -70.36 -52.18 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.304 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -110.99 -141.94 0.38 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.563 -172.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t 71.4 174.02 0.3 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.308 0.643 . . . . 0.0 109.701 -172.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 m . . . . . 0 C--N 1.322 -0.623 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.024 -177.849 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.3 mttp . . . . . 0 CA--C 1.528 0.123 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -95.64 -21.99 17.86 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.721 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.9 tp -70.88 -27.57 63.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.86 0.362 . . . . 0.0 110.245 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 ttm-85 -55.14 -41.39 71.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.518 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.06 -40.0 95.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.666 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -64.55 -46.93 80.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.851 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.543 ' O ' HG13 ' A' ' 54' ' ' ILE . 64.4 mt -61.77 -43.07 96.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.438 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.28 94.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.764 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.49 -37.28 92.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.182 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.4 ' O ' HG13 ' A' ' 57' ' ' ILE . 78.4 t80 -60.05 -46.6 89.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.71 0.29 . . . . 0.0 110.515 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 50' ' ' ILE . 34.7 mt -60.89 -50.74 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.425 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 m -47.18 -44.13 21.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.561 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.595 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 13.1 ttm180 -61.08 -45.82 93.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.966 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 53' ' ' TYR . 69.2 mt -56.81 -41.02 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.433 . . . . 0.0 110.383 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.3 mt -59.58 -49.94 81.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.82 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.1 p -65.69 -16.63 63.94 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.82 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 84.3 mm-40 -85.11 -40.09 17.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.029 0.442 . . . . 0.0 110.522 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -81.75 -33.54 30.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.711 -176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.5 mptt . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.167 175.506 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.528 0.124 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -57.85 -39.99 79.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.082 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.06 -44.11 78.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.975 0.416 . . . . 0.0 110.662 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.14 -28.75 67.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.416 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 37.0 ttt180 -61.82 -52.87 62.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.523 175.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.05 -37.73 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 0.0 110.455 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.41 -46.75 88.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.256 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 15' ' ' GLU . 36.4 pttt -69.09 -33.87 74.21 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.72 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 35.1 mt-10 -70.25 -23.05 62.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.142 0.496 . . . . 0.0 110.476 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.962 ' HB3' ' HB3' ' A' ' 38' ' ' PHE . 67.5 mtt -70.78 -48.85 52.1 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 169.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 69.6 mt -65.47 -31.6 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.271 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 10.5 pt-20 -60.89 -15.71 33.79 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -175.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.4 p -74.33 -26.76 60.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.936 0.398 . . . . 0.0 111.053 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.624 ' HB3' ' HE1' ' A' ' 38' ' ' PHE . 17.7 t-160 -148.77 89.41 5.01 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.213 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 CA--C 1.53 0.287 0 C-N-CA 123.641 2.894 . . . . 0.0 112.39 -178.738 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 . . . . . 0 CA--C 1.531 0.232 0 CA-C-O 122.032 0.92 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.31 143.25 46.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.654 -173.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.682 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 73.4 m-85 -74.03 -33.7 63.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.76 -173.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.67 -36.23 83.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.422 0.629 . . . . 0.0 109.649 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.553 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 96.4 m -61.72 -58.98 5.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.269 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.682 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.5 p-10 -63.69 -28.68 70.07 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.753 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -56.68 -54.18 49.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.179 0.514 . . . . 0.0 110.142 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -70.66 -27.27 63.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.864 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 30' ' ' THR . 69.8 mt -64.97 -51.05 63.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.761 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 31' ' ' ASN . 66.6 t -60.54 -33.09 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 110.528 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -59.25 -37.95 78.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.418 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.29 -53.82 6.02 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.19 0.519 . . . . 0.0 110.793 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.962 ' HB3' ' HB3' ' A' ' 16' ' ' MET . 14.2 m-30 -67.13 106.0 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.118 -173.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 p -144.35 98.49 3.21 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.335 0.588 . . . . 0.0 111.571 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 51.9 m . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.403 173.003 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.2 tptt . . . . . 0 N--CA 1.454 -0.256 0 CA-C-O 120.926 0.393 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -101.55 -25.7 13.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.428 HD13 ' HB2' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -68.72 -14.58 63.11 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.356 177.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -59.21 -34.41 72.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.442 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -63.75 -43.87 95.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.411 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HB2' HD13 ' A' ' 46' ' ' LEU . 62.1 mttp -66.4 -43.74 85.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.549 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 54' ' ' ILE . 42.6 mm -57.46 -46.39 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.375 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.451 ' HB1' ' ND2' ' A' ' 31' ' ' ASN . . . -57.45 -47.5 81.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.866 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.46 -35.41 91.92 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.323 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 57' ' ' ILE . 7.8 m-85 -71.37 -33.16 69.29 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.743 -0.269 . . . . 0.0 111.384 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 50' ' ' ILE . 58.4 mt -60.21 -49.3 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.511 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.82 -32.07 70.31 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.558 0.218 . . . . 0.0 111.348 175.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -70.07 -39.56 75.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.615 0.245 . . . . 0.0 110.988 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 53' ' ' TYR . 82.3 mt -64.03 -45.46 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.17 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.05 -38.19 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.995 0.426 . . . . 0.0 110.149 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -65.33 -30.88 71.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.799 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -73.49 -34.35 65.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 110.173 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -81.22 -6.45 58.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.634 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.169 -176.423 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.452 -0.33 0 CA-C-O 121.917 0.865 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.516 ' HA ' ' HB3' ' A' ' 11' ' ' ARG . 80.3 m-85 -71.21 -11.78 61.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.314 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.931 HG13 HD13 ' A' ' 50' ' ' ILE . 93.4 t -69.05 -38.84 78.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 173.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -66.19 -39.06 89.42 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.516 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 17.5 tpt180 -56.19 -51.95 66.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.808 173.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 8' ' ' PHE . 45.5 mm -65.87 -44.66 92.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.268 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.35 98.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.739 0.305 . . . . 0.0 111.222 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -61.03 -51.08 70.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.06 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.17 -23.08 61.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.569 ' HG3' ' HB2' ' A' ' 38' ' ' PHE . 49.0 ttm -68.65 -52.44 31.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.317 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.466 HG12 HD23 ' A' ' 34' ' ' LEU . 57.2 mt -75.81 -25.2 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.864 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 61.94 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.256 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 m -153.04 11.96 0.48 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.341 0.591 . . . . 0.0 109.43 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -144.63 101.8 4.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.413 -172.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo . . . . . 0 N--CA 1.461 -0.432 0 C-N-CA 122.87 2.38 . . . . 0.0 112.487 -179.829 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.97 0.891 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.05 148.37 46.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.729 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -71.82 -28.95 63.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.78 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.2 -37.39 85.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.144 0.497 . . . . 0.0 109.779 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 85.6 m -59.1 -48.76 80.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.406 173.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.39 -53.68 50.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.278 174.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -49.86 -55.21 15.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.521 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 59.4 tttm -65.09 -39.58 93.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.329 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.466 HD23 HG12 ' A' ' 17' ' ' ILE . 9.2 mp -71.76 -44.64 63.72 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.273 -0.171 . . . . 0.0 111.395 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 39' ' ' SER . 84.6 t -60.94 -50.56 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.83 0.348 . . . . 0.0 110.475 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -73.97 -7.76 53.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.647 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 5.1 tp10 -80.53 -47.39 14.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.058 0.456 . . . . 0.0 110.059 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.569 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 83.0 m-85 -110.52 -90.22 0.48 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.676 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.61 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 21.4 t 57.16 -169.37 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.509 0.671 . . . . 0.0 112.012 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.247 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.4 mttt . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.74 0.305 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.494 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 16.0 t-160 -67.32 -25.92 66.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.814 -175.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 tt -77.25 -41.52 40.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -59.34 -39.46 83.25 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.459 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -58.09 -37.33 74.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.266 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 45' ' ' HIS . 28.1 mmmt -70.15 -49.69 48.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.931 HD13 HG13 ' A' ' 9' ' ' VAL . 41.9 mm -61.71 -53.49 47.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.174 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.43 77.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.178 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -59.14 -45.32 95.49 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.113 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.481 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.9 m-85 -71.68 -37.19 70.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 50' ' ' ILE . 64.3 mt -57.71 -55.9 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.316 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 m -50.67 -44.73 57.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.055 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 98.3 mtt180 -58.82 -51.69 68.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.02 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 53' ' ' TYR . 78.8 mt -57.05 -47.11 84.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.622 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.37 -34.32 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.993 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.0 m -64.59 -40.28 95.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.775 0.322 . . . . 0.0 110.754 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -77.45 -28.34 52.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.059 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -85.18 2.67 42.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 0.0 111.0 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' A' ' 62' ' ' LYS . 13.2 tppt? . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.859 -0.591 . . . . 0.0 109.426 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.235 0.317 0 CA-C-O 121.28 0.562 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.405 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.5 m-85 -57.97 -37.2 73.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.519 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.1 t -64.39 -37.94 81.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.567 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -60.03 -46.78 88.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.6 ttm-85 -64.64 -41.84 95.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.385 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 8' ' ' PHE . 77.3 mt -63.36 -44.13 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.87 -44.06 90.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.944 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -58.63 -49.86 75.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.255 0.55 . . . . 0.0 110.696 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.2 -26.77 65.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.702 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.509 ' O ' HG22 ' A' ' 19' ' ' THR . 37.2 tpp -70.36 -39.71 74.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.633 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.435 HG23 HD23 ' A' ' 34' ' ' LEU . 87.3 mt -74.88 -42.12 46.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.276 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.21 -10.08 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 16' ' ' MET . 15.0 t -80.14 -27.51 39.05 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.193 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -130.41 97.65 21.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 111.137 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 C-N-CA 123.262 2.641 . . . . 0.0 112.051 178.957 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.51 0.671 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -98.91 144.6 27.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.704 -176.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.509 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 81.4 m-85 -74.76 -24.86 58.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.126 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 25.5 t70 -66.0 -33.95 76.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 109.697 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.538 ' O ' HD13 ' A' ' 34' ' ' LEU . 99.6 m -54.59 -59.68 4.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.438 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.509 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 3.3 p-10 -65.13 -28.12 69.21 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.688 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.25 -43.05 96.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.856 0.36 . . . . 0.0 110.458 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 75.0 mmtt -65.25 -32.98 74.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.661 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 30' ' ' THR . 8.4 mp -72.02 -43.19 65.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.754 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.531 HG11 ' HD2' ' A' ' 47' ' ' ARG . 84.4 t -72.49 -18.86 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.289 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -55.09 -39.18 69.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.271 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -76.52 -34.81 58.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.411 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 54.5 p90 48.25 114.47 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.152 1.381 . . . . 0.0 113.71 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 t -71.35 -29.98 65.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.298 177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.3 t . . . . . 0 C--O 1.24 0.599 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.288 -178.093 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -120.77 16.61 11.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 0.0 111.74 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.438 ' O ' HG12 ' A' ' 50' ' ' ILE . 36.9 tp -90.88 -33.8 15.5 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.969 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.531 ' HD2' HG11 ' A' ' 35' ' ' VAL . 22.6 tpp180 -55.12 -46.89 75.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.472 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -69.44 -32.11 70.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 110.702 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.58 -44.65 70.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.431 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 54' ' ' ILE . 44.0 mm -60.22 -45.63 95.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.772 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' HB1' ' ND2' ' A' ' 31' ' ' ASN . . . -58.12 -45.91 86.5 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.477 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.672 ' O ' ' HG2' ' A' ' 56' ' ' ARG . . . -62.55 -42.73 99.67 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.054 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CE2' HD11 ' A' ' 57' ' ' ILE . 66.9 t80 -57.62 -40.31 78.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.14 0.176 . . . . 0.0 110.626 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 50' ' ' ILE . 78.7 mt -56.14 -54.3 29.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.672 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -61.89 -35.77 79.31 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 52.8 mmm-85 -62.52 -41.83 99.11 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.68 0.276 . . . . 0.0 110.416 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.534 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 78.0 mt -58.66 -46.05 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.411 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.7 mt -57.73 -49.13 81.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -65.79 -37.0 85.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.579 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -71.62 -25.47 62.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.395 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 49.4 mt-30 -72.33 -18.43 61.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.119 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 C--O 1.246 0.897 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.794 179.163 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.846 0.355 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.434 ' O ' HG13 ' A' ' 12' ' ' ILE . 94.5 t80 -59.69 -48.19 82.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.528 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.7 t -66.21 -40.59 87.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.168 0.509 . . . . 0.0 110.194 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -60.76 -32.59 71.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.72 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -69.63 -35.86 75.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.682 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 16' ' ' MET . 29.4 mt -61.63 -40.38 86.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.99 0.424 . . . . 0.0 109.931 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.37 -35.02 79.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.962 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -64.68 -56.49 13.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.73 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.55 ' HA ' ' HB3' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -68.48 -15.26 63.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.171 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.482 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 6.8 tpt -64.98 -53.67 42.54 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.13 -28.87 21.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.688 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 15' ' ' GLU . 11.4 tp10 -60.15 153.85 20.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.423 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 18' ' ' GLU . 52.2 m 82.08 -47.72 0.2 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.517 0.727 . . . . 0.0 111.18 -176.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -147.64 96.17 4.16 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.597 0.237 . . . . 0.0 110.89 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo . . . . . 0 N--CA 1.463 -0.308 0 C-N-CA 122.778 2.319 . . . . 0.0 111.315 176.643 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.562 ' HA ' HG22 ' A' ' 55' ' ' THR . 8.0 p-10 . . . . . 0 N--CA 1.464 0.271 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -94.96 145.43 24.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -66.82 -27.47 67.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.73 0.3 . . . . 0.0 110.953 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.5 -37.95 88.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.521 0.677 . . . . 0.0 109.27 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.594 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 22.2 m -65.81 -56.27 12.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.202 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.9 p30 -61.54 -27.83 68.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 111.247 -175.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.73 -49.22 69.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.24 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -77.29 -21.02 54.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.877 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 30' ' ' THR . 41.7 mt -66.3 -50.11 64.75 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.18 174.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 31' ' ' ASN . 68.8 t -56.14 -43.43 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.039 0.447 . . . . 0.0 110.025 176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -58.24 -42.21 85.84 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.297 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.01 -48.86 11.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE2' ' HB3' ' A' ' 34' ' ' LEU . 17.1 m-30 -56.88 -76.24 0.04 OUTLIER 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -131.77 133.54 44.86 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 t . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.729 -175.048 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt . . . . . 0 N--CA 1.473 0.709 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -133.63 13.25 4.08 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.415 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 50' ' ' ILE . 58.6 tp -88.62 -28.37 20.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.361 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -66.67 -34.81 78.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.431 -177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.72 -39.69 85.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.755 175.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 33.0 mmtp -73.66 -31.91 63.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.551 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 54' ' ' ILE . 80.4 mt -62.74 -40.17 87.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.195 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.43 96.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.042 0.449 . . . . 0.0 110.558 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.92 -32.23 83.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.734 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.494 ' O ' HG13 ' A' ' 57' ' ' ILE . 23.5 t80 -71.4 -30.82 66.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 50' ' ' ILE . 79.3 mt -59.4 -49.54 83.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.894 0.378 . . . . 0.0 110.193 175.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.562 HG22 ' HA ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -62.35 -29.23 70.31 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.559 176.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.3 ttt85 -68.69 -41.59 78.95 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 110.687 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 53' ' ' TYR . 77.6 mt -59.99 -45.9 94.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.378 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.8 -50.7 79.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.247 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.0 p -66.4 -35.3 79.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.725 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -73.73 -35.99 65.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -72.81 -52.32 15.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.145 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.53 ' NZ ' ' HB3' ' A' ' 62' ' ' LYS . 1.3 ttpm? . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.4 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.569 ' O ' ' HG2' ' A' ' 11' ' ' ARG . 1.5 p . . . . . 0 N--CA 1.45 -0.453 0 CA-C-O 120.45 0.167 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.516 ' O ' HG13 ' A' ' 12' ' ' ILE . 79.3 t80 -56.27 -40.61 74.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.031 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.87 -34.6 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.254 0.55 . . . . 0.0 110.192 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -68.04 -31.45 71.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.335 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 7' ' ' SER . 22.5 mmt180 -75.34 -31.77 60.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.075 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 8' ' ' PHE . 82.1 mt -61.75 -55.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.01 -39.13 77.53 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.452 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 38.7 tptt -52.78 -56.21 17.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.066 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.92 -28.29 64.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.588 -176.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 39' ' ' SER . 87.1 mtp -66.65 -43.42 84.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.599 0.238 . . . . 0.0 110.979 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.3 mt -77.59 -31.68 17.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.108 0.48 . . . . 0.0 110.995 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -62.15 113.73 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.966 -175.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.6 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 93.1 m 76.31 -39.49 0.36 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.802 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -91.11 98.3 1.62 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.394 . . . . 0.0 110.149 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 19' ' ' THR . 27.5 Cg_endo . . . . . 0 N--CA 1.446 -1.272 0 C-N-CA 123.269 2.646 . . . . 0.0 112.69 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 121.149 0.5 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.37 162.12 14.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.716 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.3 -30.44 68.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.687 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.99 -30.63 71.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.211 0.529 . . . . 0.0 110.316 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.403 ' O ' HD13 ' A' ' 34' ' ' LEU . 97.5 m -64.94 -52.86 54.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.393 176.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.749 ' OD1' ' HB ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -61.34 -37.98 85.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.074 178.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -50.1 -49.27 52.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.573 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.68 -39.16 73.69 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.997 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 30' ' ' THR . 8.5 mp -58.77 -39.24 80.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.471 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.528 HG11 ' HG3' ' A' ' 47' ' ' ARG . 57.0 t -75.49 -37.11 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.267 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.14 -49.21 76.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.877 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -63.54 -65.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.067 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -101.6 -84.46 0.44 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.637 -168.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.482 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 90.3 p 51.33 -172.65 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.915 0.886 . . . . 0.0 112.308 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.9 m . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 173.989 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.6 tttt . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.648 0.261 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -31.23 50.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 110.501 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 7.2 mp -73.18 -18.7 61.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.49 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.528 ' HG3' HG11 ' A' ' 35' ' ' VAL . 41.5 ttp180 -57.43 -43.66 84.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.4 0.619 . . . . 0.0 110.205 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -72.71 -23.17 60.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.574 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -71.23 -46.44 61.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.969 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.0 mt -63.24 -33.15 59.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.928 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.58 84.3 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.915 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.85 -41.22 88.84 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.76 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.442 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.0 m-85 -62.03 -61.45 2.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.496 0.189 . . . . 0.0 111.483 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.749 ' HB ' ' OD1' ' A' ' 31' ' ' ASN . 62.8 mt -60.84 -44.82 98.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -172.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 p -54.26 -45.76 72.5 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.243 0.474 . . . . 0.0 111.473 176.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -60.0 -43.83 94.93 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.418 176.095 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 53' ' ' TYR . 78.1 mt -62.76 -38.63 82.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.081 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 54' ' ' ILE . 75.7 mt -59.7 -51.36 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.865 0.364 . . . . 0.0 110.855 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.2 p -65.24 -22.3 66.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.573 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -84.99 -52.09 6.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.726 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -71.54 -36.31 70.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.085 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm . . . . . 0 C--O 1.25 1.097 0 O-C-N 123.838 0.711 . . . . 0.0 109.688 -172.539 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.464 ' O ' HG13 ' A' ' 12' ' ' ILE . 25.3 m-85 -65.58 -60.55 2.81 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.834 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.87 -34.64 71.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.214 0.531 . . . . 0.0 110.479 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -66.29 -33.66 76.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.545 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -72.86 -35.76 67.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.687 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 8' ' ' PHE . 72.4 mt -57.14 -49.95 78.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.208 177.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.3 -39.58 94.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -64.84 -34.51 78.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.77 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -69.86 -35.51 74.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.665 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.567 ' HA ' ' HD2' ' A' ' 38' ' ' PHE . 48.8 ttm -70.4 -42.63 71.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.684 177.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.569 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 53.5 mt -75.55 -5.84 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.385 0.612 . . . . 0.0 110.982 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.38 134.65 53.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.53 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m 76.19 -66.74 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.598 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . 1.2 t-160 -89.64 -57.01 0.27 Allowed Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 120.483 -0.487 . . . . 0.0 112.219 -168.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.951 ' HB3' HD22 ' A' ' 34' ' ' LEU . 43.1 Cg_exo . . . . . 0 C--N 1.352 0.739 0 C-N-CA 122.151 1.901 . . . . 0.0 112.631 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 C--O 1.234 0.247 0 CA-C-O 120.7 0.286 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -100.05 160.34 14.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -71.96 -24.21 61.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.681 0.277 . . . . 0.0 111.618 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.43 -29.17 69.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.338 0.59 . . . . 0.0 109.462 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.617 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 14.3 m -65.59 -52.18 54.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.424 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.452 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.2 p30 -65.87 -28.34 68.89 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.755 -177.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -64.19 -44.02 93.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.949 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -65.2 -34.39 78.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.812 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.951 HD22 ' HB3' ' A' ' 21' ' ' PRO . 59.8 mt -70.6 -43.8 68.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.291 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.541 HG11 ' HG3' ' A' ' 47' ' ' ARG . 56.4 t -69.74 -30.81 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.378 0.609 . . . . 0.0 110.301 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.83 -23.29 60.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.327 0.584 . . . . 0.0 109.928 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -80.01 -55.66 4.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.164 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.567 ' HD2' ' HA ' ' A' ' 16' ' ' MET . 34.2 t80 -132.57 148.19 52.37 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.1 p -162.55 153.74 17.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.773 0.32 . . . . 0.0 110.848 -173.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.5 m . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.581 177.66 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.2 tptm . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -101.59 13.65 34.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.398 0.618 . . . . 0.0 109.953 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 59.8 tp -95.15 -27.78 15.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.762 173.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.541 ' HG3' HG11 ' A' ' 35' ' ' VAL . 51.2 ttp180 -67.09 -47.64 70.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.586 -174.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -61.64 -34.98 76.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.996 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 72.2 mmtt -65.57 -51.16 61.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.532 ' O ' HG13 ' A' ' 54' ' ' ILE . 66.3 mt -65.28 -51.34 66.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.8 -48.83 77.05 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.926 0.394 . . . . 0.0 111.144 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.92 -37.94 95.75 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.96 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.448 ' O ' HG13 ' A' ' 57' ' ' ILE . 2.0 t80 -69.95 -33.13 71.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 50' ' ' ILE . 80.9 mt -56.84 -55.58 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.863 0.363 . . . . 0.0 110.265 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.17 -32.31 73.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -62.05 -46.64 88.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.958 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 53' ' ' TYR . 84.1 mt -62.57 -39.01 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.671 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 54' ' ' ILE . 71.8 mt -58.25 -51.87 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.526 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.9 p -65.86 -18.9 65.66 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.785 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -84.89 -38.96 18.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 0.0 110.372 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -73.84 -38.37 64.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.32 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.471 -179.395 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.667 0.27 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.439 ' O ' HG13 ' A' ' 12' ' ' ILE . 75.6 t80 -65.62 -37.19 85.88 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.7 t -66.12 -37.29 79.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.672 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -64.93 -33.33 75.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.448 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -28.24 62.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 8' ' ' PHE . 72.9 mt -70.71 -39.23 75.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.265 0.555 . . . . 0.0 109.547 173.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.31 90.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.484 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -63.03 -42.92 99.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.071 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -55.55 -45.73 77.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.516 ' SD ' ' HB3' ' A' ' 34' ' ' LEU . 46.3 tpp -55.77 -52.44 63.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.222 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.32 -49.73 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.236 -173.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -66.09 -33.08 74.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.728 0.299 . . . . 0.0 111.792 -173.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 m -84.11 -16.87 42.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.246 0.546 . . . . 0.0 110.579 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . 47.2 t-80 -132.55 69.39 79.75 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.064 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 C--N 1.344 0.321 0 C-N-CA 123.12 2.547 . . . . 0.0 112.716 -174.904 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 121.616 0.722 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -103.9 139.93 38.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.712 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.654 ' HA ' ' ND2' ' A' ' 31' ' ' ASN . 99.5 m-85 -72.14 -40.27 68.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.777 -174.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.56 -38.35 90.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.245 0.545 . . . . 0.0 110.358 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.443 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 67.3 m -62.71 -55.03 30.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.564 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.654 ' ND2' ' HA ' ' A' ' 28' ' ' PHE . 20.9 p30 -60.87 -30.05 69.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.702 0.287 . . . . 0.0 110.997 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.586 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 14.3 tmtt? -66.93 -52.13 46.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.082 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 52.3 mtmt -67.4 -26.8 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.727 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.516 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 95.2 mt -69.33 -48.17 62.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.65 0.262 . . . . 0.0 110.713 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.572 HG11 ' HA ' ' A' ' 47' ' ' ARG . 17.8 t -68.15 -24.58 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.429 . . . . 0.0 110.11 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 7.3 mm-40 -57.42 -38.51 74.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.245 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -159.09 89.76 0.94 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 -174.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 20' ' ' HIS . 51.3 t80 -175.65 -78.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.266 171.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.424 ' HB2' ' HE2' ' A' ' 16' ' ' MET . 66.6 m -104.07 51.04 0.78 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.454 0.645 . . . . 0.0 109.347 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.8 m . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.585 -176.247 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.4 tttt . . . . . 0 N--CA 1.447 -0.581 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -98.18 -19.62 17.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.14 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.6 tp -64.87 -14.19 58.75 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.13 0.491 . . . . 0.0 110.589 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.572 ' HA ' HG11 ' A' ' 35' ' ' VAL . 38.1 ttm180 -49.49 -57.73 6.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.801 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -69.6 -18.33 63.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.538 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -75.32 -54.04 7.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.034 0.445 . . . . 0.0 110.109 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 54' ' ' ILE . 62.2 mt -64.69 -41.76 93.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.048 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.478 ' HB1' ' OD1' ' A' ' 31' ' ' ASN . . . -59.31 -38.64 80.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.172 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.86 -44.24 97.27 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.718 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -60.88 -49.83 75.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.952 -0.124 . . . . 0.0 111.08 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 50' ' ' ILE . 78.0 mt -49.05 -57.81 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 O-C-N 123.527 0.517 . . . . 0.0 111.111 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -47.32 -58.27 4.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.222 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 75.2 mtt-85 -70.8 -33.06 70.33 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -172.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.0 mt -65.26 -40.37 88.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.974 0.416 . . . . 0.0 110.118 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.35 -32.29 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.229 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.1 m -65.52 -24.62 67.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 176.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 83.4 mm-40 -75.38 -54.01 7.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.308 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.49 -51.38 8.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.637 0.256 . . . . 0.0 111.663 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.3 tttt . . . . . 0 C--O 1.249 1.071 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.329 -174.211 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.411 ' O ' HG12 ' A' ' 12' ' ' ILE . 74.9 t80 -61.65 -48.57 80.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.5 t -63.59 -44.8 98.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.772 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.15 -29.7 67.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.817 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.521 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 8.6 tpt180 -64.49 -42.32 95.92 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 176.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 8' ' ' PHE . 49.5 mm -59.24 -43.1 89.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.254 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.33 97.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.284 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -58.49 -41.66 85.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.779 178.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 11' ' ' ARG . 76.2 mm-40 -56.67 -47.08 80.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.829 0.347 . . . . 0.0 110.493 178.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.481 ' HE2' ' HB3' ' A' ' 39' ' ' SER . 42.0 ttm -65.83 -50.29 65.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.739 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.0 mt -57.72 -46.29 86.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.602 -177.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.472 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 5.2 tp10 -66.22 -46.48 77.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 m -69.19 -41.62 76.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.236 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -121.44 92.91 48.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 110.952 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo . . . . . 0 N--CA 1.46 -0.475 0 C-N-CA 123.589 2.86 . . . . 0.0 112.334 -179.643 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.97 0.414 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -89.45 159.3 17.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 176.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.68 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 62.2 m-85 -71.36 -28.24 63.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.118 -176.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.97 -36.76 85.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.121 0.486 . . . . 0.0 110.305 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 53.1 m -61.1 -56.81 16.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.661 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.68 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.7 p-10 -65.65 -23.97 66.92 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.395 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.617 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 20.6 ttpp -62.12 -52.06 65.36 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -56.58 -38.59 72.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.274 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.482 ' HA ' ' HD2' ' A' ' 38' ' ' PHE . 7.7 mp -60.15 -51.53 69.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.4 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 51' ' ' ALA . 35.7 m -82.46 -9.2 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 122.047 -0.408 . . . . 0.0 111.011 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 2.8 tp10 -76.08 -2.61 31.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -158.5 -48.14 0.06 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.854 0.359 . . . . 0.0 111.374 -171.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.482 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 36.9 m-85 -84.66 -165.98 1.34 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.809 -174.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.481 ' HB3' ' HE2' ' A' ' 16' ' ' MET . 93.3 p 62.23 174.42 0.13 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.397 1.079 . . . . 0.0 112.29 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -178.517 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.4 pttm . . . . . 0 CA--C 1.529 0.139 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -78.71 -13.18 59.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.955 0.407 . . . . 0.0 110.64 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -77.04 -39.6 49.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.044 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -69.78 -10.16 57.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.854 0.359 . . . . 0.0 111.682 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -69.59 -41.96 75.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.402 0.62 . . . . 0.0 109.635 172.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -73.24 -38.89 65.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.69 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.558 ' O ' HG13 ' A' ' 54' ' ' ILE . 50.4 mm -57.16 -49.18 80.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.487 177.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.591 ' HB1' HD22 ' A' ' 31' ' ' ASN . . . -57.85 -50.94 71.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.414 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.62 -28.48 73.65 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.767 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.501 ' O ' HG13 ' A' ' 57' ' ' ILE . 22.7 t80 -73.93 -37.27 64.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 50' ' ' ILE . 84.6 mt -58.63 -47.64 88.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 110.124 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.76 -42.23 75.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.414 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -66.22 -44.47 83.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.032 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 53' ' ' TYR . 80.9 mt -57.53 -49.36 80.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.68 -49.95 81.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.095 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 p -65.82 -25.39 67.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.709 0.29 . . . . 0.0 111.535 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -70.27 -34.19 72.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.044 0.449 . . . . 0.0 110.327 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.759 HE21 ' HA ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -86.39 -33.02 20.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.754 177.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.5 tttm . . . . . 0 C--O 1.253 1.275 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.811 -176.036 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.53 ' O ' HG13 ' A' ' 12' ' ' ILE . 55.0 t80 -64.16 -35.84 82.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.4 -48.78 85.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.095 0.474 . . . . 0.0 110.7 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 53' ' ' TYR . 87.8 tttt -58.78 -40.2 83.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.544 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -59.44 -46.31 89.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.439 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 8' ' ' PHE . 73.3 mt -57.17 -53.5 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.745 0.307 . . . . 0.0 111.094 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.503 ' HB1' HG12 ' A' ' 54' ' ' ILE . . . -63.82 -45.78 88.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.432 -177.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.2 -39.51 94.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.42 -176.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.886 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 31.0 mt-10 -71.06 -30.62 66.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.748 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.453 ' HG3' ' O ' ' A' ' 12' ' ' ILE . 59.9 mtt -55.34 -42.45 73.84 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.535 HD11 HG23 ' A' ' 54' ' ' ILE . 57.8 mt -65.23 -54.18 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.25 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.886 ' HG2' ' HA ' ' A' ' 15' ' ' GLU . 8.8 pt-20 -67.0 -6.01 15.19 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.5 m -57.59 -43.08 84.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.147 0.498 . . . . 0.0 110.662 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -150.44 120.09 3.73 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.959 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 CA--C 1.515 -0.429 0 C-N-CA 122.648 2.232 . . . . 0.0 111.914 177.364 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 121.694 0.759 . . . . 0.0 112.786 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.556 ' O ' ' HB ' ' A' ' 30' ' ' THR . 7.9 t70 -139.79 147.91 41.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.222 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -77.9 -35.25 50.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 110.633 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.433 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 36.2 t70 -65.63 -29.7 70.31 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 27' ' ' ASP . 2.5 m -61.06 -50.54 72.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.679 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.409 ' HB2' ' HB1' ' A' ' 51' ' ' ALA . 18.5 p30 -64.46 -34.77 78.97 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 110.507 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 19.6 ttpt -63.41 -48.89 75.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.517 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 33' ' ' LYS . 25.9 ttmt -69.67 -13.3 62.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.566 -173.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 30' ' ' THR . 96.7 mt -81.92 -49.9 9.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.941 0.4 . . . . 0.0 110.425 173.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.526 HG11 ' HA ' ' A' ' 47' ' ' ARG . 43.4 t -74.98 -28.39 21.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.212 -176.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 4.4 tp10 -76.08 7.03 4.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 33' ' ' LYS . 12.4 pt-20 -155.98 -43.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.646 -0.421 . . . . 0.0 112.105 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -84.68 -85.45 0.14 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 11.9 t 54.65 -159.36 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.752 0.787 . . . . 0.0 112.094 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.2 m . . . . . 0 C--N 1.319 -0.752 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.703 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.892 0.377 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -107.35 -9.06 16.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -173.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.7 tp -64.09 -34.85 78.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HA ' HG11 ' A' ' 35' ' ' VAL . 14.6 ttm105 -47.17 -52.45 15.61 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.808 0.693 . . . . 0.0 110.992 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -78.36 -30.38 47.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.664 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -74.1 -51.1 16.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.854 0.359 . . . . 0.0 110.209 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.566 ' O ' HG13 ' A' ' 54' ' ' ILE . 10.6 tt -66.37 -34.05 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.447 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 31' ' ' ASN . . . -65.26 -40.32 93.8 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.039 0.447 . . . . 0.0 110.641 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.39 -41.18 99.47 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.419 ' CE2' HD11 ' A' ' 57' ' ' ILE . 61.4 t80 -63.38 -44.28 95.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.607 -0.297 . . . . 0.0 110.631 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 50' ' ' ILE . 91.4 mt -54.62 -57.84 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.753 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -56.24 -40.7 74.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.132 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -59.1 -39.54 82.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.058 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.419 HD11 ' CE2' ' A' ' 53' ' ' TYR . 70.7 mt -68.11 -42.33 84.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 110.436 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -65.09 -45.74 93.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.868 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -58.72 -37.41 76.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.754 0.311 . . . . 0.0 110.688 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.99 -36.0 81.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.079 0.466 . . . . 0.0 110.777 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.471 HE21 ' HB3' ' A' ' 61' ' ' GLN . 0.8 OUTLIER -75.41 -24.79 57.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.527 179.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.929 -176.044 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptp . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 120.929 0.395 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -128.6 -150.78 7.3 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -85.73 151.28 23.97 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 58.6 mt -72.47 -66.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.171 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 58.43 88.61 0.06 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.477 0.656 . . . . 0.0 112.317 174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.1 t -164.73 -26.09 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.645 175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 42.6 t -60.87 -30.48 70.16 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.658 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -64.37 -36.12 83.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.064 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.8 t -66.3 -36.59 77.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.435 0.636 . . . . 0.0 109.721 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -66.39 -33.94 76.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.529 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -66.75 -41.61 87.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.412 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.62 -40.26 87.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.345 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.431 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -60.54 -47.03 87.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.391 176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 27.0 mmmt -56.63 -50.01 73.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.157 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -58.31 -39.01 78.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.808 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.579 ' SD ' HG13 ' A' ' 35' ' ' VAL . 37.6 ttm -69.82 -45.64 67.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.442 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.625 HG23 HD21 ' A' ' 34' ' ' LEU . 63.8 mt -75.38 -49.75 26.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.908 0.385 . . . . 0.0 111.481 -177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 1.7 tp10 -65.61 -8.89 22.58 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -169.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.489 HG21 ' CD1' ' A' ' 38' ' ' PHE . 5.9 t -76.69 -17.32 59.19 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.273 0.559 . . . . 0.0 109.808 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 18.1 t-160 -142.51 109.08 5.67 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 20' ' ' HIS . 20.7 Cg_exo -67.7 25.83 0.12 Allowed 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.704 2.936 . . . . 0.0 114.161 -176.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.19 60.06 4.88 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 174.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -107.88 158.43 17.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.707 -169.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.5 ' CD1' HG23 ' A' ' 58' ' ' ILE . 54.9 t80 65.07 54.91 1.18 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.562 0.696 . . . . 0.0 111.455 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.48 ' CB ' HG21 ' A' ' 30' ' ' THR . 6.1 m -105.75 0.43 26.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.502 0.668 . . . . 0.0 109.27 172.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 43.94 35.59 1.17 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.211 -1.359 . . . . 0.0 113.709 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -131.62 144.34 50.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 176.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -67.42 -36.18 80.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.389 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.523 ' O ' ' HD3' ' A' ' 33' ' ' LYS . 17.0 t70 -65.69 -39.56 91.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.104 0.478 . . . . 0.0 110.173 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.48 HG21 ' CB ' ' A' ' 25' ' ' THR . 8.7 m -61.22 -52.07 66.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.853 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.451 ' O ' HG23 ' A' ' 35' ' ' VAL . 78.3 m-20 -65.06 -32.39 74.09 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.734 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 64.0 tttm -58.93 -53.83 53.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.353 176.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.523 ' HD3' ' O ' ' A' ' 29' ' ' ASP . 1.2 mptm? -66.48 -36.27 82.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.919 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.625 HD21 HG23 ' A' ' 17' ' ' ILE . 43.4 tp -57.82 -40.63 80.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.609 178.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.579 HG13 ' SD ' ' A' ' 16' ' ' MET . 76.9 t -69.75 -46.31 74.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.907 177.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 32' ' ' LYS . 43.4 mt-10 -70.99 -25.3 62.64 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -171.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.52 -15.42 58.62 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.117 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.522 ' HD2' ' HG3' ' A' ' 16' ' ' MET . 65.5 t80 -113.83 -80.47 0.59 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 68.5 m 63.84 103.49 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.7 0.625 . . . . 0.0 112.143 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 13.9 t -132.16 17.16 4.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.951 0.882 . . . . 0.0 109.589 176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.0 p -107.75 138.61 33.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.83 -175.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.6 m -87.8 164.93 15.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.898 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.3 m 72.38 107.53 0.07 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.462 0.648 . . . . 0.0 110.054 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -66.09 -35.25 80.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.67 -0.696 . . . . 0.0 112.595 -169.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -78.78 -12.34 60.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.96 0.41 . . . . 0.0 110.841 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 49' ' ' LYS . 38.7 tp -74.31 -21.75 59.58 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.478 ' HG3' HG11 ' A' ' 35' ' ' VAL . 73.7 ttp85 -59.92 -30.25 68.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.586 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -61.69 -44.23 97.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.369 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.528 ' HD2' HD12 ' A' ' 46' ' ' LEU . 68.1 mttm -67.62 -34.26 76.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.331 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.532 ' O ' HG13 ' A' ' 54' ' ' ILE . 50.5 mm -65.35 -49.48 78.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.524 177.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.91 -42.05 97.3 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.89 -33.97 81.12 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.771 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 11.5 t80 -63.23 -45.94 89.29 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 122.502 0.321 . . . . 0.0 110.54 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.569 HG12 HD11 ' A' ' 17' ' ' ILE . 36.2 mt -58.9 -56.64 15.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.169 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.3 m -49.69 -40.24 39.42 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.677 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.09 -48.05 75.08 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.993 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 75.2 mt -59.21 -43.4 89.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 110.623 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.5 HG23 ' CD1' ' A' ' 24' ' ' PHE . 68.2 mt -62.59 -48.99 85.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.73 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 p -65.31 -31.22 72.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -84.95 -18.53 34.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.875 0.369 . . . . 0.0 111.408 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.37 -37.76 65.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.242 -177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 65.0 tttp . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.508 -0.758 . . . . 0.0 110.764 -177.716 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.984 0.421 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.15 31.75 2.5 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.747 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -62.2 -27.76 69.2 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 122.476 0.31 . . . . 0.0 111.792 -176.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.8 tp -85.13 -21.64 7.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.294 0.569 . . . . 0.0 110.477 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.8 mtm-85 -93.77 96.05 9.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.405 0.621 . . . . 0.0 110.336 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.9 t -164.48 -19.3 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.135 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 m -76.16 6.09 5.89 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.415 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -63.68 -43.53 96.42 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 122.298 -0.251 . . . . 0.0 111.307 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.52 -48.49 87.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.261 0.553 . . . . 0.0 110.628 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -64.12 -30.78 71.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.633 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.744 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -63.2 -52.98 60.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.51 177.087 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 74.5 mt -57.59 -44.41 85.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.809 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.71 -49.16 71.95 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.169 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -65.2 -44.24 89.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.983 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -62.36 -39.03 91.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.906 0.384 . . . . 0.0 110.53 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.511 ' SD ' ' HB2' ' A' ' 38' ' ' PHE . 27.2 tpp -55.97 -47.81 76.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.438 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.637 HG21 ' HE3' ' A' ' 23' ' ' LYS . 56.1 mt -76.86 -51.92 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.706 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -61.86 -25.92 67.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -168.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 p -61.29 -22.94 65.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 0.0 111.109 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -143.67 90.14 7.16 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.57 0.7 . . . . 0.0 109.324 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -67.4 163.4 34.77 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.975 2.45 . . . . 0.0 113.223 -172.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.69 -61.29 0.66 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.485 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.637 ' HE3' HG21 ' A' ' 17' ' ' ILE . 54.1 mttp 62.32 -158.39 0.33 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -174.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -158.76 -72.7 0.08 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.907 0.384 . . . . 0.0 110.386 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.6 m -154.02 160.77 42.16 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -77.92 71.57 4.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.83 0.824 . . . . 0.0 110.722 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -137.12 157.29 47.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.47 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.729 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 94.2 m-85 -62.22 -28.54 69.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.474 -176.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.58 -45.21 94.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.632 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.419 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 90.5 m -65.94 -51.57 57.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.883 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.729 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.4 p-10 -65.35 -28.92 69.63 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.978 -177.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -60.79 -49.23 78.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 109.88 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -63.65 -34.85 78.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.992 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 17' ' ' ILE . 97.4 mt -68.17 -44.4 76.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.235 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.598 HG11 ' HG3' ' A' ' 47' ' ' ARG . 56.3 t -77.12 -43.75 31.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.504 -175.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.53 -22.15 61.24 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.797 0.332 . . . . 0.0 111.833 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -65.63 -39.88 91.96 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.673 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.511 ' HB2' ' SD ' ' A' ' 16' ' ' MET . 81.8 m-85 -124.79 -52.14 1.69 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.6 t -49.47 110.95 0.43 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.229 0.538 . . . . 0.0 111.716 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.2 t -124.33 11.74 8.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.646 0.736 . . . . 0.0 110.029 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.875 HG22 ' H ' ' A' ' 42' ' ' SER . 8.9 p -83.95 -163.22 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.596 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.875 ' H ' HG22 ' A' ' 41' ' ' VAL . 14.0 m -47.65 108.25 0.15 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.407 0.622 . . . . 0.0 110.921 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.784 HG23 ' HD3' ' A' ' 47' ' ' ARG . 18.9 m -88.0 -40.42 13.88 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.084 -170.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -24.19 -83.14 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.616 1.198 . . . . 0.0 113.667 -167.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -129.23 3.45 5.19 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.233 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 51.3 tp -71.69 -42.46 67.4 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.624 0.726 . . . . 0.0 109.169 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.784 ' HD3' HG23 ' A' ' 43' ' ' THR . 18.9 ttt-85 -66.62 -36.98 83.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.86 176.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.62 -39.99 90.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.618 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -62.18 -47.24 85.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.966 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.474 ' O ' HG12 ' A' ' 54' ' ' ILE . 69.4 mt -61.64 -41.67 91.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.547 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.17 77.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.315 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.72 -37.07 93.11 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.887 177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -68.55 -30.31 69.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 17' ' ' ILE . 40.8 mm -60.29 -50.31 80.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.892 176.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -33.02 71.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.882 0.372 . . . . 0.0 110.914 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 -64.46 -48.68 74.34 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.376 175.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 54' ' ' ILE . 14.3 tt -69.02 -26.85 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 120.887 0.375 . . . . 0.0 110.784 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 54' ' ' ILE . 78.8 mt -65.12 -47.75 86.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 174.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.2 p -66.35 -16.49 64.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.828 0.347 . . . . 0.0 111.112 177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -76.02 -33.92 59.67 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.909 0.385 . . . . 0.0 110.249 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -76.33 -45.53 31.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.944 0.402 . . . . 0.0 110.4 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 tptm . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.505 -177.697 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtm . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 120.651 0.263 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.49 82.11 0.16 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.98 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -69.22 100.18 1.26 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.394 0.616 . . . . 0.0 110.7 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.444 HG23 ' H ' ' A' ' 5' ' ' ARG . 6.9 tt -98.12 -62.06 2.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.509 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.444 ' H ' HG23 ' A' ' 4' ' ' ILE . 42.2 ttp180 -87.41 65.15 8.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.322 0.582 . . . . 0.0 111.331 -171.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.9 t -170.18 -39.3 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.325 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.9 m -73.56 -4.62 35.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.978 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.476 ' O ' HG13 ' A' ' 12' ' ' ILE . 64.4 m-85 -61.97 -58.25 8.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.71 -37.22 79.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.25 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -61.85 -42.61 99.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.64 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 8.1 tmm_? -68.39 -40.74 81.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.463 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 8' ' ' PHE . 86.0 mt -58.78 -45.59 91.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 121.016 0.436 . . . . 0.0 110.132 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.53 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -62.84 -43.63 98.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.42 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -56.97 -43.39 81.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.452 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 11' ' ' ARG . 49.0 mt-10 -61.33 -41.43 97.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.982 0.42 . . . . 0.0 110.706 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.529 ' SD ' ' HA ' ' A' ' 35' ' ' VAL . 31.8 ttp -70.26 -48.52 56.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.437 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 54' ' ' ILE . 74.6 mt -58.47 -44.82 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 121.126 0.489 . . . . 0.0 111.441 -178.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.94 -4.18 6.54 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.154 -172.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -77.66 -20.77 53.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.044 0.449 . . . . 0.0 110.416 176.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.414 ' HB2' HD22 ' A' ' 34' ' ' LEU . 11.1 m-70 -140.44 84.83 13.81 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.487 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.49 -16.13 21.75 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.483 2.122 . . . . 0.0 112.136 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -83.34 63.07 4.53 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.94 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.538 ' HB3' HG23 ' A' ' 30' ' ' THR . 30.2 mmmt -145.76 -71.42 0.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 174.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.443 ' HA ' ' CG2' ' A' ' 58' ' ' ILE . 42.3 p90 42.5 28.63 0.12 Allowed 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 172.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.7 m -85.62 -21.86 28.25 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.13 -0.356 . . . . 0.0 111.196 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.3 t70 61.12 59.59 1.97 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 122.276 1.036 . . . . 0.0 109.53 -173.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -133.79 168.29 19.0 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.729 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -77.93 -18.6 55.9 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.905 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.89 -38.27 88.3 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 167.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.637 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 6.4 m -60.72 -62.06 2.13 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.814 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.703 ' O ' HG23 ' A' ' 35' ' ' VAL . 23.1 p30 -65.17 -49.25 70.55 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -173.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -55.5 -46.17 77.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.137 0.494 . . . . 0.0 111.183 -176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -71.37 -27.84 63.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.016 -176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 30' ' ' THR . 64.5 mt -76.66 -32.57 58.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.979 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 31' ' ' ASN . 32.8 t -66.38 -34.12 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.261 0.553 . . . . 0.0 110.177 178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -70.56 -12.24 61.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.386 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -79.99 -61.33 2.02 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.606 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.516 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 0.3 OUTLIER -97.92 -157.79 0.62 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.876 -171.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 48.2 t -90.47 126.1 35.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -168.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.9 p -144.23 114.44 7.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.812 169.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.62 125.97 73.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.113 0.483 . . . . 0.0 112.125 -172.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.9 m 62.45 16.58 8.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.906 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 16.1 p -115.81 37.51 3.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.18 -178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.409 ' H ' ' CD ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -53.72 -34.93 60.47 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -169.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -115.81 -16.04 11.23 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.089 -0.644 . . . . 0.0 112.432 -178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.98 -23.66 65.06 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 166.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.537 ' HG2' HG11 ' A' ' 35' ' ' VAL . 6.2 ttt180 -50.84 -38.93 51.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.287 -1.779 . . . . 0.0 111.175 174.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.86 -39.0 93.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.763 -176.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' O ' ' HD1' ' A' ' 53' ' ' TYR . 58.5 mttp -67.18 -40.37 86.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.144 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.487 ' O ' HG13 ' A' ' 54' ' ' ILE . 65.7 mt -60.08 -40.89 84.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.371 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.05 -40.1 84.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.667 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.23 -46.68 93.81 Favored Glycine 0 C--O 1.239 0.458 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.952 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.445 ' HD1' ' O ' ' A' ' 49' ' ' LYS . 57.4 m-85 -55.54 -43.72 76.04 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 176.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.55 ' HA ' HD11 ' A' ' 17' ' ' ILE . 52.9 mt -53.61 -55.32 13.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 O-C-N 123.432 0.457 . . . . 0.0 111.758 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.54 -48.34 57.34 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 111.55 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -67.68 -42.32 82.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.377 -177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 53' ' ' TYR . 84.1 mt -61.04 -43.46 96.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.745 0.307 . . . . 0.0 110.391 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 24' ' ' PHE . 72.6 mt -62.7 -42.04 94.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.323 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 31.4 p -65.18 -24.68 67.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 111.019 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -85.83 -28.25 24.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.029 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -84.73 -35.46 22.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.517 -175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.672 -178.947 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.944 0.402 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 161.04 109.75 0.25 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -84.79 99.6 10.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.007 0.432 . . . . 0.0 112.035 -172.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.809 HD13 ' H ' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -94.67 157.95 2.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 169.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.506 ' HD2' ' C ' ' A' ' 5' ' ' ARG . 2.3 tmm_? 68.19 112.78 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -169.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.604 ' O ' HG12 ' A' ' 9' ' ' VAL . 12.6 t -163.21 30.21 0.09 Allowed 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.624 -173.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t -65.21 -13.87 59.29 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.431 0.634 . . . . 0.0 109.728 175.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.498 ' O ' HG13 ' A' ' 12' ' ' ILE . 52.8 t80 -57.54 -43.45 84.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.849 176.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.604 HG12 ' O ' ' A' ' 6' ' ' THR . 8.0 p -70.38 -28.66 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-O 121.055 0.455 . . . . 0.0 110.518 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -70.12 -37.93 75.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.592 177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 -64.82 -43.71 92.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.166 174.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 8' ' ' PHE . 74.2 mt -54.93 -48.53 74.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.285 176.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.98 91.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.098 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -65.58 -49.79 67.51 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.75 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -70.04 -20.23 63.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.023 0.44 . . . . 0.0 110.838 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.421 ' SD ' HG22 ' A' ' 35' ' ' VAL . 51.2 ttm -70.58 -48.44 55.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.552 174.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 45.5 mt -75.08 -27.66 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.913 0.387 . . . . 0.0 110.303 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 73.84 -59.39 0.56 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.959 0.904 . . . . 0.0 111.954 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 14.0 t -142.16 -170.04 3.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -175.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -89.53 108.53 25.59 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 19' ' ' THR . 92.3 Cg_endo -85.98 177.9 4.46 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.695 2.263 . . . . 0.0 112.615 -178.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -90.41 -9.58 64.81 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.844 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.04 101.65 10.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.882 0.372 . . . . 0.0 110.601 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -113.98 26.26 10.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.45 0.643 . . . . 0.0 109.991 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.2 m -82.71 120.37 25.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.837 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -81.56 9.6 7.3 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -171.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.429 ' OD1' ' HB3' ' A' ' 29' ' ' ASP . 12.4 t70 -75.66 136.35 40.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 174.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.46 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 70.4 m-85 -64.35 -21.76 66.73 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -174.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.429 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 2.1 t70 -64.29 -30.85 71.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.327 0.584 . . . . 0.0 110.368 175.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.3 m -65.14 -61.73 1.97 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.156 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.6 p-10 -64.23 -28.52 69.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 -178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -60.9 -42.79 98.71 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.875 0.369 . . . . 0.0 110.61 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -73.18 -27.5 61.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.973 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 31' ' ' ASN . 97.8 mt -68.12 -47.19 68.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.371 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 31' ' ' ASN . 89.2 t -55.3 -57.56 7.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -64.99 -28.12 69.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.755 -173.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.46 -48.4 67.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.922 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -85.55 -73.63 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.107 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.6 t -140.19 108.7 5.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -79.35 -34.43 42.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.252 -173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.514 HG12 HG23 ' A' ' 43' ' ' THR . 50.2 t 61.76 104.54 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.218 0.532 . . . . 0.0 111.405 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t -62.88 103.15 0.42 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.215 0.531 . . . . 0.0 110.371 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.514 HG23 HG12 ' A' ' 41' ' ' VAL . 15.0 p -141.24 149.16 41.0 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.653 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -52.03 -64.12 0.92 Allowed 'General case' 0 N--CA 1.461 0.11 0 O-C-N 123.502 0.501 . . . . 0.0 110.326 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -154.86 21.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.77 171.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 58.3 tp -65.77 -29.48 69.99 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 47' ' ' ARG . 41.2 ttm180 -54.29 -34.11 60.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.072 175.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -66.4 -35.38 80.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.768 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -69.19 -41.3 77.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.182 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 54' ' ' ILE . 57.2 mt -63.41 -47.92 89.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.046 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.486 ' HB1' HD22 ' A' ' 31' ' ' ASN . . . -60.53 -44.41 96.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.174 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -63.01 -34.21 89.34 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.075 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.505 ' O ' HG13 ' A' ' 57' ' ' ILE . 34.9 t80 -67.04 -37.78 84.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 50' ' ' ILE . 75.0 mt -56.85 -50.03 76.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.489 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.4 m -53.12 -43.23 66.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.978 177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.552 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 96.9 mtt180 -64.0 -41.71 97.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.395 177.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 53' ' ' TYR . 79.9 mt -59.17 -40.8 81.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.706 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 54' ' ' ILE . 76.2 mt -57.36 -43.13 81.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.072 0.463 . . . . 0.0 110.548 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.7 t -65.8 -29.47 69.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.974 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 56' ' ' ARG . 72.5 mt-30 -82.18 -30.7 30.81 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.992 0.425 . . . . 0.0 110.556 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -64.77 -62.33 1.64 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.464 -171.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.238 -177.896 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.58 -175.51 48.47 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.823 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.4 m120 62.55 -144.74 0.39 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.9 HG13 ' HD2' ' A' ' 5' ' ' ARG . 40.7 pt 48.04 -155.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.376 1.07 . . . . 0.0 113.061 174.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.9 ' HD2' HG13 ' A' ' 4' ' ' ILE . 5.3 mpt_? 71.97 -158.92 0.11 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.182 0.593 . . . . 0.0 109.677 -173.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.9 t -161.47 21.83 0.12 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.893 0.854 . . . . 0.0 110.09 -176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.1 m -66.11 -17.44 64.71 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.403 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.465 ' O ' HG13 ' A' ' 12' ' ' ILE . 9.1 m-85 -64.24 -65.74 0.64 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.229 0.538 . . . . 0.0 110.736 -176.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.462 ' HA ' HD12 ' A' ' 12' ' ' ILE . 40.0 t -65.57 -32.25 57.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.586 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -60.58 -43.46 97.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.836 179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -74.04 -26.39 60.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.663 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 8' ' ' PHE . 75.0 mt -60.44 -43.27 93.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.879 0.371 . . . . 0.0 110.211 175.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.44 84.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.373 176.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' HD3' ' C ' ' A' ' 14' ' ' LYS . 12.0 tmtt? -61.12 -41.95 97.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.349 176.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -70.35 -27.14 64.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.184 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.435 ' HE1' HG13 ' A' ' 35' ' ' VAL . 42.7 ttm -70.17 -52.23 25.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.105 0.479 . . . . 0.0 110.538 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 mt -77.38 -1.37 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.074 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.406 ' O ' ' HB ' ' A' ' 19' ' ' THR . 14.1 tp10 -58.8 126.46 27.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.861 -175.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 18' ' ' GLU . 93.1 m 76.62 -54.5 0.58 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.525 173.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 21' ' ' PRO . 82.6 t60 -138.73 103.02 7.66 Favored Pre-proline 0 C--N 1.325 -0.464 0 C-N-CA 120.202 -0.599 . . . . 0.0 112.191 -176.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 20' ' ' HIS . 45.9 Cg_endo -72.09 139.62 32.99 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.326 2.017 . . . . 0.0 110.77 170.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.15 71.75 2.59 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.691 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.613 ' HB3' ' NZ ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER 60.28 92.28 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.31 0.576 . . . . 0.0 109.87 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -84.72 63.94 8.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.602 0.715 . . . . 0.0 112.379 -169.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.2 m -92.82 127.57 38.38 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -72.04 79.03 0.93 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 122.062 0.934 . . . . 0.0 111.778 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.67 132.89 33.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.367 -1.288 . . . . 0.0 107.906 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.649 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 70.5 m-85 -61.5 -19.39 62.02 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -172.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.481 ' O ' ' HD3' ' A' ' 32' ' ' LYS . 18.1 t0 -63.77 -45.45 89.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.084 0.469 . . . . 0.0 109.763 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.588 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 96.8 m -65.31 -56.25 13.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.844 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.761 HD22 ' HB1' ' A' ' 51' ' ' ALA . 2.9 p-10 -61.94 -41.93 98.53 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -173.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -70.52 -31.29 68.32 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.462 -179.219 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 33.5 ttmt -74.83 -28.19 60.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.612 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 30' ' ' THR . 84.2 mt -67.32 -49.54 63.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.119 175.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.524 ' HB ' ' HG3' ' A' ' 47' ' ' ARG . 14.9 t -63.07 -26.62 41.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.129 0.49 . . . . 0.0 110.447 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 36' ' ' GLU . 33.4 tt0 -64.11 -16.47 61.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.569 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -156.68 53.51 0.53 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.485 0.659 . . . . 0.0 111.11 -173.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.481 ' HE2' HD22 ' A' ' 34' ' ' LEU . 12.8 m-85 -148.55 -89.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.342 172.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.0 m -87.4 58.2 4.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.266 0.555 . . . . 0.0 110.087 174.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 m -94.01 86.45 5.03 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.362 0.601 . . . . 0.0 110.922 -176.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 p -157.26 109.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.8 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.6 m 64.77 2.31 1.66 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.54 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.611 ' HA ' ' HB2' ' A' ' 46' ' ' LEU . 3.2 p -89.95 47.92 1.52 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.176 0.512 . . . . 0.0 111.261 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -60.96 -75.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.881 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.5 m170 -84.45 -13.87 50.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.027 0.442 . . . . 0.0 110.053 176.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 43' ' ' THR . 3.2 mm? -67.93 -27.48 66.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.824 176.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.524 ' HG3' ' HB ' ' A' ' 35' ' ' VAL . 42.1 ttp180 -56.62 -35.04 67.84 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.559 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -65.63 -45.62 82.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.257 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.34 -45.17 48.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.545 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 54' ' ' ILE . 76.1 mt -61.65 -41.25 89.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 120.799 0.333 . . . . 0.0 110.535 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.761 ' HB1' HD22 ' A' ' 31' ' ' ASN . . . -60.13 -41.5 92.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.239 176.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.49 -42.63 99.14 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.985 177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.443 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.2 m-85 -58.32 -42.87 87.72 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.009 -0.096 . . . . 0.0 110.898 176.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 50' ' ' ILE . 62.5 mt -55.92 -53.53 37.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 123.112 0.257 . . . . 0.0 110.769 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -40.32 73.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.641 0.257 . . . . 0.0 111.531 177.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.0 mtp180 -65.91 -41.86 90.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.945 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 53' ' ' TYR . 76.1 mt -65.84 -45.54 91.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.727 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.534 ' O ' ' HG2' ' A' ' 62' ' ' LYS . 86.5 mt -58.11 -49.89 80.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.569 178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 32.9 t -65.19 -29.03 69.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.113 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -70.38 -29.32 65.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.048 0.451 . . . . 0.0 110.23 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.9 HE21 ' HA ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -83.95 -30.92 25.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.309 179.816 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 58' ' ' ILE . 17.8 ptpt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 119.22 -0.419 . . . . 0.0 110.948 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.669 0.271 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.45 87.0 0.82 Allowed Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.584 ' HB2' ' HG3' ' A' ' 5' ' ' ARG . 7.6 p30 -99.19 117.9 34.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.506 0.67 . . . . 0.0 112.232 -173.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.4 tt -80.09 -27.41 12.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 170.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.584 ' HG3' ' HB2' ' A' ' 3' ' ' ASN . 18.5 mtp85 64.29 -176.32 0.17 Allowed 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.11 175.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.6 m -161.41 20.11 0.12 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -68.18 -34.74 76.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.084 -174.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -64.8 -38.6 91.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.141 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.74 -50.93 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.815 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -61.68 -42.29 98.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.095 0.474 . . . . 0.0 110.473 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -58.77 -55.12 39.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.493 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.08 -42.42 94.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.801 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.558 ' O ' HG12 ' A' ' 17' ' ' ILE . . . -61.31 -42.52 98.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.14 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -59.14 -48.48 81.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.953 0.406 . . . . 0.0 110.701 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.69 -25.81 64.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.261 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 46.9 ttm -72.13 -40.42 68.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.798 0.332 . . . . 0.0 110.932 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.558 HG12 ' O ' ' A' ' 13' ' ' ALA . 50.5 mm -66.0 -46.99 86.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -66.09 161.92 20.7 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.953 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.5 m 72.53 -57.37 0.63 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.399 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -129.08 78.08 76.79 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.858 0.361 . . . . 0.0 110.929 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -88.84 22.17 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.09 2.527 . . . . 0.0 112.887 -177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.89 93.69 1.18 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.502 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.463 ' HZ3' HD22 ' A' ' 34' ' ' LEU . 67.8 mttm -127.83 147.11 50.43 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -94.67 -70.47 0.71 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.645 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 27' ' ' ASP . 9.8 p -138.7 -165.7 1.87 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.826 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -75.09 19.96 0.14 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.911 0.484 . . . . 0.0 111.776 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 25' ' ' THR . 31.6 t70 -71.43 127.9 34.09 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.865 0.364 . . . . 0.0 111.228 -176.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -62.78 -41.34 99.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.408 -177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.18 -38.17 89.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.123 0.487 . . . . 0.0 110.317 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 54.5 m -62.4 -45.88 91.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.91 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.568 ' O ' HG23 ' A' ' 35' ' ' VAL . 77.0 m-20 -65.02 -37.28 87.09 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.506 176.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -60.12 -39.5 86.48 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.07 0.462 . . . . 0.0 110.478 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 30' ' ' THR . 6.8 tmtm? -56.07 -43.04 77.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.171 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.463 HD22 ' HZ3' ' A' ' 23' ' ' LYS . 8.0 mp -73.61 -31.74 63.71 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.571 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 31' ' ' ASN . 59.4 t -66.99 -32.23 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.101 0.477 . . . . 0.0 109.975 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -60.5 -45.87 92.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.061 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -70.36 -52.18 24.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.304 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -110.99 -141.94 0.38 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.563 -172.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t 71.4 174.02 0.3 Allowed 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.308 0.643 . . . . 0.0 109.701 -172.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.0 m -112.48 -81.17 0.59 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.024 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 p -105.78 90.89 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.958 0.885 . . . . 0.0 110.291 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 m -106.19 110.58 22.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.047 -176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.66 162.58 26.11 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 171.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -63.86 -31.81 73.11 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -169.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -95.64 -21.99 17.86 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.721 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 53.9 tp -70.88 -27.57 63.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.86 0.362 . . . . 0.0 110.245 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 17.1 ttm-85 -55.14 -41.39 71.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.518 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.06 -40.0 95.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.666 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -64.55 -46.93 80.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.851 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.543 ' O ' HG13 ' A' ' 54' ' ' ILE . 64.4 mt -61.77 -43.07 96.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.438 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.28 94.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.764 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.49 -37.28 92.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.182 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.4 ' O ' HG13 ' A' ' 57' ' ' ILE . 78.4 t80 -60.05 -46.6 89.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.71 0.29 . . . . 0.0 110.515 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 50' ' ' ILE . 34.7 mt -60.89 -50.74 79.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.425 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 m -47.18 -44.13 21.89 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.561 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.595 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 13.1 ttm180 -61.08 -45.82 93.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.966 176.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 53' ' ' TYR . 69.2 mt -56.81 -41.02 74.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.008 0.433 . . . . 0.0 110.383 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 74.3 mt -59.58 -49.94 81.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.82 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.1 p -65.69 -16.63 63.94 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.785 0.326 . . . . 0.0 111.82 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 84.3 mm-40 -85.11 -40.09 17.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.029 0.442 . . . . 0.0 110.522 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -81.75 -33.54 30.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.711 -176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.5 mptt . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.345 -0.836 . . . . 0.0 110.167 175.506 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 121.026 0.441 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -81.02 151.04 31.29 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.427 177.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.1 t30 73.38 -53.34 0.7 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.337 0.655 . . . . 0.0 111.182 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.5 tt -91.47 100.78 11.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.636 0.731 . . . . 0.0 109.758 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 5' ' ' ARG . 29.8 ttt180 -88.97 -67.43 0.84 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.085 -172.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.3 m -164.66 -42.66 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.106 0.479 . . . . 0.0 110.157 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 p -52.29 -42.9 64.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.944 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -57.85 -39.99 79.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.082 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.06 -44.11 78.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.975 0.416 . . . . 0.0 110.662 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.14 -28.75 67.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.416 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 15' ' ' GLU . 37.0 ttt180 -61.82 -52.87 62.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.523 175.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.5 mt -58.05 -37.73 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.058 0.456 . . . . 0.0 110.455 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.41 -46.75 88.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.256 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 15' ' ' GLU . 36.4 pttt -69.09 -33.87 74.21 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.72 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 35.1 mt-10 -70.25 -23.05 62.84 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.142 0.496 . . . . 0.0 110.476 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.962 ' HB3' ' HB3' ' A' ' 38' ' ' PHE . 67.5 mtt -70.78 -48.85 52.1 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 169.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 69.6 mt -65.47 -31.6 54.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.271 -174.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 10.5 pt-20 -60.89 -15.71 33.79 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -175.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.4 p -74.33 -26.76 60.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.936 0.398 . . . . 0.0 111.053 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.624 ' HB3' ' HE1' ' A' ' 38' ' ' PHE . 17.7 t-160 -148.77 89.41 5.01 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.213 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.84 42.91 1.16 Allowed 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 123.641 2.894 . . . . 0.0 112.39 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.4 103.24 0.78 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.085 -0.579 . . . . 0.0 111.915 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -131.44 157.82 42.46 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.548 ' HD2' HG22 ' A' ' 25' ' ' THR . 60.5 t80 -85.99 -68.01 0.77 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 176.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.548 HG22 ' HD2' ' A' ' 24' ' ' PHE . 14.4 t -156.0 -165.37 1.92 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -77.35 66.48 3.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.032 0.92 . . . . 0.0 109.729 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.31 143.25 46.13 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.654 -173.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.682 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 73.4 m-85 -74.03 -33.7 63.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.76 -173.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -65.67 -36.23 83.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.422 0.629 . . . . 0.0 109.649 175.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.553 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 96.4 m -61.72 -58.98 5.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.269 177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.682 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.5 p-10 -63.69 -28.68 70.07 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.753 -176.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -56.68 -54.18 49.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.179 0.514 . . . . 0.0 110.142 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -70.66 -27.27 63.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.864 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 30' ' ' THR . 69.8 mt -64.97 -51.05 63.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.761 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 31' ' ' ASN . 66.6 t -60.54 -33.09 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.978 0.418 . . . . 0.0 110.528 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -59.25 -37.95 78.84 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.418 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -81.29 -53.82 6.02 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.19 0.519 . . . . 0.0 110.793 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.962 ' HB3' ' HB3' ' A' ' 16' ' ' MET . 14.2 m-30 -67.13 106.0 1.86 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.118 -173.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.9 p -144.35 98.49 3.21 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.335 0.588 . . . . 0.0 111.571 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 51.9 m -101.47 -41.93 6.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.403 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.3 m -136.15 155.7 35.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.972 175.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.5 t -75.15 99.37 3.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.163 0.506 . . . . 0.0 110.267 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 p -77.19 109.85 11.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.249 177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -85.62 -78.04 0.28 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.03 -175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -101.55 -25.7 13.8 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.428 HD13 ' HB2' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -68.72 -14.58 63.11 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.356 177.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -59.21 -34.41 72.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.442 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -63.75 -43.87 95.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.411 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HB2' HD13 ' A' ' 46' ' ' LEU . 62.1 mttp -66.4 -43.74 85.0 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.549 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 54' ' ' ILE . 42.6 mm -57.46 -46.39 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.375 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.451 ' HB1' ' ND2' ' A' ' 31' ' ' ASN . . . -57.45 -47.5 81.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.866 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.46 -35.41 91.92 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.323 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.447 ' O ' HG13 ' A' ' 57' ' ' ILE . 7.8 m-85 -71.37 -33.16 69.29 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.743 -0.269 . . . . 0.0 111.384 178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 50' ' ' ILE . 58.4 mt -60.21 -49.3 84.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.511 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.82 -32.07 70.31 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.558 0.218 . . . . 0.0 111.348 175.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -70.07 -39.56 75.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.615 0.245 . . . . 0.0 110.988 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 53' ' ' TYR . 82.3 mt -64.03 -45.46 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.17 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 67.8 mt -62.05 -38.19 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.995 0.426 . . . . 0.0 110.149 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.6 t -65.33 -30.88 71.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.799 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -73.49 -34.35 65.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.158 0.504 . . . . 0.0 110.173 177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -81.22 -6.45 58.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.634 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 81.1 tttt . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.169 -176.423 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.43 ' O ' ' HG2' ' A' ' 5' ' ' ARG . . . 64.79 24.44 69.85 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 116.029 -0.532 . . . . 0.0 113.268 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 59.85 20.92 9.82 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.752 0.276 . . . . 0.0 111.168 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.5 pt 45.87 27.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.631 1.172 . . . . 0.0 113.449 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 2' ' ' GLY . 4.8 ptt180 -76.01 97.5 4.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.849 0.833 . . . . 0.0 109.79 174.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.8 m -160.59 -27.24 0.06 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.633 -1.167 . . . . 0.0 108.884 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -61.84 -23.76 66.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.917 0.865 . . . . 0.0 109.092 169.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.516 ' HA ' ' HB3' ' A' ' 11' ' ' ARG . 80.3 m-85 -71.21 -11.78 61.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.314 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.931 HG13 HD13 ' A' ' 50' ' ' ILE . 93.4 t -69.05 -38.84 78.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 173.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -66.19 -39.06 89.42 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.516 ' HB3' ' HA ' ' A' ' 8' ' ' PHE . 17.5 tpt180 -56.19 -51.95 66.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.808 173.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 8' ' ' PHE . 45.5 mm -65.87 -44.66 92.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.268 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.35 98.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.739 0.305 . . . . 0.0 111.222 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -61.03 -51.08 70.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.06 178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.17 -23.08 61.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.569 ' HG3' ' HB2' ' A' ' 38' ' ' PHE . 49.0 ttm -68.65 -52.44 31.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 0.0 110.317 178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.466 HG12 HD23 ' A' ' 34' ' ' LEU . 57.2 mt -75.81 -25.2 17.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.864 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 61.94 -86.37 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.256 -175.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 m -153.04 11.96 0.48 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.341 0.591 . . . . 0.0 109.43 174.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -144.63 101.8 4.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.413 -172.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.511 ' CG ' ' HB2' ' A' ' 24' ' ' PHE . 93.8 Cg_endo -84.48 166.89 12.03 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.87 2.38 . . . . 0.0 112.487 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -88.28 -25.77 30.14 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.445 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.646 ' HD3' ' HA ' ' A' ' 30' ' ' THR . 51.5 mtpt -129.67 -51.89 1.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.883 0.373 . . . . 0.0 110.496 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.511 ' HB2' ' CG ' ' A' ' 21' ' ' PRO . 44.9 t80 64.56 81.63 0.2 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.272 -174.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.401 ' H ' HG21 ' A' ' 30' ' ' THR . 16.1 m -155.79 143.97 19.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.274 177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -74.84 62.0 1.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.97 0.891 . . . . 0.0 109.626 173.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.05 148.37 46.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.729 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -71.82 -28.95 63.93 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.78 -174.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.2 -37.39 85.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.144 0.497 . . . . 0.0 109.779 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.646 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 85.6 m -59.1 -48.76 80.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.406 173.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -54.39 -53.68 50.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.278 174.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -49.86 -55.21 15.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.521 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.599 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 59.4 tttm -65.09 -39.58 93.37 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.329 -174.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.466 HD23 HG12 ' A' ' 17' ' ' ILE . 9.2 mp -71.76 -44.64 63.72 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.273 -0.171 . . . . 0.0 111.395 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.61 ' O ' ' HB2' ' A' ' 39' ' ' SER . 84.6 t -60.94 -50.56 80.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.83 0.348 . . . . 0.0 110.475 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -73.97 -7.76 53.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.647 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.599 ' HB2' ' O ' ' A' ' 33' ' ' LYS . 5.1 tp10 -80.53 -47.39 14.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.058 0.456 . . . . 0.0 110.059 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.569 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 83.0 m-85 -110.52 -90.22 0.48 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.676 -178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.61 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 21.4 t 57.16 -169.37 0.1 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.509 0.671 . . . . 0.0 112.012 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.1 m -143.41 -62.25 0.41 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.4 t -137.03 93.54 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.573 173.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.1 p -98.57 94.22 6.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.386 0.612 . . . . 0.0 112.137 -173.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.0 p -86.18 171.87 10.97 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 169.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -61.07 -54.79 40.32 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.814 -0.355 . . . . 0.0 111.29 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.494 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 16.0 t-160 -67.32 -25.92 66.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.814 -175.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 tt -77.25 -41.52 40.76 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -59.34 -39.46 83.25 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.459 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -58.09 -37.33 74.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.266 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 45' ' ' HIS . 28.1 mmmt -70.15 -49.69 48.04 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.931 HD13 HG13 ' A' ' 9' ' ' VAL . 41.9 mm -61.71 -53.49 47.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.174 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.18 -37.43 77.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.178 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 56' ' ' ARG . . . -59.14 -45.32 95.49 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.113 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.481 ' O ' HG13 ' A' ' 57' ' ' ILE . 26.9 m-85 -71.68 -37.19 70.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 50' ' ' ILE . 64.3 mt -57.71 -55.9 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.316 178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.5 m -50.67 -44.73 57.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.055 176.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 52' ' ' GLY . 98.3 mtt180 -58.82 -51.69 68.91 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.02 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 53' ' ' TYR . 78.8 mt -57.05 -47.11 84.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.622 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.37 -34.32 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.993 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 41.0 m -64.59 -40.28 95.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.775 0.322 . . . . 0.0 110.754 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -77.45 -28.34 52.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.059 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -85.18 2.67 42.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 0.0 111.0 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' A' ' 62' ' ' LYS . 13.2 tppt? . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.859 -0.591 . . . . 0.0 109.426 174.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.8 mtp . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.78 0.324 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.96 -4.38 27.74 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -77.57 -158.62 0.12 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.26 -0.47 . . . . 0.0 109.966 175.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.1 pt -53.44 125.53 7.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.183 0.516 . . . . 0.0 111.008 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -146.71 152.51 38.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.715 -175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.6 m 67.1 28.98 8.12 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.674 0.749 . . . . 0.0 110.704 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m -64.2 -8.31 12.02 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.431 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.405 ' O ' HG13 ' A' ' 12' ' ' ILE . 40.5 m-85 -57.97 -37.2 73.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.519 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.1 t -64.39 -37.94 81.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.567 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -60.03 -46.78 88.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.6 ttm-85 -64.64 -41.84 95.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.385 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 8' ' ' PHE . 77.3 mt -63.36 -44.13 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.87 -44.06 90.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.944 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -58.63 -49.86 75.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.255 0.55 . . . . 0.0 110.696 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -68.2 -26.77 65.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.702 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.509 ' O ' HG22 ' A' ' 19' ' ' THR . 37.2 tpp -70.36 -39.71 74.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.633 177.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.435 HG23 HD23 ' A' ' 34' ' ' LEU . 87.3 mt -74.88 -42.12 46.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.276 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -65.21 -10.08 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 16' ' ' MET . 15.0 t -80.14 -27.51 39.05 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.193 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -130.41 97.65 21.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 111.137 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -91.39 40.07 0.33 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.262 2.641 . . . . 0.0 112.051 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.93 -56.02 3.93 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.639 -173.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.543 ' HB2' HG23 ' A' ' 30' ' ' THR . 49.6 mtpt -118.33 156.41 28.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.682 0.241 . . . . 0.0 111.162 -174.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -146.39 86.95 1.7 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.123 0.487 . . . . 0.0 110.323 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 27' ' ' ASP . 14.0 m -155.81 162.89 40.4 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -76.72 30.66 0.13 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.51 0.671 . . . . 0.0 110.729 176.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -98.91 144.6 27.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.704 -176.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.509 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 81.4 m-85 -74.76 -24.86 58.76 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.231 -0.44 . . . . 0.0 112.126 -174.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 33' ' ' LYS . 25.5 t70 -66.0 -33.95 76.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.241 0.543 . . . . 0.0 109.697 175.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.543 HG23 ' HB2' ' A' ' 23' ' ' LYS . 99.6 m -54.59 -59.68 4.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.438 177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.509 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 3.3 p-10 -65.13 -28.12 69.21 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.688 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.25 -43.05 96.1 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.856 0.36 . . . . 0.0 110.458 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 29' ' ' ASP . 75.0 mmtt -65.25 -32.98 74.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.661 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.538 HD13 ' O ' ' A' ' 30' ' ' THR . 8.4 mp -72.02 -43.19 65.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.754 178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.531 HG11 ' HD2' ' A' ' 47' ' ' ARG . 84.4 t -72.49 -18.86 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.289 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -55.09 -39.18 69.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.271 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -76.52 -34.81 58.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.411 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 54.5 p90 48.25 114.47 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.152 1.381 . . . . 0.0 113.71 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 t -71.35 -29.98 65.64 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.298 177.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.3 t -152.71 -169.12 3.25 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.288 -178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.9 m -66.09 178.02 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.173 0.511 . . . . 0.0 112.261 -175.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.657 ' HB3' ' HB2' ' A' ' 47' ' ' ARG . 19.7 m -96.54 -51.98 4.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.622 -174.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 46' ' ' LEU . 55.1 m 69.17 136.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.273 -170.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -33.92 -60.12 0.39 Allowed 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -167.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -120.77 16.61 11.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.761 0.315 . . . . 0.0 111.74 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.622 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 36.9 tp -90.88 -33.8 15.5 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.969 -177.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.657 ' HB2' ' HB3' ' A' ' 42' ' ' SER . 22.6 tpp180 -55.12 -46.89 75.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.472 -177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -69.44 -32.11 70.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 110.702 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.58 -44.65 70.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.431 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 54' ' ' ILE . 44.0 mm -60.22 -45.63 95.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.772 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.444 ' HB1' ' ND2' ' A' ' 31' ' ' ASN . . . -58.12 -45.91 86.5 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.477 178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.672 ' O ' ' HG2' ' A' ' 56' ' ' ARG . . . -62.55 -42.73 99.67 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.054 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.511 ' CE2' HD11 ' A' ' 57' ' ' ILE . 66.9 t80 -57.62 -40.31 78.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 122.14 0.176 . . . . 0.0 110.626 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 50' ' ' ILE . 78.7 mt -56.14 -54.3 29.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.672 177.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.1 p -61.89 -35.77 79.31 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.672 ' HG2' ' O ' ' A' ' 52' ' ' GLY . 52.8 mmm-85 -62.52 -41.83 99.11 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.68 0.276 . . . . 0.0 110.416 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.534 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 78.0 mt -58.66 -46.05 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.411 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.7 mt -57.73 -49.13 81.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.794 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 21.6 m -65.79 -37.0 85.1 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.579 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -71.62 -25.47 62.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.395 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 49.4 mt-30 -72.33 -18.43 61.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.119 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 C--O 1.246 0.897 0 CA-C-O 118.446 -0.788 . . . . 0.0 109.794 179.163 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -104.0 -125.82 5.69 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.53 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -114.47 30.31 7.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.499 0.666 . . . . 0.0 109.84 -177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.4 tt -69.22 150.12 10.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.908 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 73.72 23.82 2.28 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.499 0.666 . . . . 0.0 109.909 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -161.7 -30.91 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.22 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m -60.98 -28.15 68.79 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.106 171.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.434 ' O ' HG13 ' A' ' 12' ' ' ILE . 94.5 t80 -59.69 -48.19 82.66 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.528 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.7 t -66.21 -40.59 87.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.168 0.509 . . . . 0.0 110.194 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -60.76 -32.59 71.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.72 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.4 ttt180 -69.63 -35.86 75.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.682 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 16' ' ' MET . 29.4 mt -61.63 -40.38 86.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.99 0.424 . . . . 0.0 109.931 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.37 -35.02 79.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.962 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -64.68 -56.49 13.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.73 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.55 ' HA ' ' HB3' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -68.48 -15.26 63.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.171 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.482 ' HG3' ' CD2' ' A' ' 38' ' ' PHE . 6.8 tpt -64.98 -53.67 42.54 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.13 -28.87 21.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.688 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 15' ' ' GLU . 11.4 tp10 -60.15 153.85 20.98 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.423 177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 18' ' ' GLU . 52.2 m 82.08 -47.72 0.2 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.517 0.727 . . . . 0.0 111.18 -176.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -147.64 96.17 4.16 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.597 0.237 . . . . 0.0 110.89 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.69 95.58 0.81 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.778 2.319 . . . . 0.0 111.315 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.753 ' H ' ' HE1' ' A' ' 38' ' ' PHE . . . -68.18 -82.53 0.16 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 116.111 -0.495 . . . . 0.0 113.133 -177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.565 ' HB2' HD21 ' A' ' 34' ' ' LEU . 67.0 mttm -136.02 152.95 51.44 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.664 0.269 . . . . 0.0 110.639 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -118.0 61.35 0.77 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.505 0.669 . . . . 0.0 109.338 176.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.657 ' HB ' HG21 ' A' ' 30' ' ' THR . 21.7 m -121.34 133.71 55.12 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.346 -178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.562 ' HA ' HG22 ' A' ' 55' ' ' THR . 8.0 p-10 -88.35 32.09 0.79 Allowed 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -173.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -94.96 145.43 24.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -66.82 -27.47 67.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.73 0.3 . . . . 0.0 110.953 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -65.5 -37.95 88.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.521 0.677 . . . . 0.0 109.27 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.657 HG21 ' HB ' ' A' ' 25' ' ' THR . 22.2 m -65.81 -56.27 12.8 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.202 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 35' ' ' VAL . 28.9 p30 -61.54 -27.83 68.9 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.849 0.357 . . . . 0.0 111.247 -175.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -65.73 -49.22 69.22 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.24 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -77.29 -21.02 54.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.877 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 30' ' ' THR . 41.7 mt -66.3 -50.11 64.75 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.18 174.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 31' ' ' ASN . 68.8 t -56.14 -43.43 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.039 0.447 . . . . 0.0 110.025 176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -58.24 -42.21 85.84 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.297 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.01 -48.86 11.65 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.753 ' HE1' ' H ' ' A' ' 22' ' ' GLY . 17.1 m-30 -56.88 -76.24 0.04 OUTLIER 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -172.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.7 t -131.77 133.54 44.86 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.6 t -81.6 -1.15 45.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.729 -175.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.04 109.85 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.837 0.827 . . . . 0.0 110.517 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.7 m -80.61 162.35 24.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.638 -176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.769 ' HB ' ' HB2' ' A' ' 47' ' ' ARG . 11.1 m -150.06 117.46 6.08 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -21.51 -79.59 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.962 1.305 . . . . 0.0 113.51 -168.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -133.63 13.25 4.08 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.415 174.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 50' ' ' ILE . 58.6 tp -88.62 -28.37 20.7 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.361 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.769 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 14.1 tpp180 -66.67 -34.81 78.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.431 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.72 -39.69 85.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.755 175.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 33.0 mmtp -73.66 -31.91 63.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.551 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 54' ' ' ILE . 80.4 mt -62.74 -40.17 87.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.195 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.52 -44.43 96.05 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.042 0.449 . . . . 0.0 110.558 177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.92 -32.23 83.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.734 176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.494 ' O ' HG13 ' A' ' 57' ' ' ILE . 23.5 t80 -71.4 -30.82 66.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 50' ' ' ILE . 79.3 mt -59.4 -49.54 83.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.894 0.378 . . . . 0.0 110.193 175.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.562 HG22 ' HA ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER -62.35 -29.23 70.31 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.559 176.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 27.3 ttt85 -68.69 -41.59 78.95 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.754 0.311 . . . . 0.0 110.687 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 53' ' ' TYR . 77.6 mt -59.99 -45.9 94.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.378 177.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.8 -50.7 79.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.247 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.0 p -66.4 -35.3 79.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.725 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -73.73 -35.99 65.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.0 tm0? -72.81 -52.32 15.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.145 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.53 ' NZ ' ' HB3' ' A' ' 62' ' ' LYS . 1.3 ttpm? . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.4 -177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 CA-C-O 120.632 0.253 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.38 130.11 9.91 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.335 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.587 HD21 ' HB3' ' A' ' 7' ' ' SER . 0.0 OUTLIER 77.01 145.71 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.413 0.685 . . . . 0.0 111.543 179.782 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 62.4 mt -103.88 -72.28 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.91 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -120.34 79.69 1.51 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.688 0.756 . . . . 0.0 111.041 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.416 ' H ' ' H ' ' A' ' 7' ' ' SER . 14.4 m -161.29 3.42 0.06 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.438 -1.256 . . . . 0.0 107.751 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.587 ' HB3' HD21 ' A' ' 3' ' ' ASN . 1.5 p -67.88 -17.71 64.57 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.016 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.516 ' O ' HG13 ' A' ' 12' ' ' ILE . 79.3 t80 -56.27 -40.61 74.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.031 176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.87 -34.6 68.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.254 0.55 . . . . 0.0 110.192 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -68.04 -31.45 71.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.335 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 7' ' ' SER . 22.5 mmt180 -75.34 -31.77 60.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.075 177.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 8' ' ' PHE . 82.1 mt -61.75 -55.04 26.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.101 175.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.01 -39.13 77.53 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.452 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 38.7 tptt -52.78 -56.21 17.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.066 175.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -70.92 -28.29 64.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.588 -176.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 39' ' ' SER . 87.1 mtp -66.65 -43.42 84.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.599 0.238 . . . . 0.0 110.979 179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.3 mt -77.59 -31.68 17.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.108 0.48 . . . . 0.0 110.995 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -62.15 113.73 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.966 -175.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.6 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 93.1 m 76.31 -39.49 0.36 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.802 177.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -91.11 98.3 1.62 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.394 . . . . 0.0 110.149 176.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 19' ' ' THR . 27.5 Cg_endo -94.92 102.63 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.269 2.646 . . . . 0.0 112.69 -175.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.639 ' HA3' HD11 ' A' ' 34' ' ' LEU . . . -91.7 -125.06 3.35 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 173.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.494 ' HA ' HG21 ' A' ' 30' ' ' THR . 36.5 ttmt 61.54 77.71 0.32 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.188 0.518 . . . . 0.0 111.603 173.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -86.8 -37.54 17.71 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.42 HG22 ' N ' ' A' ' 26' ' ' ASP . 19.2 m -154.42 168.34 26.99 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 176.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.42 ' N ' HG22 ' A' ' 25' ' ' THR . 12.2 p-10 -82.32 28.0 0.47 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.149 0.5 . . . . 0.0 111.035 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -91.37 162.12 14.73 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.716 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -69.3 -30.44 68.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.687 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.99 -30.63 71.69 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.211 0.529 . . . . 0.0 110.316 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.494 HG21 ' HA ' ' A' ' 23' ' ' LYS . 97.5 m -64.94 -52.86 54.03 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.393 176.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.749 ' OD1' ' HB ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -61.34 -37.98 85.25 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.074 178.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -50.1 -49.27 52.17 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.573 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.68 -39.16 73.69 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.997 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.639 HD11 ' HA3' ' A' ' 22' ' ' GLY . 8.5 mp -58.77 -39.24 80.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.471 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.528 HG11 ' HG3' ' A' ' 47' ' ' ARG . 57.0 t -75.49 -37.11 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 110.267 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.14 -49.21 76.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.877 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -63.54 -65.87 0.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.067 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -101.6 -84.46 0.44 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.637 -168.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.482 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 90.3 p 51.33 -172.65 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.915 0.886 . . . . 0.0 112.308 -175.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 57.9 m -145.85 112.22 5.81 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 173.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.1 t 65.67 82.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -169.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 40.8 m -72.33 91.95 1.37 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.124 -174.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.578 ' OG1' ' HB2' ' A' ' 46' ' ' LEU . 2.9 p -92.71 -175.61 3.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.285 176.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -102.01 -59.33 1.72 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.468 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -78.01 -31.23 50.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 0.0 110.501 -175.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.578 ' HB2' ' OG1' ' A' ' 43' ' ' THR . 7.2 mp -73.18 -18.7 61.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.49 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.528 ' HG3' HG11 ' A' ' 35' ' ' VAL . 41.5 ttp180 -57.43 -43.66 84.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.4 0.619 . . . . 0.0 110.205 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -72.71 -23.17 60.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.574 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -71.23 -46.44 61.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.969 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.0 mt -63.24 -33.15 59.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.928 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.58 84.3 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.915 177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.85 -41.22 88.84 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.76 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.442 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.0 m-85 -62.03 -61.45 2.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.496 0.189 . . . . 0.0 111.483 178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.749 ' HB ' ' OD1' ' A' ' 31' ' ' ASN . 62.8 mt -60.84 -44.82 98.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -172.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.3 p -54.26 -45.76 72.5 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.243 0.474 . . . . 0.0 111.473 176.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -60.0 -43.83 94.93 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.865 0.364 . . . . 0.0 110.418 176.095 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 53' ' ' TYR . 78.1 mt -62.76 -38.63 82.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.081 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 54' ' ' ILE . 75.7 mt -59.7 -51.36 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.865 0.364 . . . . 0.0 110.855 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 34.2 p -65.24 -22.3 66.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.573 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -84.99 -52.09 6.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.726 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -71.54 -36.31 70.94 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.085 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm . . . . . 0 C--O 1.25 1.097 0 O-C-N 123.838 0.711 . . . . 0.0 109.688 -172.539 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.92 148.22 41.03 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.966 177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -90.69 125.56 35.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 tt -155.86 147.16 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.703 0.287 . . . . 0.0 111.538 -176.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 75.85 130.51 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.995 171.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.2 21.54 0.1 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.271 176.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 m -75.17 -21.73 58.55 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.631 -166.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.464 ' O ' HG13 ' A' ' 12' ' ' ILE . 25.3 m-85 -65.58 -60.55 2.81 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.834 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.87 -34.64 71.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.214 0.531 . . . . 0.0 110.479 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -66.29 -33.66 76.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.545 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -72.86 -35.76 67.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.687 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 8' ' ' PHE . 72.4 mt -57.14 -49.95 78.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 110.208 177.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.3 -39.58 94.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.636 178.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -64.84 -34.51 78.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.77 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -69.86 -35.51 74.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.665 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.567 ' HA ' ' HD2' ' A' ' 38' ' ' PHE . 48.8 ttm -70.4 -42.63 71.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.684 177.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.569 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 53.5 mt -75.55 -5.84 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.385 0.612 . . . . 0.0 110.982 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -65.38 134.65 53.97 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.53 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m 76.19 -66.74 0.25 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 170.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.598 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . 1.2 t-160 -89.64 -57.01 0.27 Allowed Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 120.483 -0.487 . . . . 0.0 112.219 -168.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.951 ' HB3' HD22 ' A' ' 34' ' ' LEU . 43.1 Cg_exo -60.54 133.67 50.11 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.151 1.901 . . . . 0.0 112.631 178.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -106.56 -7.01 34.99 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.641 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 57.4 pttt 41.17 86.03 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.889 0.875 . . . . 0.0 112.415 -176.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -129.19 1.91 5.19 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 122.018 -0.426 . . . . 0.0 111.981 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.454 ' HB ' ' OG1' ' A' ' 30' ' ' THR . 11.6 m -139.94 146.61 39.41 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -105.02 29.42 6.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.7 0.286 . . . . 0.0 111.382 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -100.05 160.34 14.4 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -71.96 -24.21 61.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.681 0.277 . . . . 0.0 111.618 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.43 -29.17 69.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.338 0.59 . . . . 0.0 109.462 175.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.617 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 14.3 m -65.59 -52.18 54.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.219 -0.901 . . . . 0.0 111.424 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.452 ' O ' HG23 ' A' ' 35' ' ' VAL . 27.2 p30 -65.87 -28.34 68.89 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.755 -177.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.2 ttpt -64.19 -44.02 93.29 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.949 174.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -65.2 -34.39 78.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.812 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.951 HD22 ' HB3' ' A' ' 21' ' ' PRO . 59.8 mt -70.6 -43.8 68.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.291 -177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.541 HG11 ' HG3' ' A' ' 47' ' ' ARG . 56.4 t -69.74 -30.81 46.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.378 0.609 . . . . 0.0 110.301 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.83 -23.29 60.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.327 0.584 . . . . 0.0 109.928 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -80.01 -55.66 4.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.164 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.567 ' HD2' ' HA ' ' A' ' 16' ' ' MET . 34.2 t80 -132.57 148.19 52.37 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.1 p -162.55 153.74 17.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.773 0.32 . . . . 0.0 110.848 -173.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.594 HG22 HG23 ' A' ' 41' ' ' VAL . 37.5 m -133.92 119.87 19.64 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.581 177.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.594 HG23 HG22 ' A' ' 40' ' ' THR . 66.1 t 73.63 153.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 O-C-N 123.514 0.509 . . . . 0.0 110.969 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.1 m -66.89 100.58 0.74 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.006 0.431 . . . . 0.0 109.877 175.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 47' ' ' ARG . 37.3 p -85.43 111.59 20.1 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.692 -175.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -98.63 -77.43 0.51 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -101.59 13.65 34.31 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.398 0.618 . . . . 0.0 109.953 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.401 HD23 HG22 ' A' ' 43' ' ' THR . 59.8 tp -95.15 -27.78 15.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.762 173.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.542 ' HB2' ' HB ' ' A' ' 43' ' ' THR . 51.2 ttp180 -67.09 -47.64 70.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.586 -174.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -61.64 -34.98 76.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.996 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 53' ' ' TYR . 72.2 mmtt -65.57 -51.16 61.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.532 ' O ' HG13 ' A' ' 54' ' ' ILE . 66.3 mt -65.28 -51.34 66.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.079 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.8 -48.83 77.05 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 120.926 0.394 . . . . 0.0 111.144 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.92 -37.94 95.75 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 121.039 -0.601 . . . . 0.0 111.96 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.448 ' O ' HG13 ' A' ' 57' ' ' ILE . 2.0 t80 -69.95 -33.13 71.71 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.348 -0.241 . . . . 0.0 110.348 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 50' ' ' ILE . 80.9 mt -56.84 -55.58 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.863 0.363 . . . . 0.0 110.265 175.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.17 -32.31 73.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -62.05 -46.64 88.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.958 178.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 53' ' ' TYR . 84.1 mt -62.57 -39.01 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.671 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 54' ' ' ILE . 71.8 mt -58.25 -51.87 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 110.526 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.9 p -65.86 -18.9 65.66 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.785 178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -84.89 -38.96 18.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.912 0.387 . . . . 0.0 110.372 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -73.84 -38.37 64.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.32 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 62.7 tttp . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.471 -179.395 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtm . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.779 0.324 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -90.92 95.77 2.12 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.521 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -149.79 -160.5 1.18 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.892 HG13 ' H ' ' A' ' 5' ' ' ARG . 9.6 tp -130.05 -166.58 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.892 ' H ' HG13 ' A' ' 4' ' ' ILE . 9.6 ptp85 -51.89 133.25 32.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.95 0.405 . . . . 0.0 111.368 176.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.2 m -67.41 -24.23 65.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.307 0.575 . . . . 0.0 110.601 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.9 m -67.8 -9.33 43.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.501 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.439 ' O ' HG13 ' A' ' 12' ' ' ILE . 75.6 t80 -65.62 -37.19 85.88 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 176.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.7 t -66.12 -37.29 79.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.672 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -64.93 -33.33 75.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.448 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.25 -28.24 62.04 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 8' ' ' PHE . 72.9 mt -70.71 -39.23 75.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.265 0.555 . . . . 0.0 109.547 173.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.42 -38.31 90.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.484 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -63.03 -42.92 99.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.071 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -55.55 -45.73 77.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.435 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.516 ' SD ' ' HB3' ' A' ' 34' ' ' LEU . 46.3 tpp -55.77 -52.44 63.94 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.222 177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 74.2 mt -75.32 -49.73 26.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.236 -173.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -66.09 -33.08 74.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.728 0.299 . . . . 0.0 111.792 -173.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 m -84.11 -16.87 42.06 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.246 0.546 . . . . 0.0 110.579 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . 47.2 t-80 -132.55 69.39 79.75 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.064 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.31 0.45 9.41 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.12 2.547 . . . . 0.0 112.716 -174.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -97.02 147.06 18.56 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 91.1 mttt 70.43 20.88 5.84 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.915 0.486 . . . . 0.0 110.775 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -71.38 120.52 17.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.186 0.517 . . . . 0.0 109.923 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.2 m -153.97 144.93 22.7 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.719 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -77.95 41.93 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.616 0.722 . . . . 0.0 110.191 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -103.9 139.93 38.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.712 -172.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.654 ' HA ' ' ND2' ' A' ' 31' ' ' ASN . 99.5 m-85 -72.14 -40.27 68.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.777 -174.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.56 -38.35 90.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.245 0.545 . . . . 0.0 110.358 176.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.443 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 67.3 m -62.71 -55.03 30.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.564 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.654 ' ND2' ' HA ' ' A' ' 28' ' ' PHE . 20.9 p30 -60.87 -30.05 69.9 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.702 0.287 . . . . 0.0 110.997 -176.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.586 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 14.3 tmtt? -66.93 -52.13 46.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.082 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 52.3 mtmt -67.4 -26.8 66.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.727 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.516 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 95.2 mt -69.33 -48.17 62.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.65 0.262 . . . . 0.0 110.713 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.86 HG12 HG21 ' A' ' 43' ' ' THR . 17.8 t -68.15 -24.58 30.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.0 0.429 . . . . 0.0 110.11 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 7.3 mm-40 -57.42 -38.51 74.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.245 175.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -159.09 89.76 0.94 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.922 0.391 . . . . 0.0 111.04 -174.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 20' ' ' HIS . 51.3 t80 -175.65 -78.83 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.266 171.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.424 ' HB2' ' HE2' ' A' ' 16' ' ' MET . 66.6 m -104.07 51.04 0.78 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.454 0.645 . . . . 0.0 109.347 173.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.448 HG23 ' HB ' ' A' ' 43' ' ' THR . 10.8 m -78.79 113.2 16.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.585 -176.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.22 96.79 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.922 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.7 m 53.14 34.59 17.73 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.631 0.729 . . . . 0.0 109.786 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.86 HG21 HG12 ' A' ' 35' ' ' VAL . 38.2 m -86.5 89.08 7.78 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.8 -168.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -104.31 -66.31 0.97 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.066 168.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -98.18 -19.62 17.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.14 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 43.6 tp -64.87 -14.19 58.75 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.13 0.491 . . . . 0.0 110.589 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.572 ' HA ' HG11 ' A' ' 35' ' ' VAL . 38.1 ttm180 -49.49 -57.73 6.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.801 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -69.6 -18.33 63.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.538 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -75.32 -54.04 7.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.034 0.445 . . . . 0.0 110.109 178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 54' ' ' ILE . 62.2 mt -64.69 -41.76 93.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.048 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.478 ' HB1' ' OD1' ' A' ' 31' ' ' ASN . . . -59.31 -38.64 80.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.172 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.86 -44.24 97.27 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.718 177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -60.88 -49.83 75.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.952 -0.124 . . . . 0.0 111.08 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 50' ' ' ILE . 78.0 mt -49.05 -57.81 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 O-C-N 123.527 0.517 . . . . 0.0 111.111 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -47.32 -58.27 4.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.222 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.419 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 75.2 mtt-85 -70.8 -33.06 70.33 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -172.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 80.0 mt -65.26 -40.37 88.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.974 0.416 . . . . 0.0 110.118 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.35 -32.29 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.229 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.1 m -65.52 -24.62 67.17 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 176.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 56' ' ' ARG . 83.4 mm-40 -75.38 -54.01 7.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.308 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.49 -51.38 8.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.637 0.256 . . . . 0.0 111.663 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.3 tttt . . . . . 0 C--O 1.249 1.071 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.329 -174.211 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tmm? . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 121.013 0.435 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -94.07 92.27 1.55 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.896 -0.668 . . . . 0.0 111.58 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.8 m-20 -75.26 69.07 2.06 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.4 mt 68.45 -72.88 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 O-C-N 123.725 0.641 . . . . 0.0 110.03 -173.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 62.76 177.03 0.14 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.414 0.685 . . . . 0.0 112.112 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 89.2 m -162.82 -30.24 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.407 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 m -49.16 -44.21 42.6 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.207 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.411 ' O ' HG12 ' A' ' 12' ' ' ILE . 74.9 t80 -61.65 -48.57 80.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.791 0.329 . . . . 0.0 110.886 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.5 t -63.59 -44.8 98.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.772 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -69.15 -29.7 67.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.817 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.521 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 8.6 tpt180 -64.49 -42.32 95.92 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 176.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 8' ' ' PHE . 49.5 mm -59.24 -43.1 89.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.254 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.33 97.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.284 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -58.49 -41.66 85.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.779 178.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 11' ' ' ARG . 76.2 mm-40 -56.67 -47.08 80.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.829 0.347 . . . . 0.0 110.493 178.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.481 ' HE2' ' HB3' ' A' ' 39' ' ' SER . 42.0 ttm -65.83 -50.29 65.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.739 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.478 HG23 ' HZ1' ' A' ' 23' ' ' LYS . 85.0 mt -57.72 -46.29 86.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.602 -177.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.472 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 5.2 tp10 -66.22 -46.48 77.04 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.948 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 19.8 m -69.19 -41.62 76.89 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.236 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -121.44 92.91 48.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.085 0.469 . . . . 0.0 110.952 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.99 -2.95 11.53 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.589 2.86 . . . . 0.0 112.334 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.31 62.27 2.65 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.329 -0.462 . . . . 0.0 113.038 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.478 ' HZ1' HG23 ' A' ' 17' ' ' ILE . 2.0 pptp? -169.61 142.84 2.62 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 177.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -167.23 48.73 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.651 0.738 . . . . 0.0 110.225 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.461 ' HB ' ' OD2' ' A' ' 27' ' ' ASP . 0.6 OUTLIER -139.0 146.01 40.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.488 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -106.14 21.4 17.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.0 111.503 -173.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' OD2' ' HB ' ' A' ' 25' ' ' THR . 4.3 p30 -89.45 159.3 17.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.905 0.383 . . . . 0.0 110.522 176.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.68 ' HA ' ' OD1' ' A' ' 31' ' ' ASN . 62.2 m-85 -71.36 -28.24 63.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.118 -176.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -64.97 -36.76 85.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.121 0.486 . . . . 0.0 110.305 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 53.1 m -61.1 -56.81 16.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.661 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.68 ' OD1' ' HA ' ' A' ' 28' ' ' PHE . 2.7 p-10 -65.65 -23.97 66.92 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.395 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.617 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 20.6 ttpp -62.12 -52.06 65.36 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -56.58 -38.59 72.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.274 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.482 ' HA ' ' HD2' ' A' ' 38' ' ' PHE . 7.7 mp -60.15 -51.53 69.22 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.4 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.463 HG11 ' HB2' ' A' ' 51' ' ' ALA . 35.7 m -82.46 -9.2 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 122.047 -0.408 . . . . 0.0 111.011 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.617 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 2.8 tp10 -76.08 -2.61 31.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.963 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -158.5 -48.14 0.06 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.854 0.359 . . . . 0.0 111.374 -171.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.482 ' HD2' ' HA ' ' A' ' 34' ' ' LEU . 36.9 m-85 -84.66 -165.98 1.34 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.809 -174.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.481 ' HB3' ' HE2' ' A' ' 16' ' ' MET . 93.3 p 62.23 174.42 0.13 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.397 1.079 . . . . 0.0 112.29 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.559 HG23 HG23 ' A' ' 41' ' ' VAL . 13.9 t -160.88 -161.13 0.8 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 -178.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.559 HG23 HG23 ' A' ' 40' ' ' THR . 67.6 t 79.01 149.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 123.693 0.621 . . . . 0.0 110.345 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.3 t -78.6 -171.6 2.57 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.117 -176.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.6 m 69.76 82.6 0.16 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.877 0.846 . . . . 0.0 109.95 -174.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HG2' ' H ' ' A' ' 44' ' ' LYS . 18.4 pttm -62.5 -25.74 68.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.89 -1.05 . . . . 0.0 112.316 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -78.71 -13.18 59.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.955 0.407 . . . . 0.0 110.64 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.5 tp -77.04 -39.6 49.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.044 -177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -69.78 -10.16 57.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.854 0.359 . . . . 0.0 111.682 -176.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -69.59 -41.96 75.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.402 0.62 . . . . 0.0 109.635 172.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -73.24 -38.89 65.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.69 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.558 ' O ' HG13 ' A' ' 54' ' ' ILE . 50.4 mm -57.16 -49.18 80.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.487 177.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.591 ' HB1' HD22 ' A' ' 31' ' ' ASN . . . -57.85 -50.94 71.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.414 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.62 -28.48 73.65 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.767 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.501 ' O ' HG13 ' A' ' 57' ' ' ILE . 22.7 t80 -73.93 -37.27 64.64 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 50' ' ' ILE . 84.6 mt -58.63 -47.64 88.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 120.825 0.345 . . . . 0.0 110.124 176.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.76 -42.23 75.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.414 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -66.22 -44.47 83.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.032 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 53' ' ' TYR . 80.9 mt -57.53 -49.36 80.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.806 0.336 . . . . 0.0 110.857 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.68 -49.95 81.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.095 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.7 p -65.82 -25.39 67.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.709 0.29 . . . . 0.0 111.535 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -70.27 -34.19 72.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.044 0.449 . . . . 0.0 110.327 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.759 HE21 ' HA ' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -86.39 -33.02 20.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.754 177.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.5 tttm . . . . . 0 C--O 1.253 1.275 0 CA-C-O 118.361 -0.828 . . . . 0.0 110.811 -176.036 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 120.796 0.332 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.15 -110.34 3.77 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.874 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -100.94 86.98 3.17 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 66.1 mt 66.55 -74.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.469 -178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -138.5 -63.47 0.54 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.157 0.503 . . . . 0.0 110.079 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.3 t -167.39 21.11 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.866 0.841 . . . . 0.0 109.042 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 m -67.61 -14.07 62.62 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.259 -172.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.53 ' O ' HG13 ' A' ' 12' ' ' ILE . 55.0 t80 -64.16 -35.84 82.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.4 -48.78 85.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.095 0.474 . . . . 0.0 110.7 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 53' ' ' TYR . 87.8 tttt -58.78 -40.2 83.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.544 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -59.44 -46.31 89.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.439 178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 8' ' ' PHE . 73.3 mt -57.17 -53.5 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.745 0.307 . . . . 0.0 111.094 -177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.503 ' HB1' HG12 ' A' ' 54' ' ' ILE . . . -63.82 -45.78 88.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.432 -177.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.2 -39.51 94.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.42 -176.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.886 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 31.0 mt-10 -71.06 -30.62 66.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.748 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.453 ' HG3' ' O ' ' A' ' 12' ' ' ILE . 59.9 mtt -55.34 -42.45 73.84 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 174.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.535 HD11 HG23 ' A' ' 54' ' ' ILE . 57.8 mt -65.23 -54.18 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.25 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.886 ' HG2' ' HA ' ' A' ' 15' ' ' GLU . 8.8 pt-20 -67.0 -6.01 15.19 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 25.5 m -57.59 -43.08 84.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.147 0.498 . . . . 0.0 110.662 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -150.44 120.09 3.73 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.959 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.68 100.33 0.11 Allowed 'Trans proline' 0 CA--C 1.515 -0.429 0 C-N-CA 122.648 2.232 . . . . 0.0 111.914 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.19 171.69 44.69 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.899 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.766 ' HB3' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER 57.83 -113.56 0.73 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -176.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 92.3 t80 70.77 -33.7 0.28 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 165.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.2 p -82.9 70.25 9.86 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.41 0.892 . . . . 0.0 113.41 -166.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.477 ' H ' HG21 ' A' ' 58' ' ' ILE . 32.5 t70 36.79 66.54 0.4 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.369 1.068 . . . . 0.0 112.786 170.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.556 ' O ' ' HB ' ' A' ' 30' ' ' THR . 7.9 t70 -139.79 147.91 41.46 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.222 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -77.9 -35.25 50.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.777 0.322 . . . . 0.0 110.633 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.433 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 36.2 t70 -65.63 -29.7 70.31 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.766 HG23 ' HB3' ' A' ' 23' ' ' LYS . 2.5 m -61.06 -50.54 72.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.902 -1.045 . . . . 0.0 111.679 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' HB2' ' HB1' ' A' ' 51' ' ' ALA . 18.5 p30 -64.46 -34.77 78.97 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.988 0.423 . . . . 0.0 110.507 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 36' ' ' GLU . 19.6 ttpt -63.41 -48.89 75.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.517 174.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' HB2' ' HE3' ' A' ' 33' ' ' LYS . 25.9 ttmt -69.67 -13.3 62.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.566 -173.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 30' ' ' THR . 96.7 mt -81.92 -49.9 9.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.941 0.4 . . . . 0.0 110.425 173.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.526 HG11 ' HA ' ' A' ' 47' ' ' ARG . 43.4 t -74.98 -28.39 21.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.212 -176.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 32' ' ' LYS . 4.4 tp10 -76.08 7.03 4.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -175.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 33' ' ' LYS . 12.4 pt-20 -155.98 -43.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.646 -0.421 . . . . 0.0 112.105 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -84.68 -85.45 0.14 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 35' ' ' VAL . 11.9 t 54.65 -159.36 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.752 0.787 . . . . 0.0 112.094 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 37.2 m -153.65 -44.67 0.09 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.673 HG22 HG23 ' A' ' 43' ' ' THR . 7.5 p -161.61 108.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.707 171.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 14.6 m -80.07 -28.17 39.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.813 -172.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.673 HG23 HG22 ' A' ' 41' ' ' VAL . 65.9 p 48.53 -131.84 1.61 Allowed 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.65 0.594 . . . . 0.0 111.311 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -103.39 -64.95 1.04 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.892 0.377 . . . . 0.0 111.361 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 11.7 m80 -107.35 -9.06 16.13 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -173.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.7 tp -64.09 -34.85 78.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HA ' HG11 ' A' ' 35' ' ' VAL . 14.6 ttm105 -47.17 -52.45 15.61 Favored 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.808 0.693 . . . . 0.0 110.992 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -78.36 -30.38 47.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.664 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.2 mptp? -74.1 -51.1 16.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.854 0.359 . . . . 0.0 110.209 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.566 ' O ' HG13 ' A' ' 54' ' ' ILE . 10.6 tt -66.37 -34.05 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.447 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 31' ' ' ASN . . . -65.26 -40.32 93.8 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.039 0.447 . . . . 0.0 110.641 177.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.39 -41.18 99.47 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.391 -0.683 . . . . 0.0 111.391 175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.419 ' CE2' HD11 ' A' ' 57' ' ' ILE . 61.4 t80 -63.38 -44.28 95.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.607 -0.297 . . . . 0.0 110.631 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 50' ' ' ILE . 91.4 mt -54.62 -57.84 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.753 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -56.24 -40.7 74.56 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.132 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -59.1 -39.54 82.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.058 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.419 HD11 ' CE2' ' A' ' 53' ' ' TYR . 70.7 mt -68.11 -42.33 84.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 120.976 0.417 . . . . 0.0 110.436 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.477 HG21 ' H ' ' A' ' 26' ' ' ASP . 49.4 mm -65.09 -45.74 93.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.868 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.5 m -58.72 -37.41 76.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.754 0.311 . . . . 0.0 110.688 177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.99 -36.0 81.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.079 0.466 . . . . 0.0 110.777 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.471 HE21 ' HB3' ' A' ' 61' ' ' GLN . 0.8 OUTLIER -75.41 -24.79 57.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.527 179.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.929 -176.044 . . . . . . . . 0 0 . 1 stop_ save_